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Synopsis 
 
Pocket/sulcular epithelium is the first line of defence to plaque bacteria and its 
potential role in periodontitis is investigated. This thesis describes the 
development of a model system, utilising an immortal epithelial cell line (H400) in 
order to investigate responses to periodontal pathogen stimulation (P. gingivalis 
and F. nucleatum) in terms of NF-κB activation, differential gene expression and 
cytokine production. The pathogenesis of periodontitis suggests that susceptible 
patients exhibit a hyper-inflammatory response to plaque bacteria, so an attempt 
to modulate the pro-inflammatory epithelial response using a natural di-thiol 
antioxidant α-lipoate was also investigated. 
 
Data demonstrated that periodontal pathogens P. gingivalis and F. nucleatum 
elicited a pro-inflammatory response in the H400 model system. This was 
confirmed by demonstrating NF-κB activation, gene expression changes and 
downstream cytokine production. Ontological grouping of gene expression 
changes revealed a range of gene functions which support the hypothesis that 
the epithelium may play a role in the initiation and propagation of the periodontal 
lesion. In addition, α-lipoate was able to modulate this inflammatory response but 
not completely block this essential defence mechanism. Data obtained indicates 
the potential of utilising α-lipoate as an adjunct in the management of 
periodontitis. 
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1.1 Introduction 
Periodontitis is a chronic inflammatory disease that affects the supporting 
structures of the dentition which consists of the alveolar bone, root cementum, 
periodontal ligament and the investing gingivae (Aisenberg, 1952). A number of 
forms of periodontitis have been identified the most prevalent being Chronic 
Periodontitis (CP), which undergoes a chronic course in susceptible individuals 
with increasing loss of tooth support resulting in tooth mobility and ultimately tooth 
loss if not appropriately managed (Page and Schroeder, 1976). Whilst the primary 
aetiological agent is the subgingival microbial biofilm the majority of tissue damage 
has been shown to be due to an aberrant (exaggerated) response of the host to 
these bacteria causing collateral tissue damage (Matthews et al., 2007a).  
 
A key interface between plaque bacteria in the subgingival biofilm and the host‟s 
periodontal connective tissues is the epithelial lining of the gingival sulcus; the so 
called “crevicular” and “junctional” epithelia. Epithelia act as a barrier between the 
external environment and the internalised tissues of the host. Historically, surface 
epithelium was thought to exist solely as an inert barrier which in certain situations 
can be lubricated by antimicrobial fluids (saliva or gingival crevicular fluid (GCF) in 
the oral cavity), however recent research has suggested that rather than simply 
forming an inert barrier, epithelial tissues may have the potential to play a key role 
in initiating and propagating the host‟s inflammatory response.  
 
Therefore, this thesis aims to investigate the ability of the gingival epithelium to 
respond to periodontal bacteria by production of inflammatory mediators using a 
model system. In addition, potential methods of modulating an “overactive” 
inflammatory response are investigated, which may offer potential benefits in 
managing patients with periodontitis and who exhibit such exaggerated 
inflammatory responses to plaque bacteria. 
 
It is important to set periodontal diseases in context, and the first part of this 
introduction aims to provide a background to periodontitis and our current 
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understanding of its aetiology, prior to focusing specifically on the role of the oral 
epithelium in the disease process.  
 
1.2 Inflammatory Periodontal Disease 
 
1.2.1 Epidemiology 
Inflammatory Periodontal diseases are amongst the most prevalent chronic 
diseases of man (Papapanou et al., 1991) and have a major impact on the health 
of the population not only in terms of oral health, but also in terms of their impact 
on systemic disease (e.g. diabetes) (Seymour et al., 2007). Tooth loss due to 
advanced periodontitis can impact on a patient‟s quality of life, but also on their 
diet, resulting in reduced intake of key micronutrients essential for a wide range of 
biological processes. Information on the changes in prevalence of periodontitis in 
the population is therefore key to providing adequate healthcare resources to 
manage the disease within the community, with the aim of improving the health of 
the population. Limited data on the prevalence of periodontal disease in the United 
Kingdom is available from the UK Adult Dental Health Survey 1998 (Morris et al., 
2001). In summary, this study showed that across all age groups 54% of the UK 
population had significant pocketing and 43% significant attachment loss. In the 
over 65yr old age group these levels were increased with 67% having significant 
pocketing and 85% significant attachment loss. (Figure 1.1 & 1.2). Therefore older 
age groups have a higher prevalence of periodontitis and also have higher 
prevalence of systemic diseases, so the potential impact of toothloss and 
subsequent reductions in micronutrient intake have the greatest impact on this age 
group. 
 
One of the limitations of the 1998 UK Adult Dental Health Survey is the “case 
definition” used. Utilisation of a “single site” with attachment loss is overly sensitive 
and likely to include cases of incidental attachment loss, leading to a high number 
of false positives. Equally more stringent case definitions would improve 
“specificity” of diagnosis but may miss early disease. This issue was debated at 
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the 5th European Workshop in 2005 when a consensus view was agreed that dual 
case definitions should be explained in such large scale epidemiological studies 
one of high and one of lower sensitivity (Tonetti and Claffey, 2005).  
 
Nevertheless the 1998 survey shows that a significant proportion of the UK 
population exhibit periodontal tissue destruction i.e. periodontitis, which will not 
only impact on the oral health and therefore quality of life of our society, but also 
has a major impact on our healthcare system. It has been estimated that treating 
periodontal diseases costs the National Health Service £0.5 billion per year, and 
this fails to take into account the costs within the private healthcare sector a 
growing part of dental health delivery in the UK. These figures are really the „tip of 
the iceberg‟ as they fail to show the potential systemic consequences of 
periodontal diseases and the increasing demands from an ageing population who 
now wish to retain their teeth, which will further add to the healthcare burden.  
 
Recent studies have shown potential relationships between periodontal disease 
and increased risk of atherogenic microvascular diseases and bacterial 
pneumonia, highlighting the importance of periodontal health in maintaining whole 
body well being (Fowler et al., 2001). 
 
1.2.2 Classification 
Classification systems are employed for the majority of diseases in order for 
clinicians to design suitable treatment regimes, and periodontal disease is no 
exception. Classification of periodontal diseases helps with the development of 
frameworks for study of aetiology and pathogenesis, as well as allowing the 
international community a way of communicating in a common language. The ideal 
systems employ use of aetiological agent to classify the disease; an example of 
this would be Tuberculosis which is classified on the basis of the causative 
organism M. tuberculosis. However, periodontal diseases cannot be classified in 
this manner due to their complex aetiology which is polymicrobial, polyimmune-
inflammatory & polygenetic in nature. Periodontitis is an outcome of complex 
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interactions between microbial complexes and the hosts inflammatory / immune 
response; the latter being governed by our genome as well as the environment we 
live in. 
 
The first classification scheme for periodontal disease was described by Joseph 
Fox in 1806, since this time a number of classifications for periodontal diseases 
have been developed as our understanding of the disease has grown. The most 
recent classification was proposed by „The International Workshop for the 
Classification of Periodontal Diseases 1999‟ and this used the current evidence 
base to develop a system that best fitted our current understanding of disease 
pathogenesis, and in so doing  addressed a number of issues that were lacking in 
previous classifications (Armitage, 1999). 
 
The new classification is relatively complex but in summary contains a 
classification for gingivitis (which was divided into plaque induced and non-plaque 
induced, Table 1.1) and a section covering periodontitis (which was again further 
subdivided, Table 1.2).  
 
The vast majority of periodontitis seen in the population fits into the category of 
chronic periodontitis (CP).  Whilst CP may start in adolescence (Clerehugh et al., 
1990) (Clerehugh et al., 1995) the majority of disease tends to present in older 
patients (usually over the age of 35yrs), with the amount of periodontal tissue 
destruction being consistent with local risk factors; for example subgingival 
calculus which is often a feature. The rate of disease progression tends to be slow, 
and smoking and stress can impact on the disease, with smoking being a key risk 
factor for this type of periodontitis (Palmer et al., 2005). 
 
The other major category of periodontitis is „Aggressive periodontitis,‟ this is most 
commonly seen in younger age groups (less than 30 yrs), and is characterised by 
a rapid or episodic nature of disease progression. There is often a strong family 
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history of periodontal disease which suggests an underlying genetic background in 
this type of periodontitis (Tonetti and Claffey, 2005). 
 
Due to the complex aetiology of periodontal diseases and with increasing 
knowledge of the disease process we can expect this classification to change 
further. 
 
1.2.3 Anatomy of the periodontal tissues 
The periodontal tissues support the teeth within the jaw, allowing the teeth to 
withstand the forces associated with mastication. Loss of, or disease to the 
periodontal tissues with periodontal inflammation, can lead to teeth becoming 
mobile and in advanced cases the teeth are lost. 
 
The periodontal tissues comprise: the gingivae, periodontal ligament, root 
cementum and alveolar bone. In health the alveolar crest bone lies approximately 
1.3mm apical to the cemento-enamel junction (CEJ) with the apical extent of the 
epithelial attachment close to the CEJ (Figure 1.3). In periodontitis, apical 
migration of the epithelial attachment results in pocket formation and along with 
alveolar bone loss are key clinical features used in disease diagnosis. 
 
The gingivae are part of the oral mucosa and protect the underlying periodontal 
apparatus from the oral environment. The gingival tissues can respond to changes 
in the oral environment and offer a number of defence mechanisms regarded as 
“mucosal immunity” to protect the host. Examples of mucosal immunity include:- 
 Increasing salivary flow (as well as the contents of saliva for example 
production of IgA and enzymes such as lysozyme). 
 Increased rate of cell turnover leading to desquamation of the surface layer of 
epithelium, and activation of immune mechanisms.  
 Expression of adhesion molecules on vascular endothelium which allows 
migration of inflammatory cells 
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 Gingival crevicular fluid (GCF) which is a transudate in health, but an 
inflammatory exudate in disease washing the gingival crevice, and contains 
immunoglobulins (IgG), complement, and polymorphonuclear cells  
 
The gingivae form a unique junction with the tooth (Orban, 1952), the 
dentinogingival junction. This epithelial attachment to tooth enamel represents a 
classic epithelial barrier, protecting the connective tissues from the external 
environment.  
The dentogingival junction can be subdivided into 3 zones (Figure 1.3)  
 
 The gingival epithelium running from the mucogingival junction to the gingival 
margin. 
 The crevicular epithelium which runs from the gingival margin and lines the 
gingival crevice (this also forms the pocket epithelium when periodontal 
disease is present)  
 The junctional epithelium which is found at the base of the crevice. The apical 
extent of junctional epithelium lies against the cementoenamel junction in 
health but migrates apically in the presence of periodontitis. 
 
In the presence of periodontal inflammation or trauma the junctional epithelium 
migrates apically onto the root surface, potentially exposing connective tissue to 
the oral environment which includes the plaque biofilm, thus creating a vulnerable 
physiological situation. Production of GCF, which carries components of the innate 
immune system, attempts to protect the host from the biofilm and oral 
environment. Microscopic examination of the gingivae shows connective tissue 
covered with a stratified squamous epithelium. The outer exposed epithelium of 
the gingivae is normally parakeratinized in man, while the inner or crevicular 
epithelium is much thinner and non keratinized. As with all epithelial surfaces one 
of the key functions is to act as a barrier to protect the underlying connective 
tissues from the external environment. The gingivae have a rich supply of blood 
allowing rapid mobilisation of inflammatory cells to the area of bacterial challenge. 
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In periodontitis, the junctional epithelium migrates apically forming a periodontal 
pocket lined with epithelium. This pocket epithelium is a barrier epithelium and not 
semi-permeable like junctional epithelium, i.e. a change in epithelial phenotype 
occurs. Alongside this process periodontal ligament and alveolar bone tissues are 
lost (Figure 1.4). 
 
1.2.4 Natural history of Periodontitis 
The natural history of any disease describes the course of the disease over time in 
the absence of therapeutic intervention. Over the years a number of theories 
describing periodontitis disease progression have been proposed.  
 
1.2.4.1 Evidence from population studies 
There are few studies that have looked at the rate of progression of periodontal 
disease in a population that have not been exposed to any therapeutic or 
preventive intervention. One classic landmark study (Loe et al., 1986) was in Sri 
Lanka which examined 480 male tea workers. This study looked at plaque, 
calculus, gingivitis and attachment loss in the dentition. These subjects were 
initially screened in 1970 and then five further examinations were carried out up to 
1985 when 161 subjects were left from the initial cohort. During this period the 
subjects received no treatment and did not perform any conventional oral hygiene. 
In terms of attachment loss and tooth loss the subjects were subdivided into 3 
groups:- 
 Rapid periodontal disease progression (8% of subjects) 
 Moderate periodontal disease progression (81% of subjects) 
 No periodontal disease progression (11% of subjects) 
As would be expected due to the lack of oral hygiene measures and subsequent 
levels of plaque the overall prevalence of periodontal disease were higher. 
However the data demonstrated different levels of periodontal disease 
susceptibility, with the percentage of subjects in each group closely following data 
from other population studies. 
 9 
1.2.4.2 Evidence from observational cohort studies 
Initially it was thought that disease progression followed a linear course, with 
attachment loss progressing with time (Loe et al., 1978).  However in the early 
1980‟s a series of studies from a group in Boston, USA (Goodson et al., 1982) 
(Haffajee et al., 1983) (Socransky et al., 1984) suggested that the disease followed 
an irregular pattern of attachment loss and disease activity and this was termed 
„the random burst hypothesis‟ (Socransky et al., 1984). The differences seen in 
these studies are largely related to the thresholds set for periodontal pocket 
probing measurements. Further studies during the 1990‟s (Jeffcoat and Reddy, 
1991) have added to the body of evidence with current understanding suggesting 
that untreated periodontal disease follows a pattern with bursts of disease activity 
and periods of quiescence, whereas patients who have been treated following a 
more predictable linear pattern (Claffey et al., 1996). 
 
Clinically, a number of features characterise periodontitis and these include 
inflammation of the gingival tissues, pocketing of 4mm or more (the base of the 
pocket will have migrated apically), gingival recession, drifting of teeth, and 
exposure of furcations (Figure 1.5). In addition radiographic examination will show 
loss of bone supporting the teeth. (Figure 1.6) 
 
1.3 The role of the plaque biofilm 
Plaque is a complex biofilm that develops on the surface of teeth and oral soft 
tissues; it consists of a diverse range of bacteria with some 700 species currently 
identified within the oral environment (Aas et al., 2005), over half of which cannot 
be cultivated by conventional means and require identification using molecular 
biology based techniques (ten Cate, 2006). The organisms in this complex 
microbial community interact with each other both in a synergistic as well as a 
competitive manner. In addition to the microbial component the biofilm is a matrix 
of polymers formed by bacteria as well as components derived from saliva. 
 
 10 
Research into the aetiological role of dental plaque initially consisted of a series of 
clinical studies in the 1960‟s, which showed that accumulation of dental plaque led 
to local inflammation of the gingival tissues, and subsequent removal resulted in 
resolution of this inflammation (Loe et al., 1965). It subsequently became widely 
accepted that the bacterial load directly impacts on the severity of gingivitis. 
However the link between plaque and periodontitis is more contentious, as patients 
with high plaque levels do not necessarily develop periodontitis and systemically 
healthy patients with good plaque control can develop the disease. This may 
suggest that specific bacterial species are important in the aetiology of 
periodontitis, a hypothesis known as The Specific Plaque Hypothesis (Loesche, 
1976), but to date no one bacterial species has been explicitly implicated as a 
direct causative pathogen in periodontal disease. A further proposal was made in 
the 1980‟s suggesting that it was combinations of bacteria present in a mature 
plaque biofilm, rather than a single species that were important in disease 
progression, this was termed „The Non-specific Plaque hypothesis‟ (Theilade, 
1986). In the early 90‟s, as understanding of periodontal disease increased, the 
Environmental Plaque Hypothesis (Marsh, 1991) (Marsh, 1994)  was proposed 
which suggested that the whole sub gingival environment was responsible for 
disease initiation and progression. Current evidence would support this hypothesis 
especially with the most common form, chronic periodontitis. Thus the periodontal 
microflora changes between health and disease; in health it is predominately Gram 
positive, aerobic and non-motile, whereas in disease the flora shifts to become 
Gram negative, anaerobic and motile (Socransky, 1970). 
 
Socransky and co-workers investigated the periodontal bacterial flora in health and 
disease in a classic series of studies (Socransky, 1970), they used plaque samples 
from multiple patients and showed that certain bacterial species cluster together to 
produce discrete micro-environments. These studies utilised a DNA-DNA 
hybridisation checkerboard against 43 periodontal bacteria and allowed bacteria to 
be assigned into „coloured complexes‟ (Figure 1.7) which differed in their 
association with periodontitis (the red complex being strongly associated with 
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chronic periodontitis). Therefore certain bacteria assigned to the red complex 
seem to be strongly implicated in the aetiology and progression of periodontitis. 
However it is now thought that how the host responds to these periodontal 
pathogens appears to be key to whether, and to what degree, periodontitis 
develops (Page and Kornman, 1997). 
 
1.4 The role of the host 
Current evidence indicates that periodontitis is initiated in predisposed individuals 
by the subgingival plaque biofilm, and that tissue destruction appears to be largely 
mediated by an aberrant host response to specific bacteria and their products 
(Fredriksson et al., 2003). This aberrant response is characterized by exaggerated 
inflammation, involving the release of excess proteolytic enzymes (Figueredo et 
al., 2005) and reactive oxygen species (ROS) by inflammatory cells (Matthews et 
al., 2007b). Neutrophils are recruited to the periodontal tissues in response to 
cytokines release (Tonetti et al., 1998), and following stimulation by the plaque 
biofilm, release reactive oxygen species (ROS), proteolytic enzymes and 
antimicrobial peptides as part of the normal host defence (Matthews et al., 2007b), 
with the aim of killing the colonizing bacteria. The mechanism by which neutrophils 
are recruited to the periodontal tissues forms the basis of this thesis, and proposes 
the epithelium as the key tissue involved (Figure 1.8 suggests a possible 
mechanism for this recruitment).  
The local release of ROS is balanced by local antioxidant (AO) defense 
mechanisms, such that in health a balance exists between ROS and AO.  
 
If this balance is disturbed either by excess ROS production and / or reduced 
levels of extra cellular AO then oxidative stress arises and disease may result 
(Halliwell et al., 1992). Changes in oxidative stress can lead to either direct 
damage to the periodontal tissues (large changes in oxidative stress) or by 
activation of pro-inflammatory genes via activation of REDOX regulated gene 
transcription factors resulting in further inflammatory cell recruitment (smaller 
changes in oxidative stress) (Chapple and Matthews, 2007). (Figure 1.9) 
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 This tissue damage is caused by:- 
 Oxidation of low molecular weight molecules 
 Protein oxidation 
 Lipid peroxidation 
 DNA strand breaks and base hydroxylation  
(Chapple and Matthews, 2007) 
 
A growing body of evidence implicates oxidative stress in the pathobiology of 
chronic periodontitis (Battino et al., 1999, Canakci et al., 2005, Chapple and 
Matthews, 2007). Several studies have demonstrated increased levels of 
biomarkers indicative of ROS induced tissue damage in periodontitis patients when 
compared to controls (Sugano et al., 2000) (Takane et al., 2002) (Panjamurthy et 
al., 2005). Antioxidant enzymes appear up regulated in inflamed periodontal 
tissues and in gingival crevicular fluid indicating a response to oxidative stress. 
(Ellis et al., 1998). Furthermore, extracellular antioxidant scavengers in plasma are 
depleted both individually (Chapple et al., 2007b) as well as in terms of total 
antioxidant activity (TAOC). Local levels within GCF are also compromised in 
periodontitis patients compared to controls (Brock et al., 2004) (Chapple et al., 
2007a).  
Tissue damage arises directly from oxidative stress and also indirectly via 
activation of redox-sensitive gene transcription factors like nuclear factor k-B (NF-
κB) and Activator protein-1 (AP-1) (Lyakhovich et al., 2006, Schoonbroodt and 
Piette, 2000), which in turn leads to downstream proinflammatory 
cytokine/chemokine production (Sandros et al., 2000). The resultant periodontal 
inflammation creates a low grade inflammatory response detectable within the 
peripheral vasculature (Loos et al., 2000) (D'Aiuto et al., 2005). Interest has 
therefore re-emerged in the relationship between antioxidant micronutrients and 
periodontitis. Studies from the 1970s and 1980s reported conflicting results 
regarding associations between several individual micronutrients and prevalence 
of periodontitis (Slade et al., 1976). However, many utilized dietary questionnaires 
rather than serum biochemistry (Ismail et al., 1983) or intervention studies focused 
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on chronic gingivitis rather than periodontitis patients (Jacob et al., 1987) (Leggott 
et al., 1991). The limitations of questionnaire-based approaches to determining 
antioxidant intake are now recognized (Nishida et al., 2000). Food frequency 
questionnaires deliver weak associations with serum biochemistry in non-
supplement users and only moderate correlations in supplement users (Knutsen et 
al., 2001). Serum biochemistry is a more robust method of analyzing antioxidant 
status and a recent analysis of 11,480 patients from the 3rd National Health and 
Nutrition Examination Survey (NHANES III) demonstrated that increased serum 
antioxidant concentrations are associated with reduced relative risk of periodontitis 
even in never smokers. (Chapple et al., 2007b) 
 
1.5 Risk factors for Periodontitis 
Risk factors are defined as factors that increase the probability of an individual 
developing a disease and do not imply cause and effect directly. A number of risk 
factors have been described for periodontitis which increase the likelihood that an 
individual may experience disease (Burt, 2005). They can be categorised as local 
or systemic risk factors. Local risk factors increase levels of plaque adjacent to the 
periodontium and therefore can initiate and propagate a local inflammatory 
response. Systemic risk factors on the other hand, act to modify the host response 
to the plaque adjacent to the periodontium, i.e. they may modulate the 
inflammatory response to the colonising bacteria. Examples of local risk factors 
include iatrogenic plaque retentive factors such as deficient restorations (poorly 
contoured or overhanging / deficient margins), or poorly designed dentures; 
anatomical factors such as root grooves and local overcrowding. (Figure 1.10) 
Systemic risk factors include smoking and poorly controlled diabetes. 
 
1.6 Managing periodontal disease 
Due to our limited understanding of the immune-inflammatory characteristics of 
periodontitis patients the management of periodontal disease has in general 
changed very little over the last 50 years. The key to treating periodontitis involves 
methods largely aimed at reducing the bacterial load adjacent to the periodontal 
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tissues with the secondary aim of reducing the local inflammatory response. 
Reduction of plaque can be achieved by instructing patients in methods of plaque 
removal, as well as professional removal of plaque retentive factors to help 
patients maintain the reductions in plaque levels. Subgingival calculus an 
important plaque retentive factor and a frequent finding in patients with chronic 
periodontitis, requires removal using specialist instruments; such treatment allows 
removal of the surface layer of endotoxin contaminated cementum, resulting in a 
root surface which will facilitate healing of the periodontal tissues. Alongside this 
so called “cause related therapeutic approach” other risk factors should be 
modified to improve the outcome of treatment. (e.g. smoking cessation).  
To date, little attention has been paid to modification of the hyper-inflammatory 
response, which is widely recognised as being damaging in periodontitis. So there 
is potential that future management strategies could involve modification of the 
host response (alongside conventional therapy aimed at reducing plaque levels). 
One example of such a strategy would be damping down the inflammatory 
response by  blocking activation of NF-κB, a key REDOX sensitive pro-
inflammatory transcription factor involved in the inflammatory response (Chapple, 
1997) (Van Dyke and Serhan, 2003). 
 
1.7 The role of sulcular / pocket epithelium 
Gingival epithelium is a stratified squamous epithelium and can be divided into 
oral, sulcular and junctional epithelium. The sulcular and junctional epithelium are 
non-keratinised unlike the oral epithelium, and are in close contact with bacteria 
present within the gingival sulcus. This area and its interaction with plaque bacteria 
is thought to play a key role in the initiation and propagation of the inflammatory 
response and therefore periodontal inflammation. In periodontitis the sulcar and 
junctional epithelium which are semi-permeable, converts to pocket lining 
epithelium which is less permeable and possesses rete ridges. Bacteria present in 
plaque may invade the epithelium, (either by invasion of epithelial cells or by 
passing between cells) and this is believed to be an important process by which 
pathogenic bacteria can both avoid the host immune system and inflict local tissue 
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damage (Han et al., 2000) (Eick et al., 2006). The ability of bacteria to adhere to 
host cells is important in cell stimulation. Studies in vivo have demonstrated a 
correlation between the number of bacteria attached to the periodontal epithelium 
and the magnitude of the inflammatory response (Vaahtoniemi et al., 1993). P. 
gingivalis has been shown to attach to a range primary epithelial cell lines, as well 
as to primary gingival epithelial cells. (Isogai et al., 1988) (Weinberg et al., 1997) 
(Yilmaz et al., 2002),  (Duncan et al., 1993) 
A variety of mechanisms exist to allow bacterial adhesion to epithelial cells, these 
virulence factors include fimbriae, proteases, hemagglutinins, and 
lipopolysaccharides (LPS) (Lamont and Jenkinson, 1998). Adhesion and invasion 
of periodontal pathogens is thought to be crucial in the pathogenesis of 
periodontitis especially in the initial stages, however some studies have suggested 
that adhesion is more important than invasion in terms of activation of a pro-
inflammatory response by epithelial cells (Eaves-Pyles et al., 1999). 
 
As alluded to previously, the role of stratified squamous epithelium was 
traditionally thought to be purely as a physical barrier to microbial ingress into 
connective tissues, thus protecting the host from the external environment. 
However in recent years it has been shown that epithelial cells play an active role 
in the host response to bacterial infections (Dale, 2002). The epithelium responds 
to bacterial challenge by helping to initiate the innate immune response. This 
thesis will focus on the actions of the sulcar/pocket epithelium when challenged 
with periodontal pathogens in terms of NF-κB activation, downstream changes in 
gene expression and subsequent pro-inflammatory cytokine production. 
 
1.8 Pro-inflammatory Gene Transcription Factors 
Inflammation is a normal physiological response to host injury or infection; it aims 
to isolate the area of injury or infection as well as mobilising effector cells to 
stimulate/focus the activity of an immune response leading to 
elimination/destruction of antigen. An important part of the inflammatory response 
involves activation of transcription factors, which are intracellular molecules, 
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usually proteins, which triggers the initiation, stimulation or termination of gene 
transcriptional events (Adler et al., 1999). Activation of pro-inflammatory 
transcription factors occur on cell stimulation (e.g. bacteria, oxidative stress etc). 
Two of the main pro-inflammatory transcription factors are described below:- 
 
(a) Activating protein 1 (AP-1) a group of functionally and structurally similar 
proteins that play a crucial role in a variety of cellular events including 
inflammation. Activation of AP-1 is achieved via a wide range of physiological & 
pathological stimuli  (Hess et al., 2004). 
 
(b) Nuclear factor kappa B (NF-kB) a family of nuclear transcription factors that 
play an active role in almost every aspect of cell regulation including stress 
responses, apoptosis, differentiation and immune cell activation (Makarov, 2000). 
Current scientific evidence points to the fact that NF-kB is the most important pro-
inflammatory gene transcription factor due to its wide ranging actions (Silverman 
and Maniatis, 2001). An example of such an effect would be production of pro-
inflammatory cytokines which play a key role in orchestrating the inflammatory 
response. This thesis will therefore focus of NF-kB activation and as a marker of 
cell activation. 
 
AP-1 and NF-kB are also examples of REDOX sensitive transcription factors i.e. 
changes in cellular oxidative stress can lead to their activation. Such changes can 
be induced by a number of factors including bacterial stimulation (Figure 1.11). 
Alongside these pro-inflammatory pathways other REDOX sensitive transcription 
factors exists for example nuclear factor erythroid-2 related factor 2, Nrf2, which 
are similarly regulated by changes in REDOX status but have opposite effects in 
that they positively regulate the expression of genes encoding antioxidants, and 
detoxification enzymes, providing protection against oxidative stress. Inactivation 
of Nrf2 in a mouse model caused increased oxidative stress, with  the balance 
between oxidative stress and pro-inflammatory gene activation is modulated by 
Nrf2. (Figure 1.12) (Rangasamy et al., 2004) 
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Activation of pro-inflammatory transcription factors triggers gene transcriptional 
events leading for production of a range of proteins including several pro-
inflammatory cytokines (e.g IL-8, TNF-α, IL-1). Alongside this activation a number 
of regulatory pathways are activated in order to maintain appropriate levels of 
inflammation relative to the challenge the host is experiencing. The inflammatory 
response may be acute or chronic in nature, with the chronic response lasting for 
weeks or months and potentially causing significant collateral tissue damage. 
Inflammation resulting from chronic exposure to bacteria or their products is central 
to the pathogenesis of chronic periodontitis.  
 
1.9 NF-κB  
NF-κB plays a key role in initiating and regulating the inflammatory response and 
can be activated by an extensive range of stimuli (Barnes and Karin, 1997). 
Studies have implicated dysregulation of NF-kB in a wide range of disease 
processes Table 1.3). Activation of NF-κB can occur via a range of pathways, in 
terms of bacterial stimulation this is by stimulation of Toll like receptors (TLR) 
which are expressed by host cells (Zhang and Ghosh, 2001) (Banerjee and 
Gerondakis, 2007). Studies have shown that TLR‟s play a crucial role in the 
recognition of bacterial pathogens. To date, in the region of 13 TLR‟s have been 
described, each having a specific receptor profile. NF-kB can also be activated by 
a whole range of factors, for example oxidative stress. Different pathways of 
activation can lead to different gene expression changes and thus different down 
stream peptide synthesis.   
 
 NF-κB is the collective name for a group of Rel proteins which act as transcription 
factors, 5 members of the Rel family are currently known, specifically Rel A (p65), 
Rel B, c-Rel, NF-κB1 (p50) and NF-κB2 (p52). If these proteins are found as homo 
or hetro-dimers they are termed NF-κB. The classic dimer is a p65/p50 
combination. In most resting “un-stimulated” cells NF-κB resides in the cell 
cytoplasm in an inactive form bound to its inhibitor IκB. IκB is a family of inhibitor 
proteins that include p100, p102, Bcl-3, IκBε, IκBγ, IκBβ, IκBα (Barnes, 1997, Chen 
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and Ghosh, 1999). Binding of NF-κB to IκB prevents activation of NF-κB by 
masking a region called the nuclear localization signal. This region, if exposed, 
allows NF-κB to cross the nuclear membrane and to bind to DNA and activate 
genes downstream of the binding sites. 
 
Activation of NF-κB initially requires activation of IκB kinase (IκK), present in the 
cell cytoplasm, which causes phosphorylation of IκB, marking IκB out for 
ubiquitination. Ubiquitination is a process by which ubiquitin, a small molecule, is 
attached to the target protein and acts as a tag which signals the protein-transport 
machinery to transport the ubiquinated protein to the proteasome where it is 
broken down. On breakdown of IκB,  the resulting free NF-κB can translocate to 
the cell nucleus, bind to the nuclear DNA via its κB binding site and cause changes 
in gene expression (Barnes, 1997, May and Ghosh, 1997) (Figure 1.13). The 
regulation of NF-κB is achieved via a number of auto-regulatory mechanisms 
which limit the duration and intensity of NF-κB activation. One such mechanism is 
the production of IκB on NF-κB activation (Hayden and Ghosh, 2004). The freshly 
synthesised IκB enters the cell nucleus and acts to remove NF-κB from the DNA 
and transport it out of the nucleus back into the cytoplasm in its inactive form 
bound to IκB. Another mechanism of NF-κB regulation is via IκB kinase , where the 
active IκK enzyme auto phosphorylates in order to limit its own activity and hence 
limit the duration of NF-κB activation (Hayden and Ghosh, 2004) (Figure 1.14). 
These mechanisms are in place to ensure that NF-κB activation is only transient 
on cell stimulation. However, reactive oxygen species can inhibit this regulatory 
feedback pathway leading to further activation of NF-κB. (Figure 1.14) 
 
As previously discussed, NF-κB can be activated by a wide variety of stimuli which 
will include oxidative stress, bacterial/viral proteins and their by-products, cytokines 
as well as a range of physical stimuli (e.g. temperature changes, radiation, pH 
changes etc) (Hayden and Ghosh, 2004). Activation of NF-κB is rapid, taking only 
a few minutes and results in transcriptional changes with downstream production 
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of a whole range of cytokines, chemokines, growth factors and adhesion 
molecules (Perkins, 2007). 
NF-κB activation occurs in the majority of cells including those which take part in 
the innate or acquired immune response (e.g. neutrophils, macrophages, 
lymphocytes, endothelium, epithelium and mesenchymal cells) being part of the 
normal inflammatory response. However, if NF-κB is activated in an abnormal or 
excessive manner the inflammatory response may be perpetuated and this has 
been implicated in chronic inflammatory diseases. Research has thus implicated 
NF-κB in terms of initiation and propagation of chronic inflammation (Table 1.3). So 
some way of dampening down NF-κB activation in cells where its activation is 
disproportionate may have utility in managing chronic inflammatory diseases in 
general and in terms of this thesis periodontal disease in particular. As the 
pathway to activation of NF-κB, downstream changes to gene expression and 
subsequent protein production are extremely complex, involving a number of 
interactions with other molecules, a wide range of opportunities arise to block or 
down regulate the NF-κB pathway. As research into the actions of NF-κB 
continues to gather pace the number of identified exogenous inhibitors of NF-κB 
have grown over recent years, from 125 in 1999 to around 785, with this number 
set to rise further in the coming years. These inhibitors encompass natural 
products, chemicals, metabolites, synthetic compounds, peptides and proteins 
(Figure 1.15). 
 
Despite the suggestion 13 years ago that NF-κB modulation may be a key 
therapeutic strategy in managing periodontal inflammation (Chapple, 1997) there 
are few papers reporting NF-κB activation in patients with periodontitis. To date 
only one study has examined gingival tissue samples collected from patients with 
CP and compared them to healthy controls. This paper had a number of 
drawbacks but suggested increased levels of NF-κB activation in the gingival 
epithelium of diseased sites when compared to the healthy controls (Ambili et al., 
2005) 
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1.9.1 Inhibitors of NF-κB activation 
These inhibitors can be categorised in a variety of ways, one of which is by site of 
action in the NF-κB pathway. By using this method the inhibitors can be divided 
into a number of distinct groups:- 
 
1.9.1.1 Upstream of IκB kinase (IkK) 
The IkK complex is the point at which a number of activation pathways for NF-κB 
merge, so blocking pathways prior to activation of IκK gives potential to inhibit 
downstream NF-κB activation, examples of this would be blocking the TNF NF-κB 
activation pathway by using TNF antibodies or blocking the TNF receptor, as well 
as blocking other compounds in this pathway prior to IkK activation (Blackwell et 
al., 1996). 
 
1.9.1.2 Directly on the IκB kinase complex 
This complex plays a central role in the NF-κB pathway and it therefore offers an 
important target for blockage. A whole range of kinase inhibitors have been 
developed to block IKK activity (e.g β-Carbolines, (Castro et al., 2003)) and these 
have been shown to have therapeutic potential (May et al., 2000). 
 
1.9.1.3 IκB phosphorylation  
IκB when bound to NF-κB causes inactivation of NF-κB, thus mechanisms that 
promote synthesis or prevent breakdown of IκB would help to prevent activation of 
NF-κB. A range of compounds that achieve this have been cited (e.g. Doxazosin). 
Up regulating IκB has been achieved by various peptides e.g β-amyloid peptide 
(Bales et al., 1998). 
 
1.9.1.4 Ubiquitination or proteasomal degradation of IκB  
Inhibitors of either the ubiquitination of IκB by SCF-β-TrCP ubiquitin ligase complex 
or subsequent proteosomal degradation of ubiquitinated (e.g. Ro106-9920) IκB 
results in suppression of NF-κB activation by stabilising IκB (Swinney et al., 2002). 
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1.9.2 Nuclear translocation of NF-κB 
This is another potential target for inhibiting the actions of NF-κB, even if NF-κB 
becomes active in the cell cytoplasm, in order to be effective it needs to enter the 
nucleus. One possible mechanism to block nuclear translocation is by saturating 
the nuclear import mechanism which transports NF-κB into the nucleus. A range of 
peptides have been reported to have this ability, an example being SN-50 (an 
inhibitory peptide) which has been shown to block nuclear uptake of NF-κB. 
(Torgerson et al., 1998)   
  
1.9.3 NF-κB DNA binding  
Once NF-κB has translocated into the cell nucleus it needs to bind to DNA in order 
to induce gene transcriptional changes. This is the target step in the activation 
pathway for the largest group of NF-κB antagonists which prevent DNA binding by 
a variety of mechanisms. An example of a blocking mechanism is by the use of 
decoy oligonucleotides which have κB binding sites which compete with NF-κB for 
DNA binding sites (Kupatt et al., 2002). This mechanism has demonstrated 
therapeutic benefits in animal models of inflammation (Tomita et al., 2003).  
 
1.9.4 NF-κB gene transcription 
The final step in the NF-κB pathway is transactivation (an increased rate of 
production of genes), this step gives the potential for modifications to specific 
levels of gene expression by NF-κB. A number of molecules have been shown to 
specifically inhibit gene transactivation. Several mechanisms have been cited, 
which include phosphatidylcholine-phospholipase C inhibition achieved by D609, 
protein kinase C inhibition via RO31-8220 and p38 MAPK inhibition by SB203580, 
all of which have been shown to inhibit gene transactivation via NF-κB. (Gilmore 
and Herscovitch, 2006) 
 
1.9.5 Antioxidants 
Oxidant stimulation of NF-κB has been demonstrated in a range of cell types.  A 
number of authors have demonstrated that antioxidants can block this activation 
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(Bubici et al., 2006, Gloire et al., 2006). However, the exact target for antioxidant 
action and the pathway by which they act has yet to be fully elucidated. It seems 
that antioxidants act on different parts of the pathway depending upon the cell 
type. (Figure 1.16) 
 
A range of antioxidant species have been shown to block NF-κB activation, these 
include thiols (which includes α-lipoic acid (ALA)) and vitamins. These potentially 
act by direct scavenging of reactive oxygen species (ROS), suppression of ROS 
production or by stimulating over expression of other antioxidant enzymes. (for 
example catalase which can block TNF-α activation of NF-κB; (Manna et al., 1999, 
Manna et al., 1998, Schulze-Osthoff et al., 1993).  
 
In broad terms there are 2 main antioxidant actions in blocking the NF-κB pathway: 
1) Direct scavenging of ROS, which have the ability to activate the pathway via 
signalling molecules (Haddad et al., 2000). 
2) Direct inhibition of IκK activity limiting breakdown of IκB and thus preventing 
activation of NF-κB (Gloire et al 2006, Bubici et al 2006).  
 
The literature shows that antioxidants have anti-inflammatory properties in animal 
models and in humans (Na and Surh, 2006). Because of it‟s central role in 
inflammation (Aggarwal et al., 2007) it would seem appropriate to investigate NF-
κB as a potential therapeutic target in dampening down the “hyper inflammatory” 
response, moreover inhibitors of NF-κB could modulate the pathway at a single or  
multiple points. For the majority of compounds reported to block NF-κB, the exact 
mode of inhibition has yet to be fully determined. 
 
1.10 Antioxidants and periodontitis 
Damage to the supporting tissues of the teeth is a feature of periodontitis and is, in 
the main, caused by an inappropriate response of the host to microbial plaque. A 
shift in the homeostatic balance causes disease, due to excess ROS and 
proteolytic enzyme release by neutrophils.  Current evidence suggests that 
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periodontitis is manifested in individuals who have an exaggerated inflammatory 
response to microbial plaque (Gustafsson et al., 2006) The literature suggests that 
neutrophils, which migrate to the area as part of the normal defence mechanism, 
are hyper reactive (Matthews et al., 2007b) and hyper active (Matthews et al., 
2007a) producing excess ROS and enzymes (Fredriksson et al., 1998); this 
alongside the reduced local antioxidant defences seen in these patients. Several 
studies have investigated levels of antioxidant in periodontal tissues (Chapple et 
al., 2002, Panjamurthy et al., 2005) and demonstrated reduced levels, which in the 
presence of excess ROS may result in periodontal tissue damage (Chapple and 
Matthews, 2007). 
 
1.11 α-Lipoate 
α-lipoate (ALA), which is also known as α-lipoic acid or thiocytic acid, was initially 
isolated from bovine liver in 1950 (Reed, 1957) with some 10 tons of liver yielding 
30mg of pale yellow crystals. ALA is an eight carbon dithiol containing an 
asymmetric carbon atom. It exists in two forms, the R enantiomer being found 
naturally whereas the synthetic form contains both R & S enantiomers (Figure 
1.17). ALA is an essential group found in  mitochondria being part of the α-keto 
acid dehydrogenase complex, and having a pivotal role in energy metabolism 
(Schmidt et al., 1969). In recent years ALA has attracted considerable attention 
due to its beneficial antioxidant properties, having the ability to directly scavenge 
free radicals, chelating transition metals in biological systems, preventing 
membrane lipid peroxidation and protein damage via regeneration of other 
antioxidants (e.g. vitamin C and E), as well as increasing intracellular levels of 
reduced glutathione (GSH) (Packer et al., 1995); (Matsugo et al., 1996). 
 
1.11.1 Direct Radical Scavenging 
A number of studies have shown that ALA is highly reactive to a range of reactive 
oxygen species. Concentrations of ALA in the range of 0.05-1 mM have been 
shown to scavenge hydroxyl radicals, hypochlorous acid and singlet oxygen 
(Packer et al., 1995). The reduced form of ALA, dihydro-lipoic acid (DHLA) in the 
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concentration range 0.01-0.5mM can, in addition, scavenge peroxyl and 
superoxide radicals (Packer et al., 1995) (Matsugo et al., 1996). 
 
1.11.2 Redox interactions with other antioxidants 
ALA/DHLA has been shown to regenerate other antioxidants from their oxidized or 
reduced forms. For example DHLA is able to directly reduce oxidized glutathione 
(GSSG) to its reduced form GSH (Jocelyn, 1967). Animal studies using rats have 
demonstrated that ALA administration increases GSH levels in a range of tissues  
(Busse et al., 1992); (Khanna et al., 1999). Studies have also investigated the 
action of ALA on human cells in culture and demonstrated that following exposure, 
it was rapidly taken up by the cells and reduced to DHLA before being released 
(Handelman et al., 1994).  DHLA reduces the amino acid cystine to cysteine, which 
is then taken up by amino acid transporters and used in the synthesis of reduced 
glutathione. The ability of ALA to increase the intracellular availability of cysteine 
(the central amino acid in the tripeptide GSH) has been proposed as the 
mechanism by which ALA increases intracellular GSH (Han et al., 1997); (Figure 
1.18). In addition to the effect of ALA on intracellular GSH levels, it has also been 
reported that ALA may contribute to regeneration of vitamin B, C and E from their 
oxidized forms in biological systems (Packer and Suzuki, 1993, Packer et al., 
1995), (Figure 1.19) 
 
1.11.3 In vivo antioxidant activity 
A number of experimental models have provided evidence that supplementation 
with ALA decreases oxidative stress as well as restoring levels of other 
antioxidants. One such study supplemented healthy human subjects with 600mg 
per day of ALA over a 2 month period. Results from this study showed a decrease 
in urinary F2-α isoprostane, a biomarker of lipid peroxidation, caused by oxidative 
stress (Marangon et al., 1999). In a separate study, the oxidative stress induced by 
exercise was assessed using rats administered with intragastric ALA (150mg/kg 
body weight per day). Rats administered with ALA showed protection against 
oxidative stress-induced heart, liver and muscle damage, as well as increased 
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levels of glutathione (Khanna et al., 1999). Further evidence for a potential role for 
exogenous ALA in preventing oxidative damage can been seen with ageing. One 
of the proposed mechanisms of ageing is the accumulation of DNA, lipid and 
protein damage from reactive oxygen species (Finkel and Holbrook, 2000). A study 
supplementing old rats with ALA (0.2% weight per weight) for 2 weeks showed a 
reduction in age-associated oxidant production in cardiac monocytes, restored 
myocardial ascorbic acid levels and reduced oxidative DNA damage in cardiac 
tissue (Suh et al., 2001). Other studies have shown that ALA prevents age related 
cerebral lipid peroxidation, and age-related decreases in ascorbic acid, vitamin E 
and GSH (Arivazhagan et al., 2000). 
 
1.11.4 Other biological actions of ALA and DHLA 
Studies using animal models of diabetes and in humans with type 2 diabetes have 
demonstrated that ALA has the ability to reduce elevated glucose levels (Midaoui 
et al., 2003, Packer et al., 2001). At a cellular level, cultured insulin responsive 
cells exposed to ALA (2.5mM) showed rapid glucose uptake via activation of the 
insulin signaling pathway (Yaworsky et al., 2000). The mechanism highlighted is 
believed to be due to the insulin signaling pathway being sensitive to REDOX 
status, with oxidation of thiol groups causing activation of insulin signaling (Schmid 
et al., 1999). Experiments pre-incubating adipocytes with ALA demonstrated 
increased glucose uptake and intracellular glutathione levels. (Moini et al., 2002) 
 
Therefore, ALA has been shown to increase antioxidant activity both in the 
laboratory, in animal models, and in patients. Provision of exogenous ALA to 
patients who exhibit a REDOX imbalance (Moini et al., 2002), diabetes (Packer et 
al., 2001), auto-immune disease (Morini et al., 2004), hypertension (Takaoka et al., 
2001),(Vasdev et al., 2000) as well as a number of other inflammatory diseases 
(e.g. atherosclerosis) has produced improved clinical outcomes. However the 
exact mode of activity of ALA on different biological systems has yet to be fully 
determined, and only then can its true efficacy in a particular inflammatory disease 
be established. 
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1.12 Cytokines 
Cytokines are defined as soluble factors that are produced by cells and act on a 
target cell to cause a change in cellular behaviour. This target cell can be a second 
cell or the same cell (autocrine action). Cytokines act on a wide range of biological 
processes including development of the embryo, inflammatory and malignant 
disease pathogenesis, non-specific responses to infection, specific antigen 
responses, and host ageing. The term “cytokine” encompasses a number of 
groups of cell signaling molecules: interferons, interleukins, chemokines, 
mesenchymal growth factors, tumor necrosis factors and adipokines. To date, 
there are in excess of 100 separate genes coding for cytokine-like activities many 
of which have overlapping functions. 
 
Cytokines are key to the host‟s innate immunity, which is required for host survival. 
However, dysregulated cytokine production has been implicated in disease 
aetiology where inappropriate levels of cytokine production can cause excess 
levels of inflammation (Opal et al., 2005), (Konstan and Berger, 1997). Classically, 
during infection a whole range of pro-inflammatory cytokines are produced with the 
aim of generating an inflammatory / immune response and therefore defending the 
host from infection. As the infection resolves, cytokine production is reduced and 
inflammation subsides. However, when cytokine genes fail to shut down or when 
the infective agent persists, chronic inflammation results (Opal et al., 2005). 
 
1.12.1 Cytokines and periodontal disease 
Periodontal tissue homeostasis is achieved by a delicate balance between cellular 
activity (including cell migration, proliferation and differentiation) along with the 
production of extracellular matrix. Strong evidence exists that cytokines play a 
pivotal role in ensuring that homeostasis is maintained (Moscatelli et al., 1986), 
(Garlet et al., 2006). Research has demonstrated that in healthy periodontal 
tissues a range of growth factors are expressed, examples of which include 
epidermal growth factor (EGF), platelet derived growth factor (PDGF) and 
transforming growth factor β (TGF-β) (Okada and Murakami, 1998). In addition low 
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levels of expression of inflammatory cytokines are detected at healthy sites (e.g. 
IL-1, IL-6, TNF-α), but at levels much lower than those seen in inflamed sites. This 
array of cytokines detected at healthy sites suggests that cytokines are important 
in maintaining homeostasis within the periodontal tissues. 
 
In patients with CP, histological examination of the periodontal tissues reveals an 
inflammatory cell infiltrate (Page and Schroeder, 1976). Thus, an important aspect 
of disease is how these cells are attracted to the area. A number of cytokines have 
been implicated in the initiation and progression of periodontal inflammation, the 
majority of which are pro-inflammatory in nature. Recent studies using epithelial 
cells removed from healthy and diseased sites revealed expression of IL-1β, IL-6, 
IL-8, TNF-α and TGF-β (Lundqvist et al., 1994) with the expression profiles being 
similar between healthy and diseased sites. In vitro studies using an epithelial cell 
line showed increased production of IL-1β, IL-6, IL-8, TNF-α and monocyte chemo-
attractant protein (MCP-1), when stimulated by P.gingivalis LPS (Kou et al., 2008, 
Okada and Murakami, 1998). The increased production of IL-8 and MCP-1 is of 
particular interest as they are chemotactic for neutrophils, suggesting the 
epithelium may have a role in the initial recruitment of inflammatory cells to the 
periodontium. 
These „pro-inflammatory cytokines‟ are also prominent regulators of tissue 
homeostasis, so a normal baseline level of expression is expected (Okada et al., 
1996), however this appears to be significantly increased in the inflammatory 
lesion. At sites of disease, cytokines are produced by immuno-competent cells (T 
cells and monocytes) that have infiltrated the tissues. In addition, resident cells 
such as epithelial cells and fibroblasts also produce cytokines, which play an 
important role in the inflammatory response. This thesis investigates the role of 
pocket/sulcar epithelium in orchestrating this inflammatory response seen in 
periodontitis, using an oral gingival epithelial cell model system.  
There are a number of cytokines implicated in periodontitis and 3 key pro-
inflammatory cytokines closely related to the pathogenesis of periodontitis (i.e. IL-
1, IL-8 & TNF-α) will be discussed in more detail in the following section. 
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1.12.2 Interleukin 1 (IL-1) 
IL-1 has a wide range of biological activities in tissue homeostasis, immunity, 
inflammation (Okada et al., 1996) and tissue breakdown (Dinarello, 1997, Mizel, 
1989, Schmidt et al., 1982, Stashenko et al., 1987) It can be produced by a 
number of cells once they become activated. Two forms exist IL-1α and IL-1β. In 
terms of amino acid composition they only share 27% homology but have similar 
modes of action. IL-1α has been shown to remain closely cell associated, whilst 
IL1-β is released from the cell (Hazuda et al., 1988). IL1-α and IL1-β act via the 
same cell surface receptor, which has been demonstrated on a wide range of cell 
types. 
 
In healthy tissues IL-1 stimulates cell proliferation (keratinocytes, fibroblasts, and 
endothelial cells) as well as fibroblast synthesis of collagen, hyaluronate, 
fibronectin and prostaglandins. In diseased tissues, excess production can lead to 
local tissue damage. In the periodontal tissues IL-1 can stimulate production of 
other pro-inflammatory cytokines, and enzymes which may be responsible for 
tissue destruction and therefore loss of attachment. IL-1 has thus been implicated 
as a key factor in periodontal disease pathogenesis. 
 
1.12.3 Interleukin 8 (IL-8) 
IL-8 acts as a potent chemo-attractant for neutrophils (Bickel, 1993, Skerka et al., 
1993); It has been reported to be produced by a range of cell types including 
monocytes, fibroblasts and endothelium. In inflamed gingival tissue it is seen to be 
produced by macrophages and epithelial cells (Bodet et al., 2005, Milward et al., 
2007, Sfakianakis et al., 2002). Neutrophils are implicated in the initiation and 
progression of periodontal disease, and with local IL-8 production found in 
periodontal tissues this suggests a potential important role for IL-8 in neutrophil 
recruitment to the periodontal tissues and therefore disease pathogenesis. 
Subjects with systemic neutrophil dysfunction (e.g. Chediak-Higashi syndrome) 
show increased severity of periodontal disease, which suggests that the infiltration 
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of neutrophils to the periodontal lesion plays an important role in first line defence. 
However, if the production of IL-8 becomes chronic and at elevated levels, it will 
potentially cause excess neutrophil recruitment and activation. This may be an 
important factor in local tissue destruction. The production of IL-8 is downstream of 
the NF-κB pathway (Roebuck, 1999) and is widely accepted to be a surrogate 
marker of NF-κB pathway activation, so methods of blocking this pathway have the 
potential to reduce the amount of IL-8 produced (Pease and Sabroe, 2002). 
 
1.12.4 Tumor necrosis factor alpha (TNF-α) 
TNF-α is mainly secreted by monocytes and macrophages. It has a number of pro-
inflammatory effects, inducing collagenase production, bone resorption and has 
been implicated in periodontal tissue breakdown  (Alexander and Damoulis, 1994, 
Chaudhary et al., 1992, Elias et al., 1987). TNF-α has been demonstrated to 
activate osteoclasts as well as inducing IL-1 production by macrophages (Johnson 
et al., 1989). TNF-α has been shown to act synergistically with IL-1 to enhance its 
bone resorption activities (Bertolini et al., 1986, Johnson et al., 1989, Mundy, 1989, 
Pfeilschifter et al., 1989, van der Pluijm et al., 1991). In addition, in vitro stimulation 
of fibroblasts by TNF-α has induced their ability to breakdown collagen (Meikle et 
al., 1989).  It has been shown that Gram negative bacterial lipopolysacharide 
(LPS) can induce TNF-α production in peripheral blood monocytes (Van Dyke et 
al., 1993). 
 
1.13 Aims and Objectives 
This thesis will investigate the role of sulcar/pocket epithelium in the initiation of 
inflammation when stimulated with periodontal pathogens, as well as potential 
methods of blocking the pro-inflammatory response. Studies will utilise a model 
system to investigate genomic and proteomic changes as well as exploring a 
possible method of modulating the inflammatory response seen periodontitis. The 
key stages in attempting to achieve this goal are:- 
 
1. Development and characterisation of an in vitro oral epithelial cell model. 
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2. Induction of NF-κB activation via different microbial stimuli demonstrating   
      nuclear translocation using immuno-histochemistry (IHC). 
3. Determining the effects of microbial stimulation on this model system in terms  
      of global gene expression using both high throughput microarray technology  
      and confirmatory PCR. 
4. Assessment of cytokine production downstream of gene transcription changes. 
5. Investigating methods of blocking NF-kB activation using α-lipoate, determined 
by IHC, PCR and cytokine ELISA‟s. 
 
In summary the effects of periodontal pathogens upon oral epithelial cell (OEC) 
behaviour will be examined by analysing NF-κB activation in a model system, 
specific cellular events analysed will be:-  (Figure 1.20) 
A. Translocation of NF-kB to the nucleus 
B. Changes in gene expression 
C. Cytokine production 
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CHAPTER 2 
 
Materials & Methods 
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2.1 Bacterial culture preparation 
This section describes the reagents and preparation of the bacteria used to 
stimulate the epithelial model system. 
  
2.1.1 Mycoplasma broth (Difco laboratories, USA) 
This commercially available powder requires re-hydrating and sterilizing by 
autoclave prior to use. 21g of the mycoplasma broth powder was added to 700ml 
of distilled water; thoroughly mixed and autoclaved at 121°C for 15 minutes. After 
cooling the broth was stored at +4oC prior to use. 
 
2.1.2 Trypticase soy broth (TSB) 
40g of trypticase soy base powder (Difco laboratories, USA) was dissolved in 1 
litre of distilled water, dispensed into bijou bottles and autoclaved at 121oC for 15 
minutes. The broth was allowed to cool and stored at + 4oC prior to use. 
 
2.1.3 Trypticase Soy Agar (TSA) 
40g of trypticase soy base powder was added to 1 litre of distilled water along with 
15g agar base, after mixing it was autoclaved at 121oC for 15 minutes, and whilst 
still molten, was dispensed into Petri dishes. Once the agar had set, plates were 
stored at + 4oC prior to use. 
 
2.1.4 Blood agar 
This was prepared using a TSA base (as previously described) to which 5% 
defibrinated sheep blood was added. The sheep blood was added to the TSA 
whilst still in its liquid state just above its setting temperature in order to prevent 
lysis of the red blood cells. Once mixed it was poured into Petri dishes, allowed to 
set, and the plates stored at +4oC prior to use.   
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2.1.5 Bacterial stimulants 
This thesis utilised whole dead periodontal pathogens as well as E. coli 
lipopolysaccharide (EC LPS) to stimulate the model epithelial cell system. LPS is a 
major structural and functional component of the outer membrane of Gram-
negative bacteria, which is known to interact with a variety of cells producing a 
wide array of inflammatory responses including NF-κB activation. 
 
2.1.5.1 Bacterial cultivation 
Fusobacterium nucleatum (ATCC 10953) and Porphyromonas gingivalis (ATCC 
33277) were purchased as lyophilized stocks from the American Type Culture 
Collection (ATCC, Rockville, MD). These were reconstituted using mycoplasma 
broth (Difco Laboratories, USA)  then plated out onto a trypticase soy agar 
supplemented with sheep blood and incubated at 37ºC anaerobically (anaerobic 
chamber – Don Whitley, UK atmosphere 80% nitrogen, 10% carbon dioxide, 10% 
hydrogen) (Figure 2.1). The resulting bacterial colonies were checked to ensure 
purity by Gram staining and subculture. Subsequent morphologically identical 
colonies were seeded into 10 ml trypticase soy broth, which was incubated at 37ºC 
in an anaerobic chamber for 24 hours. Following incubation the bacterial 
suspension was centrifuged to produce a bacterial cell pellet. This pellet was 
washed three times in sterile phosphate buffered saline (PBS) and then heat-
inactivated at 100ºC for 10 minutes. The optical density (OD) of the resultant 
suspension was measured at 600nm in a Jenway, Spectrophotometer, 
(Dunmow,UK) using 1ml semi-micro cuvettes (Sarstedt, UK). By using a standard 
curve (OD vs. bacterial count), the bacterial concentration was then adjusted using 
sterile PBS in order to produce a suspension containing 4x108 bacterial cells per 
ml.  Heat inactivation of the bacterial suspension was confirmed by lack of growth 
on a blood agar plate after 48h anaerobic culture. Bacterial suspensions were 
stored in aliquots at -30ºC prior to use.  
 
 
 
 34 
2.1.5.2 E. coli LPS 
Escherichia coli LPS serotype 026:B6 was purchased commercially (Sigma, UK, 
cat number L-8274) as a powder. This was dissolved in DMEM tissue culture 
media to produce a 250μg/ml stock solution that was stored at -30ºC prior to use 
 
2.2 Cell culture 
 
2.2.1 Culture media and reagents: 
 
2.2.1.1 Supplemented Dulbecco‟s modification of Eagle‟s medium (DMEM) 
This was used as a standard growth media for culturing the oral keratinocyte cell 
line and was available in 500ml sterilised bottles (Invitrogen,UK). The media was 
supplemented with L-glutamine (Sigma; final concentration 2mM), hydrocortisone 
(Sigma; 0.25mg per 500ml medium) and foetal calf serum (10% v/v; Labtech) prior 
to use, all reagents being added aseptically. In order to ensure sterility, 10ml of 
supplemented media was removed and incubated at 37oC in 5% CO2 for 24h, and 
checked for turbidity and pH change, both of which would indicate bacterial / fungal 
contamination. Supplemented growth media was stored at 4oC prior to use. Once 
supplemented the media has a 9 month shelf life, however all media was used 
within 3 months. 
 
2.2.1.2 Trypsin ethylenediaminetetraacetic acid (T-EDTA) 
This was used for disruption of the cell monolayer producing a single cell 
suspension allowing reseeding of the cell line. This commercial reagent 
(Gibco,UK)  contained 0.5g/l trypsin (1:250) and 0.2g/l EDTA•4Na in Hanks‟ 
balanced salt solution. On delivery the solution was aseptically distributed into 4ml 
aliquots prior to storing at -20oC. 
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2.2.1.3 Dulbecco’s phosphate buffered saline (D-PBS) without calcium & 
magnesium 
This buffered saline solution was used to wash the cell monolayer prior to 
application of trypsin EDTA. It is commercially available (Gibco,UK) and contains 
KCl 0.2g/l, KH2PO4  0.2g/l, NaCl 8.0g/l, Na2HPO4 anhydrous 1.15g/l. This solution 
on delivery is stored at room temperature, but once opened is kept at 4oC.  
 
2.2.2 Oral epithelial cell culture 
Experiments utilised an oral epithelial cell (OEC) line H400 which was a kind 
donation from S.Prime at Bristol University, UK. This human immortal cell line was 
derived from a squamous cell carcinoma (20-40mm, stage 2, moderately 
differentiated, node negative tumour) of the alveolar process in a 55 year old 
female patient, and has been well characterised (e.g. cytokeratins) indicating close 
similarities to gingival epithelium  (Prime et al., 1990) and represents a suitable cell 
line for use in the model system. All experiments were performed between 
passages 4-20. 
 
Cell culture is a technique sensitive discipline in which careful, aseptic 
manipulation of the cells is required in order to produce consistent results. All cell 
culture based experimental work was conducted in a positive flow biological hood 
(MSC12, Themo Scientific, USA) (Figure 2.2) in order to help minimise potential 
contamination. The practice of supplementing cell culture growth media with 
antibiotics in order to suppress bacterial contamination is widespread. This 
approach is required when using contaminated biological samples, however when 
using an immortal cell line this is an unwanted confounder having the potential to 
influence experimental results. It can give a „false sense of security‟ masking poor 
aseptic technique. All experiments in this thesis were conducted without the use of 
antibiotic supplemented media. 
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2.2.2.1 Cell storage and recovery 
Preservation of cells for future use was achieved by preparing a 1ml suspension of 
1x106 cells containing 20% (v/v) heat inactivated foetal calf serum (Labtech, UK) 
and 10% (v/v) dimethyl sulphoxide (BDH, UK). Suspensions were slowly frozen to 
-80oC overnight before long term storage under liquid nitrogen. H400 cells were 
initially supplied after being preserved and stored as described above. 
When required cell aliquots were removed from liquid nitrogen and rapidly 
defrosted in a water bath at 37oC. Once defrosted the suspension was transferred 
to 9ml of pre-warmed (37oC) DMEM cell culture media and gently mixed. This 
suspension was centrifuged at between 600-800rpm for 10 minutes, the 
supernatant gently removed using a Pasteur pipette to prevent disruption of the 
cell pellet, and re-suspended in 1ml of fresh pre warmed (37oC) DMEM. Following 
gentle mixing the resultant suspension was used to seed a 75cm2 cell culture flask 
containing 9ml of pre-warmed (37oC) DMEM. The flask was then incubated at 
37oC in 5% CO2 for 4 days. On day 4 the flask is inspected for bacterial / fungal 
contamination (turbidity / pH change), as well as being examined microscopically 
(inverted microscope – Leica, Germany) to look at cell growth (cell numbers and 
morphology). Cells are then fed with 10ml of fresh pre heated (37oC) DMEM 
following removal of the old DMEM. The flask was then re-incubated at 37oC for a 
further 2-3 days (time dependent on cell growth rate), with passage performed 
when the cells became near confluent and the pH is neutral (as indicated by the 
phenol read indicator present in DMEM). If the cells are left too long, cell growth 
results in exhaustion of nutrients in the media and an acidic swing in pH which 
leads to cell death. 
 
2.2.2.2 Cell passage 
Maintenance of a cell line requires the cells to undergo passage as they near 
confluence. This technique disrupts the cell monolayer to produce a single cell 
suspension, which is subsequently diluted and reseeded into a new flask, starting 
the process of monolayer growth again.  
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Cell passage was achieved by firstly removing the old media from the cell 
monolayer and washing with warm (37oC) D-PBS. The D-PBS was then removed, 
4ml of T-EDTA added and incubated for 10 minutes at 37oC with occasional 
mixing. Dissociation of the monolayer was confirmed microscopically. If this had 
not occurred at 10 min incubation was continued until dissolution was complete. 
The resultant suspension was transferred to a sterile universal container 
containing 4ml of warm (37oC) DMEM (stops further action of T-EDTA). After 
mixing, the cell suspension was centrifuged at 150g for 10 minutes, the resultant 
supernatant was removed and discarded, and the cell pellet re-suspended in 5ml 
warm (37oC) DMEM. Cells were counted and flasks seeded at various cell 
concentrations (Table 2.1)  
 
 
Receptacle Volume DMEM Cell number 
25cm2 cell 
culture flask 
5ml 2x105 
75cm2 cell 
culture flask 
10ml 5x105 
Petri dish 15ml 4x105 
96 well plate 150μl (per well) 8x103 
 
After initial seeding (day 0) cells were fed on day 4. Old DMEM was removed and 
replaced with fresh warmed (37oC) DMEM and incubation continued. All 
experiments were performed between passage 4-20. 
 
2.2.2.3 Growing cells on glass multi well slides 
For experiments with an immuno-cytochemical end point, cells were grown on 
multi well glass slides (Figure 2.3). Glass slides printed with 4 wells (C.A Hendley 
Ltd, UK) were sterilized using a hot air oven (OP Series, AWOP30-U, Appleton 
Woods, UK) (150oC for 2 hours), allowed to cool, aseptically transferred to sterile 
plastic Petri dishes (Appleton Woods, UK) and 15ml of warmed (37oC) DMEM was 
Table 2.1 Cell counts for seeding a range of cell culture receptacles  
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added. The dish was placed into a square plastic dish to help prevent 
contamination and evaporation of DMEM. Following passage, 4x105 cells were 
seeded into the Petri dish and incubated at 37oC in 5% CO2.  
 
2.2.2.4 Growing cells in 96 well plates 
Following passage cells were seeded (8x103 cells in 150μl DMEM per well) into flat 
bottomed 96 well plates (Costar,UK). Cells were grown for between 24 and 48 
hours until a semi confluent monolayer was achieved, and then treated depending 
on the experiment being performed. 
 
2.2.2.5 Cell counts and  viability  
Cell counts were determined using a haemocytometer (modified Neubauer). Cells 
were counted on each of the 4 quadrants. The total numbers of cells from these 4 
quadrants were then divided by 4. The results from this calculation gave a cell 
count x104 per ml.  
Cell viability was determined using a trypan blue (0.4%; Gibco, UK) exclusion test. 
This technique utilizes the principal that viable cells have intact cell membranes 
and will therefore exclude trypan blue whereas non viable cells lack cell membrane 
continuity and take up trypan blue.  
The following protocol was used:- 
1. A suitable cell suspension was produced (i.e. a cell number which could be 
easily counted using a haemocytometer, approximately 4x105 cells per ml; 
suspensions with higher cell concentrations were diluted). Ideally cells should be 
suspended in a serum free media to prevent non specific staining of the serum 
proteins. 
2. A mix of 1 part trypan blue (0.4%) with 1 part cell suspension was made and 
incubated for 2-3 minutes at room temperature 
3. The resulting suspension was introduced to a counting chamber and the 
numbers of stained and unstained cells determined 
4. A calculation was performed to determine the percentage of viable cells 
(number viable cells/ total number of cells x 100) 
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2.3 Immunocytochemistry of cells grown on multi-well slides 
Immunocytochemistry (ICC) is based on the interaction of an antibody with an 
insoluble immunoreactive tissue or cellular antigen, then localisation of the site 
using a label (e.g. an enzyme or fluorescent marker). Detection is dependent on 
the label used, and can be by ultra-violet, light or electron microscopy.  There are 
a number of methods used with antigens being localised using direct, indirect and 
multilayer techniques. These differ in the way in which the label is located at the 
site of the tissue antigen/antibody reaction. (Van Noorden et al., 1986) 
(Ordronneau et al., 1981) 
The method used in this thesis is the biotin-streptavidin amplified technique 
(StrAviGen, Biogenex). This technique involves the primary antibody binding to 
the antigen, this is followed by use of multi-link which is biotin labelled goat anti-
mouse/rabbit immunoglobulin which specifically binds to the primary monoclonal 
antibody. The next stage involves use of label, in this case peroxidase linked to 
streptavidin and binds to the multi-link. The cells are then exposed to 
diaminobenzidene (DAB) which changes colour from clear to brown. The change 
in colour occurs as a result of oxidation from exposure to peroxidase in the label. 
The outcome of these steps is to deposit a coloured complex at the site of the 
antigen which can be visualised by light microscopy.  
In order to ensure that this staining technique was specific for the target protein 
(NF-ĸB) a number of controls were used, these included use of a known positive 
section, replacing primary antibody with (i) non-immune serum, (ii) antibody 
known to have a different localisation pattern, (iii) buffer, as well as pre-absorbed 
primary antibody with (i) purified homologous antigen, (ii) non-cross reacting 
antigen (negative controls). These controls were run during development of the 
NF-ĸB staining technique, once specificity had been ascertained, subsequent 
staining of samples used a positive staining control (Ki-67) and a negative control 
which used primary antibody replaced by diluent.  
The mechanism and the practical steps involved are summarised in Figures 2.4 & 
2.5 and are described below. 
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 2.3.1 Staining procedure 
All procedures were performed at room temperature and PBS (pH7.6) was used 
for washing stages and reagent dilution. 
When the glass multi-well slides were ready for staining they were removed from 
the DMEM and washed in PBS (3x2mins), prior to fixing in dry acetone (15 
minutes at room temperature). Slides were air dried (10 mins) and then placed in 
a darkened humidified box where all subsequent incubations were performed. 
Monoclonal antibody to NF-κB p65 subunit (clone F-6, Santa Cruz Biotechnology, 
US; 1:100), a positive staining control Ki-67 was included (clone MM1; 
NovacastraTM, UK; 1:100) as well as a negative staining control which consisted of 
replacement of the primary antibody with PBS. These monoclonal antibodies and 
controls were applied to appropriate slide wells. Following 60 minute incubation 
the slides were washed in PBS (3x2mins), dried to remove excess moisture from 
around the wells then overlayed with Multilink (biotin-labelled goat anti-
mouse/rabbit Ig, 1:50 dilution. Biogenex) and incubated for a further hour. 
Following this incubation the slides were washed in PBS (3x2mins) and then 
overlaid with label (peroxidase linked to avidin. 1:50 dilution. Biogenex) and 
incubated for 1h. After washing in PBS (3x2mins) excess PBS was removed and 
the slides overlaid with freshly prepared diaminobenzidene (DAB) reagent (10mg 
in 20ml PBS - filtered then 25μl H2O2 added - used immediately <5mins). Slides 
were incubated for 5mins then washed for 2 mins in water, before applying 
copper sulphate solution (0.5% w/v in NaCl) for a further 5 mins – this step 
darkens the brown end product allowing easier visualisation. After further washing 
the cells were counterstained for 30 secs using Meyer's haematoxylin. After a 
final wash the slides were dehydrated in graded alcohols, cleared in xylene and 
mounted in XAM.  
 
2.3.2 Quantification of cell translocation 
Cell counts were performed on cell monolayers after 1h bacterial stimulation and 
histochemically stained as previously outlined. A binocular microscope (Leica, 
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Germany) fitted with an eyepiece graticule divided into 10 x 10 squares. The slides 
were viewed at x100 magnification. For cells to be classified as demonstrating NF-
ĸB activation (i.e. nuclear translocation) the presence of nuclear staining for p65 
was required with no visible staining present within the cytoplasm, where any 
ambiguity existed cells were recorded as negative. Preliminary analysis of 8 slides 
indicated that counts from a total of 30 randomly selected microscope fields would 
provide a representative cell count for a given specimen. This was determined 
using Hunting curves which plotted cell count per square against field number 
(Figure 2.6). All cells within a 30 graticule squares were counted, (i.e. 1 square 
represents 0.01mm2) and recorded as positive or negative.  The total and mean 
number of positive cells for each specimen was determined and used to calculate 
the percentage of cells demonstrating NF-ĸB activation. 
 
2.4 High throughput immuno-cytochemistry 
In addition to detection of nuclear translocation of NF-κB by standard immuno-
cytochemistry, high throughput technology was also used to determine NF-κB 
activation. This had the advantage of analysing NF-kB translocation in a 
quantitative way, with the additional benefit of high through put of samples. The 
basic principal of the method is similar to the staining techniques previously 
described (section 2.3) but uses a fluorescent marker rather than horseradish 
peroxidase. However, the main difference is the way in which the resulting stained 
images are analysed. This technology utilises an automated fluorescence 
microscopic imaging system which is computer driven allowing rapid cell 
identification as well as quantification of a vast array of parameters (e.g. cell size, 
number, shape, nuclear intensity, cytoplasmic intensity). Its use in this context 
allows determination of levels of p65 staining in the nuclei and the surrounding 
cytoplasmic area. 
 Cells were grown in black 96 well tissue culture grade flat bottom plates (Corning, 
UK) as described in section 2.2.2.4 Cells were then treated depending on the 
particular experimental protocol. 
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2.4.1 Fixing of cell monolayer  
Following removal of growth media from the wells, the monolayer was fixed for 
20min using a 1% formaldehyde solution, the formaldehyde was then removed and 
the cells were washed twice with 100μl PBS, before filling the wells to the top with 
PBS. A sealing film (Jencons, UK) was then applied to cover the wells which were 
then stored at 4oC prior to analysis. 
 
2.4.2 Staining 
Plates were washed with PBS prior to staining, then incubated with 100μl (per well) 
primary antibody (anti-NF-κB p65 monoclonal antibody (F-6) (Santa Cruz, USA) 
diluted 1:100 in 0.1M phosphate buffer pH 7.8 with 0.1% bovine serum albumin) 
for 1 hour at room temperature. Cells were then washed three times in wash buffer 
and incubated with the secondary antibody (anti-STAT1 rabbit polyclonal 
immunoglobulin – conjugated to a fluorescent label - Santa Cruz, USA) for a 
further hour. Following this stage detergent buffer (Cellomics, UK) was added to 
the wells for 15 mins. After washing with PBS, 200μl of detergent buffer added to 
each well prior to analysis. 
 
2.4.3 Data acquisition and analysis 
Data acquisition utilized ArrayScan HCS imaging cytometer (Cellomics, UK) 
(Figure 2.7). This is an automated fluorescent imaging microscope that allows 
collection of data on the spatial distribution of the fluorescent marker. The scanner 
reads multiple fields in order to build up a picture of each of the multi-wells. The 
software then allows identification of individual cells which are then subdivided into 
nuclear and cytoplasmic compartments. The software can identify the edge of the 
nucleus and then creates areas 2 pixels either side of this line, therefore producing 
a nuclear and cytoplasmic compartment (Figure 2.8). The fluorescent intensity can 
then be acquired for each. The number of cells counted or the area covered can 
be defined by the operator. The software used for data acquisition and analysis 
was ArrayScan II Data Acquisition and Data Viewer 3.0 (Cellomics,UK). The 
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localization of NF-κB was thus determined by analysis of nuclear and cytoplasmic 
fluorescence. 
 
2.5 RNA isolation and preparation of cDNA 
 
2.5.1 RNA isolation 
RNA was extracted from cells grown in cell culture flasks using a commercially 
available extraction kit (RNeasy® protect mini kit, Qiagen UK). Cell culture media 
was removed and replaced with 350µl of RLT lysis buffer, containing 1% β-
Mercaptoethanol (β-ME). β-ME is a reducing agent that induces cell lysis whilst 
protecting DNA and RNA from degradation. Culture flasks were agitated to ensure 
complete lysis of the cell monolayer (confirmed using an inverted microscope 
(Leica, Germany). The resulting lysate was transferred to a 2ml microcentrifuge 
tube and homogenised thoroughly using an Ultra-Turrax T8 tissue disrupter (Fisher 
Scientific, UK). The lysate was vortexed for 30 seconds to help shear genomic 
DNA as well as reducing the viscosity. Ethanol was then added to allow binding of 
RNA to the RNeasy® membrane. The resultant sample was pipetted onto an 
RNeasy® spin column and this was then placed in a 2ml collection tube. The 
column assembly was then spun in a 5415D microcentrifuge (Eppendorf, UK) for 
15 seconds at 10,000g. Following centrifugation 350µl of wash buffer (RW1) was 
pipetted onto the RNeasy® column and centrifuged for a further 15 secs at 
10,000g. At this point a DNase digestion was applied to remove any DNA 
contamination from the sample which would interfere with downstream analysis. 
This was achieved using the RNase-free DNase® kit (Qiagen, UK). Samples were 
treated using 10µl of DNase 1 which was mixed with 70µl of buffer RDD, pipetted 
onto the column and incubated at room temperature for 15 mins. The DNase 1 
solution was then removed from the column by washing with 350µl of buffer RW1 
and then centrifuged for 15 secs at 10,000g. Further washing was performed using 
500µl of buffer RPE and centrifuged for 15 secs at 10,000g, re-washed with 500µl 
of buffer RPE and finally centrifuged for 2 mins at 15,000g to dry the silica 
membrane. RNA attached to the column membrane was eluted by the addition of 
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30µl of RNase-free water directly onto the silica membrane followed by 
centrifugation for 1 min at 10,000g. This step resulted in RNA being removed from 
the membrane and present in the water. 
 
2.5.2 Reverse transcription (RT) 
 
Reverse transcription (RT) or first strand synthesis of RNA samples was performed 
in order to generate a DNA strand complementary to the mRNA (cDNA) present 
within the sample of total RNA. RT reactions were carried out using the Omniscript 
reverse transcriptase® kit (Qiagen, UK) coupled with an oligo (dT) primer (Ambion, 
UK) and an RNase inhibitor (Promega, UK). An oligo (dT) primer was used as it 
incorporates a run of 15-20 Thymine bases that is complementary to the sequence 
of Adenine bases (poly-A tail) found at the 3‟ end of eukaryotic mRNA molecules. 
This ensured that only mRNA species within the total RNA sample were reverse 
transcribed as RNA species other than mRNA do not possess poly-A tails.  
 
First strand synthesis was carried out in accordance with the manufacturer‟s 
instructions, Table 2.2 shows volume and final concentrations of components used 
in the RT reaction. Template RNA and oligo (dT) primers were initially incubated in 
a heated block (Eppendorf, UK) at 80°C for 10 mins in order to remove any 
secondary structure from the RNA sample, and then placed on ice for 5 mins. The 
remaining components of the RT reaction were then added, gently mixed and then 
incubated at 37°C for 60 mins. This step allowed extension of the transcription 
product. The reverse transcriptase enzyme was then inactivated by heating at 
93°C for 5 mins followed by rapid cooling on ice. 
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Table 2.2:  RT reaction set-up 
Component  Volume Final concentration 
10X RT buffer 2.0µl 1X 
5mM dNTP mix 2.0µl 0.5mM 
10µM Oligo (dT) 2.0µl 1µM 
RNase inhibitor (40 
units/µl) 
0.3µl 10 units 
Reverse transcriptase 1.0µl 4 units 
Template RNA variable 50ng-2µg 
RNase-free water to a total volume of 20µl  
Total volume 20µl  
 
2.5.3 Concentration and purification of cDNA 
This stage aims to remove unincorporated RT reaction components, which could 
interfere with downstream analysis, and to concentrate the cDNA samples. These 
samples were diluted with 500µl dH2O and centrifuged for 6 minutes at 10,000g 
using a Microcon YM-30 centrifugal filter unit (Millipore, UK). This filter unit retains 
cDNA molecules greater than 60 nucleotides in length whilst contaminants were 
eluted with the water. Samples were washed with a further 500µl dH2O and 
centrifuged at 10,000g for 8 mins to concentrate cDNA into 30µl of solution. The 
cDNA was then collected by inverting the filter into a fresh 1.5ml collection tube 
and centrifuging for 3 mins at 1000g. Recovered cDNA was quantified using a 
spectrophotometer. 
 
2.5.4 Quantification of RNA and DNA 
Following extraction, RNA and DNA were quantified spectrophotometrically using a 
Biophotometer (Eppendorf, UK). This was achieved by producing a dilution of 1µl 
of sample with 69µl of RNase-free water, which was then transferred to a cuvette 
(Eppendorf, UK). The absorbance at 260nm was then used to determine the 
concentration of RNA in the sample. An absorbance value of 1 unit at 260nm 
corresponds to 40µg/ml of RNA or single stranded DNA. In addition the sample 
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purity was determined by assessing the ratio between readings taken at 260nm 
and 280nm (A260/A280), with high purity RNA signified by a A260/A280 of 1.8-2.1. 
  
2.6 Polymerase chain reaction (PCR) 
 
2.6.1 PCR conditions 
All PCRs were set-up on ice to limit primer dimer formation and avoid reactions 
starting prematurely. All PCR assays were performed using the RedTaq PCR 
system (Sigma, UK) in 50µl reaction volumes containing; 25µl RedTaq ready 
reaction mix, 20µ dH2O, 2.5µl 25µM forward primer and 2.5µl 25µM reverse 
primer. Reactions were amplified in a Thermal Cycler (Mastercycler Gradient, 
Eppendorf, UK or GeneAmp 2700 PCR system, Perkin-Elmer, UK). A standard 
PCR programme is shown in Table 2.3, with a schematic diagram of the PCR 
process in Figure 2.9. Annealing temperatures varied according to specific primers 
used and cycle numbers varied between assays depending on relative abundance 
of the target sequence or efficiency of the specific reaction. Resulting PCR 
products were visualised using agarose gel electrophoresis.  
 
Table 2.3: Thermal cycler programme for PCR 
 
  Reaction stage     Temperature  Time 
 
  Denaturation  94°C            5 mins 
 
  Denaturation  94°C             30 secs            
         Cycle no dependant 
  Annealing    Primer Dependant  30 secs              upon abundance 
         of target sequence 
  Polymerisation  72°C   30 secs             
 
  Polymerisation  72°C   10 mins 
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2.6.2 Sample normalisation 
In order to effectively compare gene expression levels between control and 
experimental samples, glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) 
expression levels were normalised between all samples.  PCRs were performed 
using GAPDH primers with the products being visualised using agarose gel 
electrophoresis. Images of the resulting gels were taken and band intensity 
determined using AIDA image analysis software (Fuji, UK). This allowed 
calculation of the amount of cDNA required for addition to subsequent PCRs, in 
order to produce bands of equal intensity for each sample. One sample was 
chosen from each sample set to which all others in the set were normalised. 
Calculations were performed using the equation below:- 
 
 
 
 
The process of normalisation is repeated until all bands are of similar intensity, 
thus ensuring the same amount of cDNA is added to each subsequent reaction. 
 
2.6.3 Agarose gel electrophoresis 
PCR products, extracted RNA and genomic DNA were visualised using agarose 
gel electrophoresis. 1.5% agarose gels were prepared by mixing 0.6g agarose 
(Bioline, UK) with 40ml 1X Tris-acetate-EDTA (TAE) buffer solution (Helena 
Biosciences, UK). After mixing it was heated to boiling point using a microwave in 
order to dissolve the agarose. Following this the solution was briefly cooled and 
10mg/ml ethidium bromide (e.g. 1µl for a 40ml gel) was added to enable 
visualisation of nucleic acids upon exposure to ultra-violet (UV) light. The gel was 
subsequently formed using a gel tray whilst the sample wells were formed using a 
plastic sample comb (Figure 2.10). The gel was allowed to set at room 
temperature and if not used immediately was stored at 4oC for a maximum period 
Intensity of test 
band 
Intensity of band to normalise 
to 
Volume of 
sample 
Used in PCR 
Volume of cDNA 
required to 
normalise 
GAPDH levels 
X = 
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of 2-3 h. For use the gel was placed in an electrophoresis tank containing sufficient 
1X TAE buffer to cover the gel and wells. The sample comb was removed 
producing sample wells which were flooded with TAE buffer and PCR products 
were loaded into each well (The RedTaq system has a dye to allow tracking of the 
PCR products on the gel).  Hyperladder IV, a 100bp ladder (Bioline, UK) was 
added to a separate well to enable size determination of DNA products. 
Electrophoresis was performed at 80-120 Volts. The tracking dye (present in 
RedTaq mix) can be visualised and has a low molecular weight when compared to 
DNA. The gel is run for sufficient time to allow good separation of sample, but 
ensuring tracking dye is not run off the plate (dye will run further than DNA so if 
tracking dye is still on the plate so will DNA products). Following electrophoresis, 
gel images were captured using the Electrophoresis Documentation and Analysis 
System (EDAS) (Kodak, UK) under exposure to UV light (300nm) and analysed 
with AIDA image analysis software (Fuji, UK). 
2.7 DNA laddering  
2.7.1 Genomic DNA extraction and analysis 
In order to look for apoptotic DNA laddering in the cell line, DNA was extracted 
from cell cultures using the Wizard® SV Genomic DNA Purification System 
(Promega, UK) according to manufacturers‟ instructions. Cell culture samples were 
lysed in 275µl SV lysis buffer, transferred to 1.5ml microcentrifuge tubes containing 
a mini spin column (Qiagen,UK) then centrifuged at 13000g for 3 mins, DNA binds 
to the membrane of the mini spin column. The filtrate was discarded and 650µl of 
SV wash solution added to the column and further centrifuged at 13000g for 1 
minute. The filtrate was again discarded and samples washed a further five times 
with 650µl wash solution as previously described. Following the final wash, 
samples were spun for a further 2 mins to dry, before transferring the column to a 
fresh collection tube. Elution solution (2µl RNAse A, 100µl nuclease free water) 
was then added and the column incubated at room temperature for 5 mins before 
centrifugation at 13000g for 1 min in order to elute the DNA from the mini spin 
column membrane.  
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To determine whether extracted genomic DNA was intact or had fragmented 
(suggesting apoptosis), samples were visualised using 1% agarose gels (as 
described previously) using 2µl orange G as a loading dye. Gels were imaged 
under UV illumination for indications of 180 bp DNA laddering which is a specific 
indicator of early apoptosis. One of the early events following induction of 
apoptosis is DNAase activation, condensation of chromatin and a characteristic 
pattern of DNA fragmentation (laddering) (Khodarev et al., 1998) 
 
2.8 Microarray analysis of gene expression 
This high throughput technique allowed analysis of multiple gene expression 
changes in H400 cells stimulated with periodontal pathogens P. gingivalis & F. 
nucleatum. This technology utilises microarray chips which are spotted with many 
thousands of DNA oligonucleotide probes to which fragmented labelled cRNA is 
hybridised. The degree of hybridisation is detected and analysed giving an insight 
into the level of a particular gene expressed in the sample (Figure 2.11) 
Gene expression in epithelial cells grown in 25cm2 cell culture flasks (Corning,UK) 
and stimulated with a) P. gingivalis [109 cfu/ml], b) F. nucleatum [109 cfu/ml],  and 
c) Media alone (negative control) were analyzed using human Affymetrix 
HG_U133A oligonucleotide arrays. 
For microarray analysis DNA free RNA was extracted from H400 cells (method as 
described in section 2.5)  
 
2.8.1 First strand synthesis of cDNA from total RNA: 
This was performed using the SuperScript Choice kit (Invitrogen, UK) and 
GeneChip promoter primer kit (Applied Biosystems, UK). To 5μg of total RNA 
extracted from H400 cells 2μl of 50μM HPLC purified T7-Oligo (dT) primer was 
added to give a final concentration of 100 pmol. The resulting samples were then 
incubated for 10 minutes at 70oC to allow primer hybridisation. Following 
incubation, 4μl of 5x first strand cDNA buffer, 2μl 0.1DTT and 1μl of 10 mM dNTP 
mix were added resulting in final concentrations of 1x, 10mM and 500μM 
respectively. The mixture was briefly vortexed and incubated at 42oC for 2 mins. 
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Following incubation, first strand cDNA was synthesised by adding 1μl SuperScript 
II RT (200 U/μl) and further incubated at 42oC for 60 mins.  
 
2.8.2 Second strand cDNA synthesis 
To the first strand synthesis was added (Table 2.4):- 
 
Reagent Volume added Final concentration 
5x second strand reaction buffer 30μl 200μM 
dNTP mix                                                                                          3μl 200μM 
10U/μl E.coli DNA ligase   1μl 10U 
10U/μl E.coli DNA polymerase 1 4μl 40U 
2U/μl E.coli RNase H 1μl 2U 
 
 
The resulting mixture was adjusted to 150μl by the addition of 91μl of RNase free 
water and then incubated for 2 h at 16oC. On completion of incubation 2 μl (10U) of 
T4 DNA polymerase was added to the reaction mix and the incubated for a further 
5 mins at 16oC. To complete second strand cDNA synthesis, 10 μl of 0.5M EDTA 
was added to the samples and sample integrity verified by electrophoresis (1μl 
sample). 
 
2.8.3 Purification of double stranded cDNA 
This was achieved by mixing the samples with 162 μl of a mixture of phenol, 
chloroform, isoamyl alcohol in a ratio of 25:24:21. This was then transferred to a 
phase lock gel tube (Eppendorf, UK) and centrifuged (Eppendorf 5415D -  
Eppendorf, UK) for 2 mins at 12,000g. Using these tubes allows a distinct 
separation of the organic and aqueous phases, with the resulting aqueous phase 
being transferred to a new 1.5 ml Eppendorf tube. To this was added 0.5 volume of 
7.5M ammonium acetate and 2.5 volumes 100% ethanol prior to mixing and 
Table 2.4: Reagents used for second strand cDNA synthesis 
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centrifugation (5 mins at 12,000g). The supernatant was removed, the remaining 
pellet dried (Speedvac – Savant,UK) for 2 minutes prior to rehydration with 12 μl of 
RNase free water with overnight incubation at 4oC to ensure complete dissolution. 
From the resulting solution 1 μl was taken for gel electrophoresis to confirm cDNA 
integrity.  
 
2.8.4 Synthesis of biotin labelled cRNA 
This stage for synthesis of biotin labelled cRNA utilised reagents supplied in a the 
Enzo BioArray high yield in vitro transcription (IVT) labelling kit (Affymetrix, UK).  
To each sample of 10 μl of purified double stranded cDNA were added (Table 2.5) 
 
Reagent Volume added (μl) 
RNAse free water variable 
10X reaction buffer. 4 
10X Biotin-labelled ribonucleotides 4 
10X DTT (Dithiothreitol) 4 
10X RNase inhibitor 4 
20X T7 (promoter sequence) RNA polymerase 2 
 
Following these additions the volume was adjusted to 40 μl by the addition of 12 μl 
RNase free water. Samples were mixed and incubated for 5h at 37ºC, with gentle 
mixing by inversion every 30-40 mins throughout the incubation. Sample integrity 
was confirmed using 1 μl of biotin labelled cRNA and analysing by gel 
electrophoresis. 
 
2.8.5 Purification of Biotin labelled cRNA 
All reagents and materials required for purification of biotin labelled cRNA were 
supplied in the gene chip sample clean-up module (Affymetrix, UK). 
Table 2.5: Reagents used for synthesis of biotin labelled cRNA 
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To the biotin labelled cRNA synthesised in the previous step was added (Table 
2.6): 
 
Reagent Volume added (μl) 
RNase free water 60 
IVT cRNA binding buffer 350 
100% ethanol 250 
 
 
Samples (700μl) were vortexed for 5 secs, and then applied to an IVT cRNA clean-
up spin column placed in a 2 ml collection tube and centrifuged for 15 secs at 
8,000g. The filtrate was discarded and the spin column transferred to a fresh 2 ml 
collection tube. 500 μl of IVT cRNA wash buffer was applied to the spin column and 
centrifuged for 15 sec at 12,000g. Then 500 μl of 80% ethanol was added to the 
spin column and samples centrifuged for 15 secs at 12,000g. The filtrate was 
discarded, the cap of the spin column opened and samples centrifuged for 5 mins 
at 12,000g to ensure complete drying of the filter membrane. The spin column was 
then transferred to a fresh 1.5 ml Eppendorf tube, 100 μl RNase free water applied 
directly to the spin column membrane and then centrifuged for 1 min at 12,000g to 
elute the sample. 4 μl of the resulting solution underwent spectrophotometric 
analysis with the remainder being reduced to 40 μl in a Speedvac. 
 
2.8.6 Quantification of biotin labelled cRNA: 
In order to ensure that quantities and purity of cRNA were adequate, 
spectrophotometric analysis was used as previously described (section 2.5.4). An 
absorbance value of 1 at 260 nm corresponds to 40 μg/ml cRNA, and a A260/A280 
ratio of 1.9 to 2.1 was acceptable for sample purity. For quantification of cRNA 
when using total RNA as starting material, an adjusted cRNA yield was calculated 
to reflect carryover of unlabelled total RNA.  
Table 2.6: Reagents used for synthesis of biotin labelled cRNA 
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The formula below was used to determine adjusted cRNA yield assuming 100% 
carryover: 
 
Adjusted cRNA yield = RNAm – (total RNAi)(y) 
 
where 
RNAm = amount of cRNA measured after IVT (μg) 
Total RNAi = starting amount of total RNA (μg) 
y = Fraction of cDNA reaction used in IVT 
 
2.8.7 Fragmentation of cRNA 
To obtain optimal microarray hybridisation, fragmentation of cRNA targets was 
performed. 8 μl of 5X fragmentation buffer, which was supplied with the GeneChip 
sample clean-up module (Affymetrix, UK), was added to 20 μg of cRNA target and 
the volume adjusted to 40 μl with RNase free water. Reactions were subsequently 
incubated for 35 mins at 94ºC. This allowed fragmentation of full-length cRNA 
targets to 35-100 base fragments, this was achieved using fragmentation buffer by 
a process of metal induced hydrolysis. From the resulting samples 1μl was 
removed and analysed by gel electrophoresis. 
 
2.8.8 Target hybridisation 
5 µg of fragmented cRNA was initially hybridised to GeneChip Test3 arrays (Figure 
2.12) in order to confirm sample integrity. Following confirmation of sample quality 
from these test arrays, 15 μg of sample was hybridised in duplicate onto Human 
Genome U133A arrays [HG U133A, (Affymetrix, UK)].  
The following components were added to fragmented cRNA samples to create a 
hybridisation cocktail either for GeneChip Test3 or HG U133A arrays (Table 2.7) 
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Reagent Volume added (μl) Final concentration 
Fragmented cRNA 15 0.05μg/μl 
Control oligonucleotide B2 
(3nM) 
5 50ρM 
20x Eukaryotic hybridization 
controls (bioB, bioC, bioD, 
cre) 
15 
1.5, 5, 25 and 100ρM 
respectively 
Herring sperm DNA 
(10mg/ml) 
3 0.1mg/ml 
BSA (50mg/ml) 3 0.5mg/ml 
2x Hybridization buffer 150 1x 
DMSO 30 10% 
H2O To final volume of 300 
 
Final volume 300 
 
The final reaction volume was adjusted to 100 μl (300 μl) with RNase free water, 
and the hybridisation cocktail incubated for 5 mins at 99ºC. Whilst the hybridisation 
cocktail was incubating, the room-temperature equilibrated arrays were filled with 
80 μl (200 μl) of 1X hybridisation buffer through the array septa to wet the probe 
array (Figure 2.13) and incubated for 10 mins at 45ºC, rotating at 60 rpm in a 
hybridisation oven 640 (Affymetrix, UK). The hybridisation cocktail was incubated 
for a further 5 mins at 45ºC and centrifuged for 5 min at 12,000g to remove any 
insoluble material. The 1X hybridisation buffer was removed from the array and 80 
μl (200 μl) hybridisation cocktail added via the septa. The arrays were incubated for 
16 hours at 45ºC, rotating at 60 rpm. 
 
 
Table 2.7: Reagents used for cRNA preparation prior to hybridisation onto GeneChip 
Test3 or HG U133A microarray. 
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2.8.9 Probe array wash and stain 
Following 16h of hybridisation, the hybridisation cocktail was removed from the 
array and replaced with 100 μl wash buffer A. The arrays were then loaded onto a 
primed fluidics station (Affymetrix, UK) and run through an automated washing and 
staining cycle. This cycle was controlled via microarray suite software (Affymetrix, 
UK) installed on a workstation computer The protocol for this washing/staining 
protocol can be seen in Table 2.8: 
 
 
Procedure Protocol Reagent 
Temperature 
(oC) 
Post hybridisation 
wash 1 
10 cycles of 2 
mixes/cycle with wash 
Wash buffer A (6x 
SSPE, 0.01% Tween 
20) 
25 
Post hybridisation 
wash 2 
4 cycles of 15 
mixes/cycles with 
wash 
Was buffer B (100mM 
MES, 0.1M Na+, 0.01% 
Tween-20) 
50 
Stain 10mins 
SAPE solution (1xMES 
stain buffer, 2mg/ml 
BSA, 10μg/ml 
streptavidin) 
25 
Post stain wash 
10 cycles of 2 
mixes/cycle 
Wash buffer A 25 
2nd stain 10mins Antibody solution 25 
3rd stain 10mins SAPE solution 25 
Final wash 
15 cycles of 2 
mixes/cycle 
Wash buffer A 30 
 
 
 
Table 2.8: Affymetrix wash and stain protocol for GeneChip Test3 and HG U133A 
microarrays. 
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2.8.10 Array scan 
On completion of staining the arrays were scanned at 488nm using a GeneArray 
scanner and software package (Affymetrix, UK). The scanning process was 
controlled by Affymetrix Microarray Suite 4.0 (AMS v4) software package. Each 
array was scanned in duplicate, this process took 5 mins for GeneChip Test3 
arrays and 20 mins for HG U133A arrays. Once scanning was complete, the 
software calculated a mean of the two scanned images, by measuring intensity for 
each cell. Duplicate scanning results in improved sensitivity and reduction in 
background noise. 
 
2.8.11 Array analysis  
A number of software packages are available in order to analyse the large amount 
of data produced from microarray analysis, thus allowing comparisons between 
different samples. The raw data produced from microarray scanning results in an 
image, where the colour and intensity of the fluorescence reflect the extent of 
hybridisation of the sample to the probes present on the chip. Colours are used to 
show whether the sample has hybridised to one of the two probes (red), the other 
probe (green) and if both hybridise then resultant image is yellow (green + red). 
Initial data processing aims to produce a gene expression table. Due to redundancy 
within the microarray, each gene may be represented by several spots 
corresponding to different sequences of the same gene; controls are included with 
deliberate gene mismatch, which allows validation of gene presence. A single gene 
may correspond to around 30-40 spots. 
The analysis of the generated microarray data was performed using the DNA-Chip 
analyser (dChip) software package (Havard School of Public Health, USA). Array 
normalization to adjust overall brightness was performed by default selecting an 
array with median overall intensity as the baseline array against which all other 
arrays were normalized at probe intensity levels. The Invariant Set of 
Normalization method was used to identify a subset of probes with small, within 
subset rank, differences in the different arrays to serve as the basis for fitting a 
normalization curve. Following normalization, we identified genes differentially 
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expressed between the control, F. nucleatum, & P. gingivalis stimulated OEC 
samples. Based on previous experiences, Affymetrix and dCHip recommendations 
and published literature (Fan et al., 2005) (Corradi et al., 2008) the criteria we used 
to identify differentially expressed genes were that they showed at least a 2-fold 
change in expression level and had an absolute difference of more than 100 in the 
expression level between the samples on the control vs. test arrays. In addition, 
the following criteria were used in the analysis: the p-value threshold was set at 
0.05 (per default), filtering genes that differ within the group means with a two-tail 
p-value 0.05.  
To classify genes according to standardized Gene-Ontology (GO), vocabulary for 
the categories of biological process information from the NetAffx software 
(Affymetrix, UK) was utilised or entire datasets were imported into the Onto-
Express software (http://vortex.cs.wayne.edu/projects.htm). The default binomial 
probability distribution and Bonferroni multiple experiment correction settings of the 
software were used for data analysis. Microsoft Access (Microsoft, US) database 
queries were used to compare genes in P. gingivalis and F. nucleatum. 
In addition to utilisation of dChip bioinformatics software package, the data were 
analysed by a second bioinformatics software package GeneSpring (Agilent 
Technologies, USA). This commercially available program and is often considered 
the gold standard for micro array data analysis (Dresen et al., 2003). As well as 
analysing the data into lists of differentially expressed genes, (similar to dChip) it 
has the added benefit of having the ability to perform a wide range of advanced 
microarray analysis functions. This protocol was used to ensure that no 
differentially expressed genes were missed by utilising just one software package 
to analyse the data. In this thesis it was used to produce lists of differentially 
expressed genes using similar parameters to those used for dChip analysis.  
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2.9 Determination of cytokine levels in culture supernatants 
 
2.9.1 Enzyme linked immunosorbent assay (ELISA) 
Commercially available kits (IDS Limited, UK) were used for cytokine 
determination within the cell culture media removed from H400 cell monolayers. 
The assays were based upon sandwich ELISA methodology which allows sensitive 
and specific detection and quantification of soluble cytokines and chemokines. 
This method uses a highly-purified anti-cytokine antibody coated onto the walls of 
a plastic multiwell plate. The antibody specifically captures cytokine molecules 
present in the cell culture media introduced into the wells. Following washing of the 
wells to remove unbound material, the bound cytokine molecules are detected by 
biotin-conjugated anti-cytokine detection antibodies, followed by an enzyme-
labeled avidin or streptavidin stage. The final stage is the addition of a 
chromogenic substrate, which results in the formation of a coloured end product 
which can be quantified spectrophotometrically. The amount of colour produced is 
proportional to the amount of cytokine present in the cell culture media. All kits 
included an appropriate standard protein which is serially diluted producing a 
range of standards dilutions. These are included on the multiwell plate and allow 
production of a standard curve allowing sample quantification. 
The following protocol was used for cytokine assay of cell culture media.  
1. Cell culture media was removed from the cell monolayer and filtered through a 
0.2 micron filter in order to remove any residual cellular debris. 
2. Media was then immediately stored in 1ml aliquots at -80oC prior to use 
3. On day of assay samples were removed from storage, quickly defrosted and 
thoroughly mixed before immediate use. 
4. Samples and reagents used in the assay were equilibrated to room 
temperature prior to use. 
5. All assays (samples, controls, standards and blanks) were run in duplicate. 
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6. 100μl of standard was taken and serial diluted in the wells to produce a        
suitable standard dilution range. 
7. 100μl of sample, or blank was added to appropriate wells. 
8. 50μl of diluted biotinylated anti-body (specific to cytokine being tested e.g. IL8)     
was added to all wells  
9. The plate was then covered and incubated at room temperature (18-25oC) for 1 
h. 
10.  Following incubation the plate was washed 3 times 
11.  100μl of avidin peroxidase was added to all wells, the plate was recovered and 
incubated at room temperature for 30 mins 
12.  Following incubation wells were aspirated and the washed 3 times. 
13.  100μl of Tetramethylbenzidine (TMB) was added to all wells and incubated in 
the dark at room temperature for 12-15 mins. 
14.  Following incubation the reaction is stopped by adding 100μl of 1.8N sulphuric 
acid to all wells 
15.  Absorbance was immediately read at 450nm. 
16.  A standard curve was drawn and this was used to determine sample 
concentrations which were expressed in pg/ml. 
It should be remembered that all sample values should fall within the standard 
curve, and the curve should not be extrapolated beyond the highest standard as 
this would invalidate the results. If samples were in excess of the maximum 
standard then they were diluted prior to assay, values falling below the minimum 
standard may require addition of more sample, concentration or the assay may not 
be sensitive enough for sample assay. 
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CHAPTER 3 
 
Development & Validation of an in 
vitro Oral Epithelial Model System 
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3.1 Introduction 
Initial experiments involved the development, validation and characterisation of a 
model system to investigate the potential role of oral epithelium in the 
establishment of inflammatory responses to colonising bacterial species. An 
immortal oral epithelial cell line (H400) was chosen because it is currently one of 
the best characterised oral epithelial cell lines available (Prime et al., 1990). This 
facilitated a range of relevant experimental procedures to be employed 
(summarised in Figure 3.1) without the need for basic re-characterisation studies. 
Cells were exposed to a variety of bacterial stimulants and downstream cellular 
responses were characterised at the gene and protein expression levels. 
Specifically, activation of NF-κB, changes in expression of key pro-inflammatory 
genes and downstream cytokine production were studied.  
 
This chapter describes the characterisation of H400 cells in terms of growth 
characteristics on a range of substrates (cell culture flasks, glass slides and 96 
well plates) necessary for the proposed investigations and initial studies to 
determine the effect of E. coli LPS on activation of NF-κB.  
 
3.2  Establishing cell growth characteristics 
 
3.2.1 H400 cell growth characteristics in cell culture flasks 
In order to establish a cell culture flask-based model for the H400 cells, growth 
characteristics needed to be determined, which would optimise survival, growth, 
and production of a semi-confluent monolayer, thus permitting subsequent 
experimentation to determine the effect of microbial challenge.  
 
The aim was to achieve sufficient cells to allow detection of cellular changes, prior 
to development of a confluent monolayer, since this results in altered cell 
phenotype (Jiang et al., 2004) and ultimately induces cellular quiescence (Gos et 
al., 2005). Excessive cell growth also potentiates nutritional exhaustion of the 
growth media, inducing changes in media pH and accumulating metabolic waste 
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products. These changes invoke cellular stress and ultimately cell death. In order 
to avoid such confounding factors, a time point must be established where cells 
are semi-confluent and still actively growing in a buffered, nutritionally rich 
medium. For these reasons it was decided that the ideal level of confluence would 
be in the region of 70-80%. 
 
Cells were seeded in 25cm2 culture flasks (passage 11) at a density of 2x105 cells 
per flask in 5ml of DMEM and incubated for 2-4 days (37oC, 5% CO2). Triplicate 
flasks were included for each time point and cell counts performed after 2, 3 and 4 
days incubation (Figure 3.2). In order to determine non-adherent cell counts, cell 
culture media was removed, counts performed and viability determined using 
trypan dye exclusion as described in section 2.2.2.5. Adherent cells were then 
trypsinized to produce a cell suspension, which was counted and viability 
determined.      
Cells grew well with cell counts increasing 5-fold by day 4. Microscopic analysis 
revealed typical epithelial cell morphology and confluence was estimated to be in 
the region of 30-40% (Figure 3.3). 
 
 The results clearly showed that these culture conditions did not produce the 
desired 80% confluence. Therefore,  a second culture experiment was performed 
extending the  time course to 9 days (each time point run in duplicate) and also 
determining cell viability and the number of non-adherent cells at each time point. 
Due to the likelihood of media exhaustion over this extended experiment, media 
was removed and replaced with fresh DMEM (+10% FCS) on days 4 and 7. The 
pH of the growth media removed at each time point was also determined. 
 
Adherent cell number continued to increase over the 9 day period but the rate of 
increase was reducing by day 9 (Figure 3.4) and a semi-confluent cell monolayer 
in the region of 80% was achieved between days 5 and 7 (Figure 3.5).  
Interestingly, the numbers of adherent cells counted on days 2, 3 and 4 were 
similar to those obtained in the previous experiment (Figure 3.2). The percentage 
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of adherent, non-viable cells peaked at day 4 (11.25 %), corresponding with the 
greatest fall in media pH (Figure 3.6). The numbers of unattached cells were 
extremely low throughout the experiment (Figure 3.7) and varied between 0.006-
0.6% of the total cell count. 
 
These data demonstrated that to achieve the required level of confluence (~80%) 
with a high level of cell viability (>90%) for subsequent experiments,  25cm2 flasks 
should be inoculated with 2x105 cells in 5ml DMEM, supplemented with 10% FCS, 
and incubated for between 5 and 7 days at 37°C in 5% CO2, with the media being 
changed on day 4.  
 
3.2.2 Oral epithelial cell growth on glass slides 
In order to allow immuno-cytochemical analysis of H400 cells they would need to 
be grown on multi-well glass microscope slides, so growth characteristics were 
determined, thus allowing studies to demonstrate the cellular localisation of NF-κB. 
Glass represents a markedly different substrate from cell culture plastic ware, 
which has coated surfaces to aid cell adhesion and subsequent growth. Therefore 
this series of experiments aimed to determine the optimal growth characteristics of 
H400 cells on glass slides. 
 
Sterile glass multi-well slides in Petri dishes (2 slides per dish) containing 15ml of 
DMEM  were seeded with H400 cells at 3x105, 4x105, and 5x105 cells per dish.  
Cells were cultured for 6 days with the media being changed on day 4, slides were 
examined using an inverted microscope (x10) each day to estimate cell 
confluence. Results  (Table 3.1; Figure 3.8) demonstrated that the initial inoculum 
size was inversely related to the time taken to attain  80% confluence. The use of 
an initial inoculum of 4x105 resulted in 80% confluence at 5 days and was was 
adopted for all subsequent experiments involving stimulation of cell monolayers 
with bacteria and E. coli LPS.  This allowed for media replacement with fresh 
DMEM at day 4 and, if required, pre-incubated at this time with NF-κB modulators. 
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3.2.3 Oral epithelial cell growth in 96 well plates 
96 well, flat bottomed plates were used for the high throughput fluorescence 
immunocytochemical analyses and thus studies were performed to determine the 
growth characteristics of H400 cells in this plate format to attain a semi-confluent 
monolayer at around 80%.  
 Pilot experiments were performed that investigated initial seeding of wells with 3, 
6 and 8 x103 cells  and growth  for 5 days (being fed on day 4 with fresh DMEM). 
Microscopic examination of wells from the middle and edge of the plate were 
performed daily to estimate levels of confluence. Results suggested that 80% 
confluence was achieved at day 5 with an initial inoculum of 6x103 cells per well.  
This allowed for media replacement with fresh DMEM at day 4 (and, if required, 
pre-incubated at this time with NF-κB modulators). Counts of 20 individual wells 
following trypsinisation were performed and demonstrated a mean cell number of 
4164.9+513.2 (range of 2610 – 4898). Two wells showed low cell numbers (2610 
and 3278); their exclusion resulted in  a mean count of 4292.9+313.5.   These 
results suggested that, under these culture conditions, suitable monolayers of 
H400 cells within microwells could be produced for the high throughput 
immunocytochemistry studies. 
 
3.3  A model of NF-κB translocation 
This section reports the development of a model system, based on H400 cells, to 
identify NF-κB within the cytosol of un-stimulated cells (inactive form of NF-κB) 
and/or within the nuclei of stimulated cells (active form of NF-κB). This aim was to 
demonstrate nuclear translocation (activation) of NF-κB in H400 cells after 
stimulation/treatment with oral bacteria. Initial proof of principal studies utilised E. 
coli LPS,  a recognised activator of NF-κB (Prince et al., 2004). Studies 
investigated size of stimulus and length of stimulation to produce maximal nuclear 
translocation of  NF-κB  in this H400 model system. 
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3.3.1 Determination of nuclear translocation of NF-κB in H400 cells 
H400 cells grown for 5 days on glass slides were stimulated with E. coli LPS 
(10μg/ml; n=4) or DMEM, as the negative control (n=4), for 1h. 
Immunocytochemical staining of the cells for NF-κB after acetone fixation revealed 
cytoplasmic staining in cells treated with DMEM but extensive nuclear localisation 
in cells exposed to E. coli LPS (Figure 3.9).  Cell counts  to determine the 
percentage of cells showing NF-κB nuclear translocation demonstrated that under 
these conditions nuclear translocation had occurred in 50% of cells treated with E. 
coli LPS (Figure 3.10). 
 
3.3.2 Effect of  stimulation time 
The following studies aimed to determine the optimal stimulation time required to 
produce maximal nuclear translocation of NF-κB. Cells grown on slides were 
stimulated with E. coli LPS (10μg/ml) or DMEM (negative control) for 30, 45, 60, 75 
and 90 mins. The percentage  of cells showing nuclear translocation of NF-κB  
changed with time of stimulation and was maximal (54.2+23.2%) at 60 mins 
(Figure 3.11).  By contrast, control cells challenged with medium exhibited very low 
levels of nuclear staining (range 0.98 – 2.11%), which did not vary with time of 
treatment.  Interestingly, treatment of cells for 30 minutes with E. coli LPS did not 
stimulate activation of NF-κB above the low level seen in medium-challenged 
controls. 
 
3.3.3 Effect of E. coli LPS concentration on NF-κB activation 
Initial experiments utilised 10 μg/ml of E.coli LPS because this is a frequently 
reported standard concentration used for cell stimulation, however it appeared that 
this level produced in the region of 50% NF-κB stimulation in this model system. 
Therefore in an attempt to increase the levels of translocation H400 cells were 
stimulated with E. coli LPS at 10 and 20 μg/ml for 1h. The percentage of cells 
showing nuclear translocation of NF-κB increased from 45.5+22.6% to 98.5+8.49% 
when the LPS concentration was doubled to 20μg/ml (Figure 3.12). As a result, all 
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subsequent experiments using E. coli LPS were performed using the higher 
concentration of 20μg/ml due to the enhanced levels of NF-κB activation.  
 
3.3.4 Effect of cell confluence on E. coli LPS stimulated NF-κB translocation 
Another potential variable on NF-κB translocation in H400 cells was the effect of 
the degree of cell confluence. To investigate this Petri dishes containing 2 glass 
slides were seeded with a range of cell concentrations (3, 4 & 5 x 105 cells) and 
after 4 days growth they were stimulated for 1h with E. coli LPS (20μg/ml) or 
growth media as a  negative control.  
 
Cell confluence was estimated as 30%, 40% and 70% for initial seeding 
suspensions of 3, 4 & 5x105 cells respectively, by day 4. There appeared to be no 
differences between levels of translocation (Figure 3.13) following stimulation at 
confluence levels between 30-70% (range of NF-κB translocation 97.6 – 98.7%).  
Similarly, control levels of translocation were at a similar level to previous 
experiments and unaffected by percentage confluence (range 2.3 – 4.2%).  
 
3.3.5 Effect of time from passage (seeding) on NF-κB translocation 
Another potential confounder, which may influence epithelial cellular responses, 
was the time from cell passage or seeding prior to stimulation. As previously 
described, the passage protocol involves trypsinisation of cells in order to detach 
them from the culture plate substrate and produce a single cell suspension. This 
may involve significant cellular stress and it was hypothesised that this may affect 
cell responses to stimulation. In addition it may also cause stimulation of NF-κB in 
“un-stimulated” cells at earlier time points thus masking the effects of bacterial 
stimulation. To investigate this, cells were seeded into Petri dishes containing 
growth media and multi-well slides at a concentration of 4x105 cells and cultured 
for between 3 – 6 days. At each time point (days 3, 4, 5 & 6) slides were either 
stimulated with 20μg/ml of E. coli LPS for 1h or media (negative control). Slides 
were then removed, fixed,  stained and the percentage nuclear translocation 
determined as previously described (Figure 3.14). The levels of NF-κB activation in 
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un-stimulated cells remained low during the course of the experiment suggesting 
that at day 3 there is no detectable residual NF-κB activation resulting  from initial 
passage. However, there was an increase in the percentage of cells showing 
nuclear translocation of NF-κB from day 3 (59.8+12.5%) to day 6 (86.8+7.6%). In 
terms of developing the model system day 5 or day 6 post-seeding showed high 
levels of NF-κB activation (79.2% and 86.8% respectively) and thus deemed 
appropriate time points for investigation of NF-κB activation. 
 
3.3.6 Conclusions 
Data from this series of experiments which aimed to develop an H400 model 
system to demonstrate NF-κB translocation support the following conclusions: 
 
1. NF-κB translocation can be induced in the H400 cells when stimulated with E. 
coli LPS at 10 & 20μg/ml. 
2. E. coli LPS induces nuclear translocation in almost 100% of cells when 20μg/ml 
LPS is used for 1 hour. 
3. Nuclear localisation of NF-κB  peaks at about 60 minutes post stimulation.  
4. There appears to be no effect of cell confluence level (30-70%) in terms of the 
percentage of cells demonstrating NF-κB activation. 
5.  Levels of NF-κB translocation appear to increase with time post-passage (days 
3-6). 
 
By utilizing the data generated from this series of experiments a model system has 
been developed and validated using a known NF-κB activator (E. coli LPS).  
 
3.4  Effect of periodontal pathogens P. gingivalis (PG) & F. nucleatum (FN) on 
NF-κB translocation in H400 cells 
 
After establishing a model system for NF-κB translocation using E. coli LPS, the 
following experiments aimed to determine the effect of whole heat-killed 
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periodontal pathogens P. gingivalis and F. nucleatum upon activation of NF-κB in 
H400 cells. 
 
3.4.1 Quantitative analysis of NF-κB activation with P. gingivalis and F. nucleatum 
using manual counting methods 
H400 cells, grown on glass slides for 4 days,  were stimulated for 1 hr using whole 
dead bacteria at a concentration of 1x109 bacteria per ml (Multiple of infection 
(MOI) of 1:100, i.e. 100 bacteria per epithelial cell). Following stimulation cells 
were washed, fixed and stained for NF-κB.  
Levels of nuclear translocation of NF-κB in medium-stimulated negative controls 
were low (2.8+1.2%; Figure 3.15). By contrast, stimulation with P. gingivalis and F. 
nucleatum  produced increased levels of NF-κB translocation when compared to 
negative controls with F. nucleatum inducing higher levels of translocation 
(98.1+2.2%) than P. gingivalis (16.6+9.7%)  
 
3.4.2 Quantitative analysis of NF-κB with P .gingivalis and F. nucleatum by high 
throughput fluorescent immunocytochemistry 
The previous experiment clearly demonstrated that both  P. gingivalis and F. 
nucleatum could stimulate nuclear translocation of NF-κB in H400 cells and 
suggested quantitative differences in the ability of these two bacteria in activating 
this transcription factor. However this relied upon time consuming manual counting 
methods  (Material and methods, section 2.3.2) limiting the number of replicates 
possible. Therefore, in order to further confirm the actions of the periodontal 
pathogens tested, high throughput quantitative analysis of NF-κB translocation was 
performed (Materials and methods, section 2.4). This methodology allows analysis 
of large numbers of cells, and results can be normalised based on cell number, 
and expressed as relative intensity of cytoplasmic relative to nuclear NF-κB 
staining. 
 
The data obtained confirmed that derived from manual methods demonstrating 
that E. coli LPS (20μg/ml), F. nucleatum (MOI of 100:1) and P. gingivalis (MOI of 
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100:1) all stimulated increased nuclear translocation of NF-κB verses un-
stimulated (negative) controls (Figure 3.16).  Both bacteria stimulated greater NF-
κB activation than E. coli LPS, with P. gingivalis demonstrating higher mean of NF-
κB activation levels than F. nucleatum.  This result differed from the result obtained 
by manual counting, which relied only on nuclear staining rather than a ratio of 
nuclear to cytoplasmic staining.  
 
3.4.3 NF-κB activation time course with P. gingivalis & F. nucleatum  
Experiments in which H400 cells were stimulated by E. coli LPS suggested that the 
optimal time for maximal nuclear translocation of NF-κB was about 60 mins, but 
this may differ for intact bacteria. In order to address this issue, the high 
throughput fluorescence technique for quantification of NF-κB activation was used 
to investigate H400 stimulation by both  P. gingivalis (MOI of 100:1) and  F. 
nucleatum (MOI of 100:1)  at the time points of 0, 30, 45, 60, 90, 120 and 240 
mins. The data generated (Figure 3.17) demonstrated that both bacteria caused 
high levels of NF-κB activation at 60 mins, which was the peak time for P. 
gingivalis. Fusobacterium nucleatum appeared to stimulate maximal nuclear 
translocation of NF-κB over a wider time range, peaking  between 60 – 90 mins 
after challenge.  However, the mean maximal level of stimulation (ratio of nuclear 
to cytoplasmic staining) attained with F. nucleatum (mean+SD) was lower  than 
that found with P. gingivalis. At 240 mins after challenge, activated levels of NF-κB 
approached un-stimulated control levels. 
 
3.4.4 Conclusions 
These data demonstrated that: 
 Heat treated whole P. gingivalis and F. nucleatum activate NF-κB in the H400 
cell model. 
 Levels of NF-κB activation differed between the two techniques employed; 
manual counting, based on assessing nuclear staining alone, showed higher levels 
of activation of NF-κB by F. nucleatum, compared to P. gingivalis,  whereas the 
 70 
high throughput analysis showed equivalent or higher levels of activation  by P.  
gingivalis compared to F . nucleatum. 
 Time course experiments demonstrated that NF-κB activation peaked at 
around 60-90 mins, and there appeared to be a slight lag in activation with F. 
nucleatum compared to P. gingivalis, but F. nucleatum showed prolonged 
activation.  
 Levels of P. gingivalis and F. nucleatum induced NF-κB activation approached 
baseline (un-stimulated control) levels at 240 mins. 
 
3.5  Chapter summary 
The aim of this chapter was to develop a model system for investigating oral 
epithelial responses to the periodontal pathogens P. gingivalis and F. nucleatum. 
Experiments were separated into two main areas firstly, characterisation of H400 
cell growth patterns on a range of substrates, and secondly to determine if 
stimulation of these cells demonstrated activation of key pro-inflammatory REDOX 
sensitive transcription factor NF-κB. The results of these experiments are 
summarised below: 
 
1. Cell growth characteristics aimed at achieving 80% confluence are listed below:  
 25 cm2 plastic culture plates; seeded at 2x105 cells in 5ml DMEM and grown for 
5-7 days. 
 Glass slides in Petri dishes; seeded at 4x105 cells in 15ml DMEM and grown for 
5 days. 
 96 well plates; seeded at 6x103 cells per well in 150μl of DMEM. 
 
2. The effect of H400 cells stimulation on NF-κB activation:  
 Stimulation of H400 cells with a known activator (E. coli LPS) of NF-κB showed 
nuclear translocation with optimal levels seen with 20μg/ml of E.coli LPS for 60 
mins. 
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 Stimulation of H 400 cells with intact, heat-killed P. gingivalis and F. nucleatum 
at an MOI of 100:1 demonstrated NF-κB nuclear translocation, which was maximal 
between 60-100 mins after challenge. 
 
The data generated suggests both qualitative and quantitative differences in 
activation of NF-κB in H400 cells stimulated by these two periodontal pathogens. 
 
Having established the model system the next stage was to determine whether 
activation of NF-κB reported could be modulated using the natural antioxidant (α-
lipoate), experiments to investigate this possibility are discussed in subsequent 
chapters. 
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CHAPTER 4 
 
Effects of α-lipoate 
on 
H400 epithelial cells 
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4.1 Introduction 
The previous chapter described the development of an epithelial model system 
which on epithelial cell stimulation activated NF-κB. This chapter aimed to 
determine whether the antioxidant α-lipoate was able to modulate the activation of 
NF-κB. 
 
Initial pilot experiments suggested that α-lipoate at certain concentrations may 
reduce cell number and levels of attachment. These observations could be 
explained by a number of factors, including growth inhibition, cytotoxicity, or effects 
on cell attachment mechanisms reducing levels of cell adhesion (epithelial cells 
are unable to grow if they are not attached to a substrate). Experimentation was 
directed initially at characterising these observations and secondly at determining 
a suitable concentration / exposure time of H400 cells to α-lipoate to minimise 
these effects. 
 
4.2 Effect of α-lipoate on H400 cell viability and adherence 
 
4.2.1 Concurrent cell seeding / growth with α-lipoate 
Initially, experiments investigated H400 cells seeded into cell culture flasks 
containing media supplemented with α-lipoate. Flasks were seeded in duplicate for 
each time point (2, 3, 4, 7 and 9 days) with 2x105 H400 cells containing either 1mM 
α-lipoate supplemented DMEM or vehicle control (DMEM, no α-lipoate) and 
incubated at 37°C in 5% CO2. At each time point growth media was removed, cells 
washed and trypsinized to produce a single cell suspension. Cell counts and 
viability were performed on growth media (unattached cells) and trypsinized cell 
suspensions (attached cells). 
 
Results from this experiment indicated that α-lipoate at a concentration of 1mM in 
DMEM inhibited proliferation of H400 cells over a 9 day period when compared to 
cells incubated with DMEM containing vehicle (negative control) (Figure 4.1). 
Increases in detached cell number were also seen during the 9 days this 
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experiment was run (Figure 4.2). Up to day 5 there was little difference in the 
viability of detached cells between those grown in the presence or absence of 
1mM α-lipoate, this suggests that although detached cells are unable to proliferate 
they do retain viability (up to day 5) as determined by trypan blue staining. 
However a difference in levels of cell viability was seen on day 7 with considerably 
lower levels observed with α-lipoate treatment (63.8%) compared to those cells 
grown in plain growth media (89.4%) (Figure 4.3). When investigating attached cell 
viability on days 2, 3 & 9 there appeared to be little difference between cells grown 
with or without α-lipoate, however on days 4, 5 & 7 a difference was seen which 
suggested that attached cells supplemented with α-lipoate demonstrated higher 
levels of viability (Figure 4.4). 
 
4.2.2 The effect of α-lipoate on an established cell monolayer 
In order to determine the effect of α-lipoate on the H400 cell model system (i.e. 
glass multi-well slides with cells grown to 80% confluence), an initial pilot 
experiment was performed with α-lipoate added to growth media providing a final 
concentration of 4mM (negative control without α-lipoate was included). Slides 
were incubated under standard conditions for 24h and then microscopically 
examined (Figure 4.5). Results demonstrated reductions in levels of confluence 
with α-lipoate (number of attached cells) compared to controls. In addition, high 
numbers of unattached cells were present within the media. This suggested that 
incubating an established monolayer of H400 cells with 4 mM α-lipoic for 24h  
effected cell growth and/or attachment. 
 
To determine if the observed changes with cells exposed to 4 mM α-lipoate were 
reversible, the media was removed; the remaining attached cells were washed in 
sterile PBS and then incubated under standard conditions with fresh growth media 
(no α-lipoate). Microscopic examination over the next 3 days showed a return to 
normal epithelial cell growth patterns. In addition, the media removed from the 
treated monolayer (which contained free cells) was centrifuged with the resulting 
cell pellet being washed, re suspended in growth media and seeded into a cell 
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culture flask.  These cells reattached and grew normally. Taken together these 
observations suggest that the changes induced in cell attachment by α-lipoate are 
reversible and that this may be due to cell adhesion mechanisms rather than 
inducing cell death. 
 
The previous experiment indicated that 4mM α-lipoate had a significant effect upon 
H400 cell growth and adhesion over 24h, In order to determine the effects of α-
lipoate on the model system in terms of activation of NF-κB, experimental 
conditions that minimised these cellular effects were required.  
 
To achieve this goal 2 options were considered:-  
1. Reduction in the concentration of α-lipoate used. 
2. Reduce the cellular exposure time to α-lipoate. 
 
4.2.3 Effects of varying α-lipoate concentrations upon H400 cell growth 
Semi-confluent H400 cells were incubated with a range of α-lipoate acid 
concentrations (4, 2, 1, 0.5, 0.25, 0.125 and 0.0624 mM) for 24h and cell growth 
was examined. Duplicate cultures were run with a negative control included (no α-
lipoate-vehicle control). 
 
Results indicated a dose response between increasing concentrations of α-lipoate 
and reductions in cell count (Figure 4.6). Incubation with 4mM α-lipoate for 24h 
resulted in a 92.9% reduction in cell count. There appeared to be a marked 
difference between 1mM and 0.5mM α-lipoate, with an increase from 43.7% to 
85.5% of the control cell count. 
 
This data suggested that the use of 0.5mM α-lipoate (or less) would be a suitable 
concentration to employ for 24h incubation studies with H400 cells, with > 85% of 
cells remaining attached 
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4.2.4 The effect of varying the exposure time of H400 cells to α-lipoate on cell 
attachment  
Cells were seeded onto glass multi-well slides (in duplicate) and grown to semi 
confluence before exposure to 4mM α-lipoate or control solution (no α-lipoate). 
Slides were then incubated under standard growth conditions and examined every 
30 mins over a 3h period. At each time point, cells were examined microscopically 
with a comparison made between cells incubated with α-lipoate and the negative 
controls. 
  
Microscopic examination revealed no discernable difference between cells 
incubated with 4mM α-lipoate acid and those without, additionally no observed 
increase in the numbers of detached cells were seen. This suggested that short 
term incubation (< 3 hours) with 4 mM α-lipoate avoided the reduction in attached 
cell number seen with longer term exposure at this concentration. 
 
The results from these two experiments suggested 2 potential methods for 
exposing the H400 cells to α-lipoate whilst minimising reductions in cell growth / 
loss of cell adhesion seen in previous experiments: 
 
1. Exposure of H400 cells to < 0.5mM α-lipoate over 24h 
or 
2. Exposure of H400 cells to 4mM α-lipoate for < 3h 
 
Although these methods would allow further experimentation utilising the model 
system, the loss of attachment seen was an interesting phenomenon that was 
deemed worthy of further investigation.  
 
4.2.5   α-lipoate and apoptosis in H400 cells 
One potential reason for poor attachment and growth of H400 cells in the presence 
of α-lipoate was the induction of apoptosis. This possibility was investigated by 
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determining DNA fragmentation patterns and the expression of caspase 3, both 
characteristic signatures of apoptosis. 
4.2.5.1 DNA laddering:                                                                                            
H400 cells were grown to semi confluence (~80% confluence) and exposed to a 
range of α-lipoate concentrations (0.125, 1, 4mM) for 24h (n=2 per concentration). 
Cells were then trypsinized and harvested into lysis buffer (duplicate flasks were 
pooled for each concentration). The extracted DNA was then separated by agar 
gel electrophoresis and examined under ultra violet light (Figure 4.7). 
No evidence of DNA laddering was detected, suggesting that α-lipoate was not 
inducing apoptosis in H400 cells.  
4.2.5.2 Caspase 3 expression: 
H400 cells were grown in 96 well plates seeded at 5x103 cells per well to semi-
confluence and incubated with a range of α-lipoate concentrations and vehicle 
control for 48h (n=3 for each concentration).  After fixation, caspase 3 expression 
was determined by high throughput immunocytochemistry. 
 
Control (non-treated) cells exhibited no detectable caspase 3 expression and no 
significant change in caspase 3 expression was induced by 0.25 and 0.5mM α-
lipoate after 48h incubation. By contrast, cells incubated with 1mM α-lipoate 
showed substantial increases in caspase activity (Figure 4.8 & 4.9).  
Results from these 2 experiments suggested that apoptosis does not appear to be 
induced in H400 cells on incubation with < 4mM α-lipoate for 24h, or < 0.5mM for 
48h, however 48h incubation with 1mM α-lipoate produced substantial increases in 
levels of apoptosis.  
 
4.2.6 Methods of increasing α-lipoate treated H400 cell adherence. 
This section investigates potential methods of increasing cell adherence and 
growth of H400 cells treated with high concentrations of α-lipoate. Although the 
previous section suggested potential protocols to overcome this issue, this section 
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will investigate methods of increasing cell adherence and potentially allowing 
higher concentrations of α-lipoate to be used. 
 
4.2.6.1 Calcium supplementation 
Calcium plays a key role in cell attachment (Ko et al., 2001) both to substrates and 
adjacent cells, resulting in the development of classic tissue architecture (or 
monolayers seen in cell culture). This is achieved by calcium modulation of a 
family of molecules central to cellular interactions and adherence (cadherins, 
selectins and integrins). So the possibility exists that increasing the concentration 
of calcium in DMEM may be a potential method of increasing cell adhesion. 
Interestingly α-lipoate has been reported to chelate a range of divalent metallic 
cations (e.g. zinc, copper) (Ou et al., 1995).  Although not yet published within the 
literature, it is possible that α-lipoate could chelate calcium, reducing levels 
available to cells and therefore reducing levels of cell-cell and cell-substrate 
attachment.  
 
Calcium in the form of CaCl2 is present in DMEM at a concentration of 1mM, and 
so a range of concentrations (1, 2, 3, and 4mM) were investigated by additional 
supplementation of CaCl2 +/- 1mM α-lipoate. H400 cells were grown to semi-
confluence then incubated with 1mM α-lipoate for 24h (n=2). Following incubation, 
monolayers were examined microscopically.  Thereafter, they were washed in PBS 
to remove any non-adherent cells, trypsinized and counts performed on the 
resulting cell suspensions (Figure 4.10, 4.11) 
 
Increasing the levels of CaCl2 from a baseline of 1mM (present in DMEM) to 4mM 
in H400 cells grown to semi-confluence (without α-lipoate) resulted in a substantial 
reduction in attached cell count from 163.6x105 to 116.0x105. By contrast, 
increasing the levels of CaCl2 to 4mM in DMEM increased mean attached cell 
number after exposure to 1mM α-lipoate for 24h to control levels. (Figure 4.11).  
However, supplementation with CaCl2 at 4mM effectively reduced cell attachment 
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levels to those resulting from treatment with 1mM α-lipoate, rather than increasing 
attachment levels to those of non-supplemented (CaCl2 or α-lipoate) controls. 
 
This experiment suggested that by increasing the levels of CaCl2 in DMEM in the 
presence of α-lipoate had little beneficial effect on the number of attached cells; 
however when levels of calcium were increased without α-lipoate a reduction in 
attached cell number occurred. The net effect of CaCl2 supplementation (1-4 mM) 
was a reduction in attached cell number in un-supplemented cells, with a slight 
increase in cell attachment in the presence of 1mM α-lipoate with both 3 and 4 mM 
CaCl2 supplementation, but overall numbers of cells attached were greatly reduced 
when compared to un-supplemented CaCl2 controls without α-lipoate. Therefore it 
was concluded that the there would be little benefit in adopting this technique for 
future experimentation.   
 
4.2.6.2 Glass slide surface treatments 
The surfaces of cell culture flasks are normally treated (hydrophilic and ionic 
surface treatment in manufacture) to help cell attachment and monolayer 
development. The glass multi-well slides used to determine NF-κB activation in this 
model system were not treated in this manner and, as discussed, cell attachment 
was a particular issue in the presence of certain α-lipoate concentrations. In an 
attempt to improve cell adhesion two approaches were investigated. 
 
1. The use of commercially available electro-statically charged slides (Super 
Frost, Jencons,UK). 
2. The use of poly-L-lysine (0.1%)-treated slides. 
 
H400 cells suspended in DMEM were seeded into Petri dishes with (a) untreated 
slides, (b) Superfrost slides and (c) slides pre-treated with poly-L-lysine. Cells were 
grown to semi confluence before 24h exposure to 4mM α-lipoate or control solution 
(DMEM).  
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All control slides (no α-lipoate) showed intact semi-confluent monolayers, whereas 
near complete loss of cell adherence was seen in those exposed to α-lipoate. 
There was no microscopically discernable difference in cell attachment between 
plain slides, Superfrost & 0.1% poly-L-lysine treated slides in the presence of α-
lipoate. These results demonstrate that the treated slides investigated offered no 
benefit in increasing levels of cell attachment in the presence of this concentration 
of α-lipoate. 
 
4.2.7 Conclusions about the effect of α-lipoate on H400 cell viability and adherence  
Results from the reported series of experiments suggested that either reducing the 
exposure time or reducing the concentration of α-lipoate was the best method to 
adopt in the H400 cell model system in order to maintain cell adherence and 
growth. The other variables investigated demonstrated no benefit and may 
potentially result in the introduction of other confounding factors. 
 
Although the effect of α-lipoate on H400 cell adherence, and therefore cell 
proliferation, is substantial at concentrations greater than 0.5mM, its effect on cell 
viability is less marked.  Indicating that: 
 Attached cells had similar levels of viability to cells not exposed to α-lipoate 
(>95%). 
 Unattached cells had similar levels of viability (dye exclusion) up to day 5 of 
growth, however levels of viability reduced (~64%) with α-lipoate compared to 
untreated controls (~90%) on day 7. 
 Unattached cells exposed to α-lipoate for up to 5 days were able to attach and 
grow normally after reseeding into α-lipoate free media. 
 
4.3 Effect of α-lipoate on post stimulation NF-κB translocation 
Previous experiments aimed to determine the effects of α-lipoate on H400 cells in 
terms of cell attachment and apoptosis, with results suggesting the  maximal levels 
of α-lipoate that could be used, whilst minimising issues surrounding loss of cell 
adhesion were 0.5mM for 24h incubation and up to 4mM for short term incubation 
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(<3h). This resulted in a model system that could be treated with α-lipoate prior to 
bacterial stimulation, allowing investigations into the effect of α-lipoate on NF-κB 
activation.  
 
4.3.1 Effect of α-lipoate on NF-κB nuclear translocation in LPS-stimulated H400 
cells 
In order to determine whether α-lipoate was able to modulate levels of NF-κB 
activation, H400 cells were grown to semi-confluence on multi-well glass slides, 
pre-incubated with and without α-lipoate and than stimulated with E.coli LPS 
(20μg/ml).  NF-κB nuclear translocation was detected immunocytochemically after 
1h stimulation using an NF-kB monoclonal antibody to the p65 subunit (clone F-6, 
Santa Cruz Biotechnology, USA; diluted 1:100)  Staining controls included 
omission of the primary antibody (negative control) and use of clone MM1 (Ki67; 
positive control). Semi-quantitative analysis was performed using cell counts to 
determine percentage of cells exhibiting nuclear translocation of NF-κB. 
  
4.3.1.1 Effect of pre-incubation with 4mM α-lipoate (1h) prior to stimulation 
Un-stimulated cells showed cytoplasmic localisation of NF-κB both when pre-
incubated with vehicle (DMEM) or α-lipoate, with less than 2% of cells showing 
nuclear staining (Figure 4.12).  In contrast, stimulated cells pre-incubated with 
vehicle showed high levels of nuclear localisation of NF-κB (95.8%). Pre-
incubation of cells with α-lipoate prior to stimulation caused a >80% reduction in 
nuclear localisation of NF-κB compared to cells stimulated without α-lipoate.   
 
4.3.1.2 Effect of pre-incubation with 0.5mM α-lipoate (24h) prior to stimulation 
Un-stimulated cells showed cytoplasmic localisation of NF-κB with <1% cells 
showing nuclear localisation (Figure 4.13).  Stimulated cells showed high levels of 
nuclear localisation of NF-κB (mean=50.2%).  As seen in the previous experiment, 
pre-incubation with α-lipoate reduced levels of E.coli LPS stimulated nuclear NF-
κB translocation (mean=11.2%)  
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The results of these experiments confirmed that un-stimulated levels of NF-κB 
nuclear translocation were low and that stimulation with E.coli LPS induced high 
levels of nuclear translocation which were similar to those seen in previous 
experiments. However, the key finding was that pre-incubation with either 4mM α-
lipoate for 1h or 0.5mM for 24h prior to stimulation, induced reductions in nuclear 
translocation of between 84.6 and 77.7% respectively when compared to positive, 
non-α-lipoate controls. It was also noted that pre-incubation with α-lipoate (by 
either method) did not return levels of NF-κB activation to un-stimulated levels.  
This is a potentially important finding, as in vivo activation of NF-κB is key to the 
immune/inflammatory response, and the challenge in anti-inflammatory therapy 
would be to dampen down pro-inflammatory gene transcription in hyper 
inflammatory periodontitis patients rather than completely blocking activation of 
this essentially defence process. 
 
4.3.2 Effect of different concentrations of α-lipoate on NF-κB nuclear translocation 
on LPS-stimulated H400 cells  
To determine the effects of α-lipoate concentration on the overnight dosing model, 
H400 cells were grown to semi-confluence on multi-well glass slides and incubated 
overnight with a range of concentrations (0.25, 0.5 and 1mM) to determine if lower 
levels could be used to block LPS induced (1h) NF-ĸB translocation. Following 
stimulation, cells were fixed and immunocytochemically stained prior to performing 
cell counts to determine levels of NF-κB translocation.  
 
Both microscopic inspection of slides (Figure 4.14) and cells counts (Figure 4.15) 
clearly showed a dose related trend in levels of NF-κB translocation, with 2mM 
producing a 91% reduction and 0.25mM a 65% reduction in the levels seen in the 
vehicle treated control. 
 
This series of experiments demonstrated that 0.5mM α-lipoate incubated for 24h 
with H400 cells is a suitable concentration and time scale to use for future 
experiments. This was concluded because this protocol:   
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 had minimal effect on cell adhesion, with 85.5% cell attachment 
 did not induce apoptosis 
 blocked 78% of LPS induced nuclear NF-κB translocation 
 
4.3.3 The effect of α-lipoate on periodontal pathogen-induced NF-κB translocation. 
Previous results have shown that α-lipoate can modulate NF-κB activation in H400 
cells when stimulated by E.coli LPS.  The following experiments, based upon high 
throughput immunocytochemistry, aimed at determining whether a similar result 
was obtained after stimulation with periodontal pathogens. H400 cells were grown 
to semi–confluence in 96-well plates, pre-incubated with 0.5mM α-lipoate for 24h 
prior to stimulating with F. nucleatum or P. gingivalis (whole dead bacteria, MOI 
1:100) for 1h. Following fixing, wells were stained for NF-κB and resulting images 
analysed for NF-κB translocation using image analysis software. 
 
4.3.3.1 P. gingivalis stimulation 
Un-stimulated (vehicle control) cells demonstrated cytoplasmic NF-κB localisation 
whereas cells stimulated with P. gingivalis showed nuclear localisation (Figure 
4.16). However, when cells were pre-incubated with 0.5mM α-lipoate for 24h prior 
to stimulation levels of NF-κB activation approached those of un-stimulated 
controls (Figure 4.17). Statistically significant differences were noted between un-
stimulated control and P. gingivalis stimulated cells (p=0.0016); and between 
stimulated cells and stimulated cells with α-lipoate (p=0.0026) 
 
4.3.3.2 F. nucleatum stimulation 
Stimulation with F. nucleatum caused NF-κB activation and nuclear translocation 
whereas NF-κB in un-stimulated (vehicle control) cells remained within the 
cytoplasm (Figure 4.18). When cells were pre-incubated with 0.5mM α-lipoate for 
24h and stimulated with F. nucleatum, levels of NF-κB activation approached un-
stimulated control levels (Figure 4.19). Statistically significant differences were 
noted between un-stimulated control and F .nucleatum stimulated cells (p=0.02); 
and between stimulated cells and stimulated cells with α-lipoate (p=0.008). 
 84 
 
These data suggest that, in addition to α-lipoate modulating E.coli LPS NF-κB 
activation, it also has the ability to reduce activation when stimulated with intact 
dead  whole periodontal pathogens such as P. gingivalis and F. nucleatum. 
 
This chapter has determined suitable conditions to culture H400 cells in the 
presence of α-lipoate in order to minimise issues surrounding cell adherence. The 
methods investigated have resulted in conditions that allow investigation of α-
lipoate in the H400 model system. In addition, it has been shown that at lower 
concentrations of α-lipoate, cells do not appear to undergo apoptosis. Furthermore, 
results have shown that α-lipoate can modulate the activation of NF-κB in this 
model system when stimulated with E.coli LPS, F. nucleatum and P. gingivalis. 
This phenomenon may be important in down regulating the hyper-inflammatory 
response to plaque seen in patients with chronic periodontitis. 
 
Activation of the pro-inflammatory transcription factor NF-κB represents an early 
stage in the cellular response to stimulation and a range of downstream changes 
in gene expression will inevitably follow. Changes in gene expression resulting in 
mRNA production can ultimately lead to production of cytokines which are key to 
the initiation and propagation of the immune/inflammatory response.    
 
The following chapter will investigate the next stage of this process i.e. 
downstream changes in gene expression subsequent to NF-κB activation.  
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CHAPTER 5: 
 
 
Gene expression changes in 
periodontal pathogen stimulated 
H400 cells 
 
 
 
 
 
 86 
5.1 Introduction 
Results from previous chapters have demonstrated the ability of E. coli LPS, P. 
gingivalis and F. nucleatum to activate NF-κB in an oral epithelial model system. 
Activation of this key pro-inflammatory transcription factor is an early response to 
cell stress (in this case bacterial stimulation) resulting in phosphorylation of the NF-
kB-IkB cytoplasmic complex, ubiquitination of IkB resulting in translocation of NF-
κB into the nucleus, binding to DNA and gene transcription.  
 
Therefore the next stage of this study aimed to examine changes in gene 
expression invoked by microbial stimulation. Such gene expression changes are a 
precursor to changes in cell protein production including cytokines, which play a 
key role in cellular immune / inflammatory responses. 
 
A variety of techniques exist to investigate changes in gene expression e.g. (i) 
PCR:  which investigates genes using specific gene primers, therefore this 
technique only allows investigation of individual pre-selected genes and does not 
allow high throughput screening of large numbers of genes, thus limiting the 
amount of information on cellular response to stimulation. (ii) Microarray analysis: 
this technique allows for screening of many thousands of individual genes, and 
may identify novel genes that have an important but as yet not identified role in the 
cellular inflammatory/immune response. 
 
5.2 Verification of gene expression changes in stimulated H400 cells 
  Prior to microarray analysis, experiments utilizing sq-RT-PCR were performed to 
ensure gene expression changes could be seen in this model system. As changes 
in gene expression are downstream of NF-κB activation, a decision was made to 
look at 2 time points, 4h and 24h post bacterial stimulation. Genes that might be 
expected to be differentially expressed because of their involvement in the 
inflammatory response (IL-1β, TNF-α, IL-8 and GM-CSF) were chosen. H400 cells 
were grown to semi-confluence, stimulated with non-viable F. nucleatum, P. 
gingivalis or media (negative control), cells were harvested, RNA extracted and 
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processed to cDNA. Gene expression was determined by sq-RT-PCR normalised 
against the house keeping gene GAPDH.  
 
Results from these experiments demonstrated that stimulation with media 
(negative control) produced low levels expression of these selected genes (no 
detectable expression of TNF-α) (Figures 5.1, & 5.2).  P. gingivalis and F. 
nucleatum stimulation resulted in increased levels of gene expression at both 4 & 
24h when compared to media controls. When comparing stimulation with P. 
gingivalis or F. nucleatum, it was noted that F. nucleatum stimulated higher levels 
of gene expression compared to P. gingivalis for all 4 genes investigated and at 
both time points. Gene expression changes for both P. gingivalis and F. nucleatum 
tended to be higher at 24h compared to 4h (however this was not the case for IL-8 
in cells stimulated with P. gingivalis where relative expression dropped from 55.1% 
at 4h to 31.1% at 24h). 
 
These data confirmed that gene expression changes could be seen in the 
stimulated H400 model system and that the 24h post stimulation time point 
generally produced greater changes in gene expression when compared to 4h. In 
view of the increased expression at 24h and the hypothesis that this time point 
better represented molecular changes occurring in vivo (i.e. interactions and 
feedback mechanisms seen in chronic disease), this time point was chosen for 
subsequent microarray analysis.  
 
5.3 Microarray analysis of gene expression in stimulated H400 cells 
Changes in gene expression in H400 cells grown to semi confluence and 
stimulated with non-viable P. gingivalis, F. nucleatum or media alone were 
determined using human U133A oligonucleotide arrays. 
 
Prior to microarray analysis, the quality of RNA extracted from the stimulated cells 
was determined by using agarose gel electrophoresis (Figure 5.3). The gel showed 
2 sharp 28s and 18s RNA bands with increased intensity at 28s (which should be 
 88 
twice as intense as the 18s). This suggested intact RNA was present in all 
samples, as denatured RNA would lack the sharp 28s and 18s bands and show a 
low molecular weight smear.  The latter would not be suitable for further 
processing. The quality and integrity of RNA was further confirmed by 
spectrophotometry utilizing the 260/280 ratio, all sample ratios were >1.8 indicating 
suitable RNA quality. RNA was then processed to fragmented labelled cRNA. The 
efficiency of fragmentation and target labelling was confirmed using gel 
electrophoresis (Figure 5.4), which revealed a bright band close to the end of the 
gel. The resulting labelled cRNA was initially hybridised onto Test3 GeneChips to 
confirm sample integrity and quality. Data from the test chips was within 
manufacturer‟s recommended parameters as outlined by Affymetrix. Thereafter, 
15μg of cRNA was hybridised onto the U133 Affymetrix microarrays, stained and 
analysed.  
 
5.4 Bioinformatic analysis of microarray data 
Scanning of microarrays produced a vast quantity of gene expression data from 
the samples analysed.  Analysis of this data is key to understanding the biological 
processes taking place at the genomic level, and is termed “bioinformatics”. Data 
generated from this study was analysed using the software package DNA-Chip 
analyser (dChip). This allowed identification of differentially expressed genes 
between media (negative control) and P. gingivalis or F. nucleatum stimulated 
cells. Based on recommendations from the literature, (Seo et al., 2006) the criteria 
used to determine differentially expressed genes were that they demonstrated a 2-
fold change in expression levels with an absolute difference of more than 100 units 
in levels of expression  between samples on the control and test arrays. 
Additionally, the P-value threshold for statistical significance was set at 0.05, for 
between group means using a two-tailed test (two sample t-test) 
 
By utilising the dChip package, lists of differentially expressed genes (both up-
regulated & down-regulated) between test (P. gingivalis or F. nucleatum) and 
control (media) were generated (Tables 5.1, 5.2, 5.3, 5.4, 5.5 & 5.6).  Analysis of 
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this data indicated that P. gingivalis and F. nucleatum stimulation resulted in 
differential expression of 409 and 609 genes respectively.  Cells stimulated with P. 
gingivalis showed 170 genes up-regulated and 239 down-regulated. By 
comparison, stimulation with F. nucleatum produced 247 up-regulated and 362 
down-regulated genes. To determine commonality between F. nucleatum and P. 
gingivalis differential gene regulation, data was analysed using a Microsoft Access 
database with the Affymetrix Probe ID as the primary key. This indicated that from 
a total of 1018 differentially expressed genes only 91 were common to both 
datasets, with 47 up-regulated and 44 down-regulated (Figure 5.5). Results 
demonstrated a number of genes that have been widely reported as important in 
immune/inflammatory responses in other epithelial based systems, however it also 
highlighted a number of other genes, so called novel genes, that have not 
previously been associated with periodontal disease.  In order to represent this 
data in a biologically relevant format and to more thoroughly characterise sets of 
functionally related genes, the data was organised into gene ontological groupings 
by using the Onto-Express software package. This approach allowed the 
determination of biological processes that were up or down regulated following 
stimulation with periodontal pathogens. This data is summarised in Figures 5.6, 5.7 
& 5.8. 
  
Analysis of data and ontological grouping demonstrated that gene expression 
changes seen in this stimulated epithelial cell model were consistent with functions 
that may indicate a role of pocket epithelium in disease pathogenesis such as 
neutrophil chemotaxis, neutrophil activation and the inflammatory response. These 
findings lend support to the hypothesis that gingival epithelium may play a role in 
the initiation and orchestration of the exaggerated inflammatory response which 
characterises the periodontitis phenotype. 
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5.5 Confirmatory sq-RT-PCR to validate microarray results 
The results obtained from microarray analysis were supported by the initial gene 
expression changes utilising sq-RT-PCR (Figures 5.1 & 5.2).  However to further 
validate the microarray results, additional sq-RT-PCRs were performed for genes 
selected using the following criteria:- 
 
 Previously not described as being induced in oral epithelial cells by periodontal   
      pathogens or reported as being involved in periodontal disease pathogenesis 
 Genes differentially expressed by either P. gingivalis or F. nucleatum      
 Genes that may have a role in periodontal disease pathogenesis 
 
Based upon these selection criteria, sq-RT-PCR was performed to determine 
levels of expression of genes coding for haemoxygenase (HMOX), lysyl oxidase 
(LOX), superoxide dismutase 2 (SOD2), chemokine (C-C motif) ligand 20 (CCL20), 
migration inhibitory factor related protein 8 (MRP8 / S100A8) and migration 
inhibitory factor related protein 14 (MRP14 / S100A9).  
 
 Haemoxygenase:  has a key role in cellular protection against injury caused by 
reactive oxygen species and oxidative stress and was differentially expressed in 
the microarray data (up-regulated by P. gingivalis +21.1 not differentially 
expressed by F. nucleatum) 
 Lysyl oxidase: an extracellular enzyme that catalyses the cross-linking of 
collagen and elastin, essential for stabilization of collagen fibrils and for the 
integrity and elasticity of elastin. (down regulated by both P. gingivalis and F. 
nucleatum, -6.07 and -4.14 respectively) 
 Superoxide dismutase 2: the mitochondrial superoxide dismutase which 
catalyzes the break down of superoxide into oxygen and hydrogen peroxide and 
therefore is an important antioxidant cellular defence mechanism. (up-regulated in 
P. gingivalis and F. nucleatum, +2.7 and +4.69 respectively) 
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 Chemokine (C-C motif) ligand 20: a chemotactic cytokine for lymphocytes and 
neutrophils, induced by lipopolysaccharide and TNF-α (up-regulated in P. 
gingivalis and F. nucleatum, +6.39 and +5.7 respectively) 
 Migration inhibitory factor related protein 8 (S100A8) & 14 (S100A9): Members 
of the S100 protein family. Increased levels of this protein are seen in inflammatory 
lesions. Functionally they have antibacterial properties implicated in protection 
against invading bacteria. Reactive oxygen species (ROS) implicated in 
periodontal disease pathogenesis, induce production of Migration inhibitory factor 
related proteins (MRP) which has been reported to offer host cell protection to 
ROS. These genes have interesting properties in terms of periodontal disease 
pathogenesis and epithelial barrier function. MRP-8 was not differentially 
expressed in the microarray data on stimulation with F. nucleatum but with P. 
gingivalis showed reduced levels of expression (-4.15 fold change). MRP-14 was 
up-regulated by F. nucleatum (+2.49 fold change) but down regulated by P. 
gingivalis (-2.56 fold change) 
 
5.5.1 Results 
This section will present the results of analysis of individual genes by sq-RT-PCR 
(Figure 5.9) and compare with individual gene microarray data.  
 
SOD-2 and CCL-20 gene expression showed the same trend for both RT-PCR and 
microarray analysis with both P. gingivalis and F. nucleatum stimulation increasing 
levels of gene expression. S100A8 and S100A9 showed a similar trend between 
these two techniques, with F. nucleatum stimulation causing increased gene 
expression. P. gingivalis reduced gene expression as tested by microarray 
analysis, and showed little difference over un-stimulated controls when utilising sq-
RT-PCR. Fusobacterium nucleatum stimulation resulted in little change in HMOX 
gene expression when compared to controls for either technique, however 
stimulation with P. gingivalis did increase HMOX gene expression.  In the case of 
LOX, high levels of un-stimulated gene expression were seen by both microarray 
and sq-RT-PCR techniques, stimulation with P. gingivalis or F. nucleatum resulted 
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in reductions in gene expression. These reductions were large for P. gingivalis and 
F. nucleatum (microarray analysis) and P. gingivalis (sq-RT-PCR), however when 
sq-RT-PCR was used to determine F. nucleatum stimulated gene expression this 
change was small. 
 
In an attempt to compare the data obtained by these two techniques (RT-PCR & 
microarray), individual graphs were plotted for each gene which included data from 
both microarray and RT-PCR (Figure 5.9). Data from microarray analysis included 
negative values (indicating gene down regulation) and therefore all microarray 
gene data was normalised to the most negative value, which allowed a more 
meaningful graphical representation, facilitating identification of trends between 
methodologies. From these graphs, microarray analysis produced similar trends to 
the confirmatory PCR data. There were 2 results that contradicted the microarray 
results – (a) F. nucleatum stimulation on S100A8 (not differentially expressed in 
microarrays but increased expression in PCR analysis). (b) P. gingivalis 
stimulation on S100A9 (down-regulated in microarrays but up-regulated when 
assessed by PCR). There may be a number of reasons for this discrepancy which 
include different methods of RNA processing required for each technique, 
bioinformatic handling of data from microarray analysis, different levels of 
sensitivity between the two techniques and interference between RNA within the 
sample (Ach et al 2008).  Apart from these 2 outlying results, microarray and PCR 
data showed close similarities in gene expression and increased confidence in the 
validity of the microarray results.    
 
5.6 Conclusions 
This chapter has demonstrated that stimulation of H400 cells with the periodontal 
pathogens F. nucleatum and P. gingivalis results in differential effects at a 
molecular level. Analysis of these gene expression changes allows increased 
understanding of the pathways induced by microbial stimulation and highlights 
potential mechanisms underpinning the pathogenesis of chronic periodontal 
disease. Examples of such mechanisms are the recruitment and activation of 
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immune system cells (e.g. IL-8, TNF-α, IL-1β and GM-CSF), and genes having an 
important role in cellular protection (e.g. HMOX, and S100A8/S100A9). 
 
In addition to confirming a pro-inflammatory response microarray analysis allowed 
identification of a number of novel genes not previously described in periodontitis, 
and which may play an important role in disease pathogenesis, and are worthy of 
further investigation (e.g. S100A8/A9, LOX, HMOX, CCL-20, SOD-2). 
 
The changes in gene regulation reported in this chapter do not tell the whole story 
in terms of cellular responses to stimulation; regulatory changes in gene 
expression are not always represented by protein production (e.g. cytokines) and 
ultimately responsible for immune/inflammatory effects. The following chapter aims 
to address this issue by investigating downstream stimulated cell cytokine 
production. 
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The effects of α-lipoate on H400 
gene expression & cytokine 
production 
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6.1 Introduction 
Previous chapters have reported the ability of F. nucleatum and P. gingivalis to 
activate NF-κB within oral epithelial cells. A wide range of pro-inflammatory gene 
expression changes have also been demonstrated, a number of which have been 
reported as downstream to NF-κB activation. The most widely reported gene up-
regulated post NF-κB activation is IL-8, which has been termed a „surrogate 
marker‟ of NF-κB activation. Data from this thesis has indicated that on stimulation 
with P. gingivalis and F. nucleatum H400 cells demonstrated large increases in IL-
8 gene expression at both 4 and 24h post stimulation. In addition a number of 
other key pro-inflammatory genes associated with NF-κB activation were up-
regulated e.g. IL-1β, TNF-α, and GM-CSF. Immuno-cytochemical analysis has 
demonstrated the ability of α-lipoate to reduce NF-κB activation in H400 cells 
following stimulation with P. gingivalis and F. nucleatum; however the effect of α-
lipoate on pro-inflammatory gene expression has yet to be determined. Thus the 
first part of this chapter reports upon studies that investigate the action of pre-
incubation with α-lipoate on P. gingivalis and F. nucleatum stimulated H400 gene 
expression. The choice of genes for these experiments was based on those having 
a potential role in periodontal disease pathogenesis e.g. pro-inflammatory genes 
and genes involved in bacterial recognition (Toll-like receptors). In addition, novel 
genes detected by microarray analysis of stimulated H400 cells, which may have 
an as yet unreported role in periodontal disease pathogenesis were also included. 
 
The second part of this chapter examines whether the gene expression changes 
detected are manifest at a protein level i.e. that they are potentially biologically 
relevant. These cytokines are produced downstream of cell stimulation and are 
bioactive end products which may have a role in periodontal disease 
pathogenesis. Results thus far have shown a variety of gene expression changes 
in H400 cells stimulated with P. gingivalis and F. nucleatum, however gene 
expression changes do not necessarily equate with cytokine production. Therefore 
this section will investigate post-stimulation cytokine production with or without α-
lipoate pre-incubation. A range of cytokines known to be important in the 
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inflammatory response, and whose gene expression have previously been shown 
to be up-regulated were chosen for analysis i.e. IL-8, GM-CSF, TNF-α, & IL-1β. 
 
6.2 Effect of α-lipoate on gene expression by sq RT-PCR 
H400 cells were pre-incubated for 24h + α-lipoate (0.5mM), and then stimulated 
with P. gingivalis, F. nucleatum or media (un-stimulated control) for a further 24h. 
RNA was extracted from the H400 cells and processed to cDNA then normalised 
to the house keeping gene GAPDH prior to sq RT-PCR. 
Results from this series of experiments are grouped ontologically, based on the 
reported main function of each gene, as described below. Electrophoresis gel 
images of individual genes are shown in Figure 6.1  
 
6.2.1 Pro-inflammatory genes 
Interleukin 8, GM-CSF, TNF-α, and IL-1β (Figure 6.2) demonstrated increases in 
gene expression when stimulated with both P. gingivalis and F. nucleatum and 
compared to un-stimulated controls. The levels of gene expression were higher 
with P. gingivalis stimulation compared to F. nucleatum for these pro-inflammatory 
genes. Pre-incubation with α-lipoate prior to stimulation with P. gingivalis or F. 
nucleatum resulted in reduced levels of gene expression. However, reduced 
expression levels were still higher than those of un-stimulated controls, suggesting 
that α-lipoate did not completely block bacterial stimulation of these pro-
inflammatory genes.  
 
6.2.2 Bacterial recognition (Toll-like receptors) 
Gene expression of TLR-2 and TLR-9 (Figure 6.3) in un-stimulated H400 cells was 
relatively high; in contrast to un-stimulated levels of TLR-4 which were low. Pre-
incubation with α-lipoate without stimulation, resulted not change in TLR-2 gene 
expression, however significant increases in TLR-9 (increase of 51.3 to 85.7%) 
and TLR-4 (increase of 2.1 to 87.7%) expression. When cells were stimulated with 
F. nucleatum or P. gingivalis increased gene expression was noted for TLR-2 
(increase from 87.2 to 100 or 92.9% respectively) and TLR-4 (increase from 2.1 to 
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29.6 or 61.0% respectively). By contrast F. nucleatum or P. gingivalis stimulation 
caused a reduction in TLR-9 expression (reduced from 51.3 to 44.5 or 25.0% 
respectively).  Pre-incubation of H400 cells with α-lipoate prior to F. nucleatum or 
P. gingivalis stimulation resulted in a small reduction in gene expression for TLR-2, 
however in contrast a marked increase in expression was seen for TLR-4 (F. 
nucleatum from 29.6 to 93.6%; P. gingivalis from 61.0 to 82.1%) and TLR-9 (F. 
nucleatum from 44.5 to 100%; P. gingivalis from 25.0 to 74.0%). The increases in 
TLR-4 and 9 gene expression in both un-stimulated and periodontal pathogen 
stimulated cells pre-incubated with α-lipoate is a novel and interesting finding and 
suggests it‟s addition may increase the efficacy of cellular bacterial recognition.  
 
6.2.3 Epithelial protection 
Two members of the S100 protein family (Calprotectin – S100A8 & S100A9) were 
differentially expressed in previous experiments (Section 5.4). PCR analysis 
demonstrated high baseline (un-stimulated) gene expression levels of these 
proteins (Figure 6.4). Fusobacterium nucleatum stimulation caused increases in 
both S100A8 and S100A9 (both showing an approximate 30% increase over un-
stimulated control). Porphyromonas gingivalis stimulation appeared to result in little 
difference from the baseline levels of gene expression. Pre-incubation with α-
lipoate for both of these genes resulted in substantial reductions in gene 
expression for both un-stimulated and stimulated cells.  
 
6.2.4 Antioxidant defence 
Cellular antioxidant levels have a major impact on pro-inflammatory responses via 
NF-κB. Analyses were performed on two genes important in antioxidant defence 
(SOD-2 & HMOX) and differentially expressed in the microarray analysis (Section 
5.4). SOD-2 (Figure 6.5) gene expression levels increased after stimulation with P. 
gingivalis and F. nucleatum when compared with un-stimulated controls (increase 
from 29.2 to 84.3 or 94.1% respectively). The addition of α-lipoate to un-stimulated 
cells resulted in a small increase in gene expression. The addition of α-lipoate to 
cells stimulated with P. gingivalis and F. nucleatum made little difference to levels 
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of SOD-2 gene expression, (P. gingivalis a small reduction and F. nucleatum a 
small increase). Baseline H400 cell HMOX gene expression in un-stimulated cells 
was relatively high (Figure 6.5), and stimulation with F. nucleatum resulted in little 
change in expression. Stimulation with P. gingivalis resulted in increased gene 
expression when compared to un-stimulated controls. α-lipoate appeared to have 
little effect on un-stimulated cells, however, its effects on gene expression of 
stimulated cells were variable. Pre-incubation with α-lipoate reduced P. gingivalis 
stimulated gene expression (reduced from 100 to 63.3%), but increased (from 60.6 
to 75.8%) F. nucleatum induced gene expression. 
 
6.2.5 Tissue repair 
From the microarray data, one of the genes that was strongly down-regulated 
following stimulation with both P. gingivalis (-6.9 fold) and F. nucleatum (-4.1 fold) 
that was the gene that codes for lysyl oxidase (LOX). The gene product has been 
shown to be a key enzyme in the biogenesis of connective tissues, acting via cross 
linking of collagen and elastin. This enzyme may therefore play a role in the 
formation and repair of the periodontal tissues. RT-PCR analysis revealed high 
levels of basal un-stimulated LOX gene expression (Figure 6.6). Stimulation with F. 
nucleatum caused little effect on gene expression. By contrast stimulation with P. 
gingivalis resulted in a large reduction in expression, when compared to control 
levels (reduced from 100 to 20.2%). Similarly, pre-incubation of cells in α-lipoate 
resulted in a reduction in LOX gene expression (reduced from 100 to 15.1%). Pre-
incubation of cells with α-lipoate prior to stimulation with F. nucleatum reduced 
levels of gene expression (from 94.2 to 34.3%). α-lipoate had little effect on the 
levels of LOX gene expression resulting from stimulation with P. gingivalis. 
 
6.2.6 Other genes 
The effects of periodontal pathogen stimulation, and pre-incubation with α-lipoate 
were determined for three other genes, NF-κB1, CCL-2 & CCL-20.  
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6.2.6.1 CCL-2 & CCL-20 
These chemokines both have chemo attractant properties for inflammatory cells. 
Stimulation with P. gingivalis and F. nucleatum resulted in increased expression for 
both of these genes. Pre-incubation with α-lipoate resulted in reduced gene 
expression of CCL-20 in both stimulated and un-stimulated cells. CCL-2 showed a 
similar trend for un-stimulated and P. gingivalis stimulated cells, however pre-
incubation with α-lipoate and stimulation with F. nucleatum resulted in no 
differences (Figure 6.7).  
 
6.2.6.2 NF-κB1 
NF-κB1 is a precursor protein of NF-κB subunit p50, and therefore has a key role in 
the maturation of NF-kB. Expression of this gene was high in un-stimulated cells, 
and these levels increased further on stimulation with P. gingivalis and F. 
nucleatum. Pre-incubation with α-lipoate resulted in a reduction in gene expression 
both in un-stimulated cells as well as P. gingivalis and F. nucleatum stimulated 
cells (Figure 6.8). 
 
6.3 Pro-inflammatory cytokine production 
 
6.3.1 ELISA cytokine analysis 
Commercially available cytokine ELISA kits (Section 2.9) were used to determine 
supernatant (DMEM growth media) levels of IL-8, GM-CSF, TNF-α, & IL-1β. 
Growth media was removed, filtered and stored at -80oC prior to analysis. Each 
sample was run in duplicate, with a range of standards included to produce a 
standard curve All standard curves were shown to exhibit straight line relationships 
(IL-8 R2=0.986; TNF-α R2=0.998; GM-CSF R2=0.987 & IL-1β R2=0.992). 
 
6.3.1.1 Effect of P. gingivalis & F. nucleatum stimulation 
Un-stimulated H400 cells produced low levels of IL-1β (5.61, 9.06 ρg/ml) and GM-
CSF (17.06, 18.58 ρg/ml), compared to IL-8 (325.6, 309.33 ρg/ml). By contrast, 
basal levels of TNF-α were not detectable. Stimulation of H400 cells with F. 
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nucleatum caused increased levels of all of the tested cytokines when compared to 
un-stimulated controls (Figure 6.9). In each case the levels seen were higher than 
those produced with P. gingivalis. Stimulation with P .gingivalis also resulted in 
increased levels of IL-8, GM-CSF & IL-1β over un-stimulated controls. However P. 
gingivalis failed to stimulate production of detectable levels of TNF-α. 
 
6.3.1.2 Effect of α-lipoate pre-incubation 
Pre-incubation of H400 cells with 0.5mM α-lipoate resulted in reductions in the 
levels of IL-8, GM-CSF and IL-1β, stimulated by P. gingivalis and F. nucleatum. In 
addition α-lipoate appeared to cause a small reduction in un-stimulated levels of 
cytokine production. In the case of TNF-α, pre-incubation with α-lipoate reduced 
levels of the F. nucleatum stimulated cytokine. In all cases, the reduced cytokine 
production elicited by α-lipoate did not completely remove the cellular response, as 
levels were still greater than those produced by un-stimulated cells. Thus, α-lipoate 
reduced but did not stop P. gingivalis and F. nucleatum stimulating cytokine 
production by H400 cells 
 
6.4  Conclusions 
This chapter aimed to investigate the effect of α-lipoate on the H400 model system 
in terms of changes in gene expression and cytokine production. Data from these 
experiments demonstrated the ability of F. nucleatum & P. gingivalis to produce 
changes in gene expression as well as enhanced production of a range of key pro-
inflammatory cytokines. H400 cell pre-incubation with α-lipoate demonstrated a 
range of variable effects including reduction of key pro-inflammatory gene 
expression levels and cytokine production in stimulated cells.  
Interestingly, when comparing gene expression changes in IL8, TNF-α, GM-CSF 
and IL1-β with cytokine production, differences were evident. The trend is for 
higher gene expression levels post P. gingivalis stimulation compared to F 
.nucleatum, however the reverse is true when assessing cytokine production 
levels. These differences may be due to gene expression changes not being 
represented in protein production (gene expression changes don‟t necessarily 
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equate to protein production), assessment at a single time point (24h) different 
result may be evident if a longer time course was investigated, the two bacteria 
may activate other cell processes causing feedback mechanisms preventing or 
down regulating protein production. Both PCR and cytokine production of these 
cytokines in stimulated H400 cells is reduced when pre-incubated with α-lipoate.  
The effect of α-lipoate on TLR receptors is of interest with a slight reduction in 
gene expression of TLR-2, but increases in expression of TLR-4 & 9, and may 
suggest that α-lipoate increases levels of TLR 4 & 9, therefore increasing the 
ability of the cells to detect periodontal pathogens. Interestingly, when α-lipoate 
pre-incubation has reduced periodontal pathogen stimulated effects on epithelial 
cells it does not return to un-stimulated levels. This finding may be of considerable 
significance, as complete blocking of this key first line epithelial defence response 
to bacterial challenge may render the host susceptible to infection. Rather α-lipoate 
appears to modulate the stimulated response, therefore having potential in 
modulating the hyper-inflammatory response seen in periodontitis.   
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CHAPTER 7 
 
Concluding discussion 
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7.1 Introduction 
This thesis proposed a biological role for crevicular/pocket epithelium in 
periodontal disease pathogenesis. The results obtained are now discussed with 
specific reference to those that underpin this proposal (Figure 7.1) including novel 
findings that may augment our current understanding of periodontal disease 
pathogenesis. In addition, modulation of this process with a novel antioxidant 
dithiol, α-lipoate is discussed. 
  
7.2 Epithelial cell activation 
Individual stages in epithelial cell activation are discussed in terms of NF-κB 
activation (Figure 7.1: label 1), induction of gene expression changes (Figure 7.1: 
label 2) and cytokine production (Figure 7.1: label 3). Data from this thesis 
demonstrating the activation of H400 epithelial cells for each of these stages is 
presented. 
 
7.2.1 Bacterial recognition / Toll-like receptor expression. 
Toll-like receptors (TLR) are important pattern recognition receptors which are 
present on cell surfaces and have the ability to recognise bacterial components. 
Once stimulated these receptors cause cell activation via a range of pathways 
including NF-κB (Zhang and Ghosh, 2001). Gene expressions of three Toll-like 
receptors were investigated in this thesis (TLR-2, 4 and 9; Results section 6.2.2). 
Baseline expression of these receptors in un-stimulated H400 cells appeared to 
vary, however all were identified as being expressed. Stimulation with P. gingivalis 
or F. nucleatum resulted in a relatively large increase in expression of TLR-4 
(small increase in TLR-2), and a decrease in TLR-9 expression. Increased 
expression of TLR-4 by microbial stimulation, and specifically Gram negative 
bacterial lipopolysaccaride (LPS), may be due to autocrine feedback mechanisms 
in response to TLR activation by P. gingivalis and F. nucleatum. This increased 
TLR-4 gene expression (which may translate to increased surface receptor 
expression) may enhance epithelial responses to LPS. Moreover as bacterial 
clearance from cells may also be regulated by this receptor (Song et al., 2009), 
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elevated levels of TLR-4 may also contribute in vivo to cellular sensitivity to 
facilitate removal of intracellular pathogens such as P. gingivalis. 
 
The data presented in this thesis suggest a difference in levels of TLR-4 activation 
between P. gingivalis and F. nucleatum, with F. nucleatum stimulating lower levels 
of gene expression when compared to P. gingivalis.  Potentially, this difference 
could confer an advantage to F. nucleatum in vivo, as reduced TLR-4 expression 
may facilitate evasion of detection by the host‟s immune system (Wolfe et al., 
2009). 
 
Interestingly, a recent study has reported that P. gingivalis interacts with TLR-2 
(more commonly associated with Gram positive bacteria, viruses and yeasts) to 
stimulate epithelial cells rather than via TLR-4, the classic Gram negative LPS 
receptor (Kocgozlu et al., 2009).   The increased expression of the TLR-2 gene in 
H400 cells stimulated by P. gingivalis, perhaps indicates that this organism has the 
ability to up-regulate pro-inflammatory responses of epithelial cells to itself and 
other bacteria within the subgingival biofilm.  Such a property would support the 
role of this “red-complex” organism (Socransky, 1970) and crevicular/pocket 
epithelium in the aetiology and pathogenesis of periodontitis. Whilst it is important 
to remember that gene expression data may not be reflected in changes in levels 
of cellular TLRs, the data does suggest that two organisms present in the 
subgingival biofilm are associated with periodontitis have the potential to increase 
epithelial responses to bacteria, viruses and yeasts by modulating expression of 
these important cell receptors. 
 
7.2.2 NF-κB activation 
Initial experiments using a „gold standard‟ NF-κB activator [E.coli LPS; (Prince et 
al., 2004)] demonstrated nuclear translocation of NF-κB in the H400 cell model 
system. Additionally, immunocytochemistry (individual slide and high-throughput 
data) demonstrated the ability of both F. nucleatum and P. gingivalis to activate 
NF-κB as indicated by nuclear translocation (Results section 3.3). Porphyromonas 
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gingivalis and F. nucleatum stimulated maximal nuclear translocation of NF-κB at 
60-90 mins post stimulation, which was in agreement with time course data 
obtained using E. coli LPS stimulation. Thus, periodontal bacteria clearly have the 
ability to activate the epithelial NF-κB pathway, which has a central role in 
promoting expression of pro-inflammatory genes (Silverman and Maniatis, 2001). 
This step is likely to be crucial for subsequent synthesis and secretion of the 
epithelial-derived cytokines necessary to initiate and/or propagate a local 
inflammatory response within the periodontal tissues. 
 
Assessment of the temporal differences in NF-κB activation between the 
periodontal pathogens appeared to indicate that P. gingivalis caused maximal 
activation of NF-κB at a marginally earlier time-point, and at a higher level of 
induction compared with F. nucleatum. In addition, activation by F. nucleatum also 
appeared more prolonged (Results section 3.4.3). These findings may have 
important implications for disease pathogenesis as they could indicate that P. 
gingivalis initiates epithelial cell activation and downstream pro-inflammatory 
responses, whereas subsequent F. nucleatum stimulation prolongs this response. 
This data suggests that these two bacteria, as part of the plaque biofilm, may 
synergistically activate the epithelium thereby contributing to the exaggerated 
inflammatory response observed in periodontitis patients. Time course 
experiments demonstrated that activated NF-κB returned to levels comparable with 
those of un-stimulated cells 4h post stimulation. The reduction in NF-κB activation 
at this time point, occurred in the presence of chronic bacterial exposure, which 
notably mimics the situation present within the periodontal pocket. These findings 
pose further important questions which include i) does NF-κB require further 
stimulation to become re-activated?, or ii) is a time lag necessary to allow the 
biological system to recycle itself prior to further NF-κB reactivation? As the data 
indicate that there is a time period when NF-κB is not reactivated despite the 
stimulant still being present, the length of this „refractory‟ period may be of 
considerable importance in chronic inflammatory diseases. Hypothetically it may 
be that this period is reduced in patients with periodontal disease, leading to 
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increased frequency of NF-kB activation which may therefore contribute to chronic 
hyper-inflammation. Review of the literature currently demonstrates little research 
into this phenomenon, and this therefore represents an important area for future 
study. 
 
7.2.3 Gene expression analyses 
NF-κB nuclear translocation and subsequent promoter binding results in gene 
expression which in turn leads to the production of proteins, especially pro-
inflammatory cytokines, implicated in the inflammatory and immune responses.  
 
7.2.3.1 Pro-inflammatory cytokine gene expression 
Initial sq-RT-PCR confirmed that stimulation of H400 cells with either P. gingivalis 
or F. nucleatum  for 4 and 24h caused up-regulation of key pro-inflammatory 
genes (including IL-1β, TNF-α, IL-8 and GM-CSF), with the largest changes seen 
at 24h.  Further microarray analysis confirmed these findings and demonstrated 
that the majority of up-regulated genes were associated with immune/inflammatory 
and chemotaxis responses (Results section 5.4). The stimulated up-regulation of 
pro-inflammatory genes demonstrated both with sq-RT-PCR and microarray 
analysis, fits well with the hypothesis that the epithelial lining of gingival 
crevice/pocket can mount and regulate a pro-inflammatory response following 
interaction with bacteria within the subgingival plaque biofilm. 
 
Analysis of microarray data for the two periodontal bacteria examined identified 
relatively few differentially expressed genes common to both organisms (91 up- 
and down-regulated), and the majority of differentially regulated genes were 
specific to either P. gingivalis or F. nucleatum. Ontological grouping of the 
commonly up-regulated genes demonstrated a predominance of transcripts 
involved in regulating inflammatory functions including cell proliferation, cell 
signalling, protein metabolism, signal transduction and apoptosis (Figure 7.2).  
Further investigation of this dataset may provide a better understanding of the 
epithelium‟s molecular response to the complex bacterial challenge induced by 
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biofilm exposure, rather than individual organisms. However investigation of genes 
that are specific to either P. gingivalis or F. nucleatum epithelial stimulation may 
also provide a better understanding of the role of specific bacteria in periodontal 
disease pathogenesis.  
 
It may be hypothesised that a balanced non-pathogenic plaque biofilm may induce 
a relatively low level of epithelial inflammation, enabling the existence of 
homeostasis between the host and biofilm. However if certain key periodontal 
pathogens dominate (e.g. P. gingivalis or F. nucleatum) then the gene 
transcriptional changes associated with these bacteria could predominate causing 
an elevated pro-inflammatory response, along with other changes that could effect 
healing of the periodontal lesion and of epithelial barrier function. Further study of 
the molecular interactions between the epithelium and single bacteria or complex 
biofilms would help to determine the validity of this hypothesis and its relevance to 
periodontal disease pathogenesis. 
 
7.2.3.2 Potential importance of other genes identified in periodontitis  
Microarray analysis also identified genes (Results section 5.4) which may play a 
role in the pathogenesis of periodontitis that are part of the specific disease model 
under investigation (Figure 7.2). Haemoxygenase (HMOX) was up-regulated by P. 
gingivalis but not F. nucleatum, and notably this molecule has been implicated in 
cellular protection against reactive oxygen species (Hisada et al., 2000) which are 
now considered important in the pathogenesis of periodontitis (Chapple and 
Matthews, 2007). In addition, increased HMOX production has been reported to 
decrease TNF-α induced inflammation via reduction in NF-κB activation in airway 
smooth muscle cells (Lee et al., 2009). The differential expression of the HMOX 
gene between these two organisms may be of particular interest. Whilst P. 
gingivalis increased HMOX gene expression, suggesting that it may induce anti-
inflammatory pathways activated via HMOX, in contrast F. nucleatum stimulation 
did not increase HMOX gene expression. These data indicate that P. gingivalis 
may have the capacity to modulate the pro-inflammatory response and thereby 
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evade host defence mechanisms, thus aiding it‟s colonisation of the periodontal 
tissues. 
 
Superoxide dismutase (SOD) is a key enzyme important in antioxidant defence 
(Sasaki et al., 2000), and was up-regulated in H400 cells stimulated with P. 
gingivalis and F. nucleatum. Recent reports indicate elevated SOD levels can 
reduce levels of IL-8 production in stimulated cells (Mulligan et al., 2009). This 
effect may be due to its antioxidant action influencing the intracellular REDOX 
status and acting via the REDOX sensitive transcription factors such as NF-κB. 
Notably reduced levels of SOD have recently been reported in patients with 
chronic periodontitis (Akalin et al., 2009, Akalin et al., 2008). These studies 
compared SOD levels in GCF, serum and gingival biopsy samples, with results 
indicating a statistically significant difference in levels between chronic periodontitis 
patients and healthy controls. The reduced levels seen in periodontitis patients 
may indicate compromised host antioxidant defence mechanisms in chronic 
periodontitis.  Combined data indicate that it is therefore possible that SOD activity 
may play an important role in epithelial cell defence as well as periodontal disease 
pathogenesis. 
 
The Lysyl oxidase (LOX) gene, which encodes an enzyme important in collagen 
maturation (Rodriguez et al., 2008), exhibited decreased epithelial cell expression 
following exposure to P. gingivalis and F. nucleatum.. The finding that both 
bacteria down-regulated its expression may be of importance in periodontitis, as 
maturation of collagen is important in the wound healing and tissue repair 
processes (Lau et al., 2006). Whilst it is acknowledged that collagen is mainly 
produced by fibroblasts and is a key component of the submucosa (Grinnell, 2008) 
reduction in LOX levels by the epithelium may impact deleteriously on the 
supporting periodontal tissues. Moreover whilst LOX expression was examined 
here in epithelial cells it is known that fibroblasts express TLR-2 and -4 (Hirao et 
al., 2009) and therefore it is logical to speculate that periodontal infection may also 
lead to reductions in fibroblast LOX levels. Combined, the data suggest that 
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reductions in the production of tissue derived LOX, due to periodontal pathogen 
infection, may lead to a frustrated healing response and contribute to the 
pathogenesis of periodontitis. 
 
Chemokine ligand 20 (CCL20) is an important cytokine implicated in neutrophil and 
lymphocyte trafficking and recent research has highlighted its role in T(H)17 cell 
chemotaxis. This newly characterised T(H) cell contributes to host defence via its 
actions on extracellular bacteria (Louten et al., 2009). T(H)17 encompasses a 
subset of T-helper cells, producing a range of cytokines, two of the most 
interesting being interleukin 17, which orchestrates pro-inflammatory responses 
(Miossec et al., 2009), and interleukin 22, which acts via epithelial cells to produce 
anti-microbial peptides (Aujla and Kolls, 2009). These proteins are important in 
microbial immunity at epithelial/mucosal barriers, with reduced levels implicated in 
opportunist infections (Pitta et al., 2009). As both P. gingivalis and F. nucleatum 
up-regulated CCL20 gene expression in H400 cells, it is possible that 
crevicular/pocket epithelium may play an important role in mediating local host 
defences to the subgingival bacterial biofilm via T(H)17 cells. 
 
The genes for Migration inhibitory factors 8 and 14 (MRP-8/-14 also known as 
S100A8 and S100A9 respectively) encode multifunctional proteins which form 
heterodimers with antibacterial properties and which have been implicated in host 
defence against invasive bacteria (Nisapakultorn et al., 2001) . In addition they 
have been implicated in neutrophil recruitment and activation and therefore behave 
in a pro-inflammatory manner (Foell et al., 2008). Whilst periodontal pathogen 
stimulation did not appear to give rise to differential expression for MRP-8, 
increased gene expression of MRP-14 following F. nucleatum stimulation was 
detected, although P. gingivalis reduced gene expression levels. As has previously 
been discussed for HMOX the reduced gene expression of MRP-14 by P. 
gingivalis afford this bacterium protection from the innate immune system by its 
modulation of the inflammatory response. 
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As the role of several of the genes identified by microarray analysis and discussed 
above have not been studied in periodontitis pathogenesis, further studies on 
these molecules with respect to periodontitis are warranted. 
 
7.2.4 Cytokine production  
Whilst activation of NF-κB and regulation of gene expression have been 
demonstrated in stimulated H400 cells, these changes do not necessarily translate 
to downstream protein production. Subsequently, therefore, levels of cytokines 
important in the inflammatory response (eg. TNF-α, GM-CSF, IL-8, and IL-1β) 
were investigated in cell culture supernatants. Stimulation with P. gingivalis and F. 
nucleatum resulted in increased production of these cytokines when compared to 
unstimulated controls. Stimulation with F. nucleatum generated higher levels of 
cytokines compared with P. gingivalis, and this data might indicate that F. 
nucleatum in vivo stimulates elevated levels of inflammation. It is therefore logical 
to interpret this finding in several ways, which include i) F. nucleatum is more 
important in promoting the inflammatory response which could result in more 
efficient bacterial killing, or ii) P. gingivalis may be able to modulate the host‟s 
inflammatory response to enable evasion and further unchecked infection. 
Fusobacterium nucleatum has the ability to adhere to a wide range of plaque 
bacteria and acts as a bridge between early and late colonizers (Uitto et al., 2005). 
Therefore F. nucleatum may have a central role in the transition between health 
and disease (Krisanaprakornkit et al., 2000).  
 
These data demonstrate the ability of oral epithelial cells to produce pro-
inflammatory cytokines on stimulation with periodontal pathogens, these key 
proteins have a central role in innate immunity, and their production lends support 
to the hypothesis that epithelia initiate and orchestrate the local inflammatory 
response to colonising bacteria.   
 
 
 
 111 
7.2.5 Summary 
Data presented in this thesis has shown that the periodontal pathogens P. 
gingivalis and F. nucleatum can stimulate key stages in epithelial cell activation 
(Figure 7.1, labels 1,2 & 3), i.e. NF-κB translocation, gene expression changes and 
cytokine production. This suggests that stimulated crevicular/pocket epithelium 
plays a role in the initiation and propagation of periodontal inflammation, thus 
supporting the proposed hypothesis. 
 
7.3  Action of α-lipoate on epithelial cell activation 
Our current understanding of periodontal disease pathogenesis suggests that in 
susceptible individuals the exaggerated inflammatory response causes the tissue 
damage seen in periodontitis; with 80% being host mediated and only 20% directly 
attributable to bacteria (Grossi et al., 1994). Initial results have demonstrated the 
ability of periodontal pathogens to stimulate oral epithelium to mount a pro-
inflammatory response. The second stage was to investigate a method of 
“dampening down” this inflammatory response as a potential novel therapeutic 
strategy in periodontitis patients where an exaggerated host inflammatory 
response underpins disease. NF-κB is a REDOX sensitive transcription factor 
activated by changes in intracellular REDOX status, so a natural dithiol antioxidant, 
α-lipoate, which boosts intracellular antioxidant levels was chosen in an attempt to 
modulate NF-κB activation. As Toll like receptor activation is key to NF-κB 
activation and subsequent pro-inflammatory gene expression, initial experiments 
were performed to determine whether α-lipoate affected expression of these 
receptors, prior to investigating effects on gene expression and cytokine 
production.  
 
7.3.1 Bacterial recognition / Toll-like receptor gene expression 
Three key Toll-like receptors were investigated by sq-RT-PCR.  Pre-incubation of 
H400 cells with α-lipoate generated a small reduction in TLR-2 gene expression 
and large increases in expression of TLR-4 and TLR-9 transcripts. These changes, 
detected in un-stimulated, P. gingivalis and F. nucleatum stimulated cells, if 
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translated into cellular TLR protein expression, suggests that α-lipoate may have 
the ability to increase cellular sensitivity to bacterial challenge, or indeed increase 
the pro-inflammatory response. Potentially, this may not be beneficial to the 
periodontally susceptible host where excess inflammation may result in local tissue 
damage. 
 
7.3.2. NF-κB activation 
Immunocytochemical analysis of H400 cells pre-incubated with α-lipoate and 
stimulated with E. coli LPS, P. gingivalis or F. nucleatum showed reduced levels of 
NF-κB activation when compared to controls (no α-lipoate). This is a key finding 
suggesting that irrespective of changes induced in the TLR transcriptome α-lipoate 
is able to reduce periodontal pathogen induced activation of this important pro-
inflammatory transcription factor. As previously described, NF-κB is REDOX 
sensitive, so a potential mechanism by which α-lipoate reduces NF-κB activation is 
via changes in intracellular antioxidant levels.  The literature reports the ability of α-
lipoate to increase levels of reduced glutathione (GSH) a key intra-cellular thiol 
antioxidant (Sen et al., 1997), therefore as NF-κB is activated by oxidative stress, it 
seems plausible that α-lipoate, reduces intra-cellular oxidative stress by boosting 
intracellular GSH levels thereby reducing NF-κB activation. Indeed α-lipoate has 
been shown to reduce levels of NF-κB activation in a range of cell types (Packer et 
al., 1995) (Zhang and Frei, 2001). A recent paper demonstrated the ability of α-
lipoate to down-regulate NF-κB activation, and boost antioxidant levels in lung 
tissue in septic shock (Cadirci et al., 2009). 
 
7.3.3 Gene expression 
As discussed earlier periodontal pathogen stimulation demonstrated a range of 
gene transcription changes, this section therefore discusses how pre-incubation 
with α-lipoate effects gene expression 
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7.3.3.1 Pro-inflammatory gene expression 
Pre-incubation with α-lipoate resulted in a reduction in stimulated transcript levels 
of pro-inflammatory genes IL-8, GM-CSF, IL-1β and TNF-α. These genes possess 
a range of functions important in the initiation and propagation of the inflammatory 
response and clearly, if extrapolated to cytokine production, indicate that α-lipoate 
is able to reduce the pro-inflammatory response of epithelium to periodontal 
pathogens. 
 
Chemokine ligand 2 (CCL-2) and 20 (CCL-20) genes were down-regulated by P. 
gingivalis and F. nucleatum stimulation when pre-incubated with α-lipoate, the 
exception being CCL-2 in F. nucleatum stimulated cells which showed little 
change. The down-regulation seen with α-lipoate, if this indeed does equate to 
reduced production of cytokines, would result in an anti-inflammatory response.   
 
7.3.3.2 Potential importance of other genes identified in periodontitis  
The effect of α-lipoate pre-incubation on gene expression for the antioxidant 
enzymes, superoxide dismutase (SOD) and haemoxygenase (HO) were 
investigated. Results revealed little change in terms of un-stimulated levels of 
these two genes. Stimulated levels showed little change for SOD, a small increase 
in levels for F. nucleatum stimulated HO, with α-lipoate causing a reduction in P. 
gingivalis stimulated levels (HO). These results are somewhat difficult to interpret 
and whether α-lipoate has beneficial or detrimental effects on expression of these 
genes remains unclear. 
 
As previously discussed, lysyl oxidase is an important enzyme in collagen 
maturation, pre-incubation of cells with α-lipoate led to reduced gene expression in 
both stimulated and un-stimulated cells. Stimulation with P. gingivalis or F. 
nucleatum caused reduced gene expression and this reduction was further 
enhanced by α-lipoate. Stimulation by these pathogens and and/or pre-incubation 
with α-lipoate could prevent collagen maturation and thus frustrate healing within 
the periodontal tissues leading to promotion of a chronic inflammatory lesion. It 
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would appear that α-lipoate may not be beneficial in this regard. Recent research 
has suggested that excess production of lysyl oxidase may be an important factor, 
and prognostic indicator, in oral squamous cell carcinoma (Albinger-Hegyi et al., 
2009). To date the role of lysyl oxidase in periodontal disease pathogenesis 
remains unclear and further investigation into this role is warranted. 
 
Two genes important in cellular protection, neutrophil recruitment and activation 
are MRP-8 (S100A8) and MRP-14 (S100A9). α-lipoate pre-incubation reduced 
both stimulated and un-stimulated expression levels of these genes. These 
reductions may reduce cellular protection to bacterial challenge, which may not be 
beneficial to host defence, however in terms of reduced chemotaxis this may result 
in reduced inflammatory response. In addition a recent publication suggests that 
combined increased expression of these two genes is implicated in ROS mediated 
transcription pathway activation (Nemeth et al., 2009) which, along with reduced 
neutrophil recruitment, and activation may suggest that α-lipoate may be beneficial 
in reducing  the hyper-inflammatory response associated with tissue damage. 
 
7.3.3.3 NF-κB 
Gene expression was investigated for NF-κB1 (p50) a component of the NF-κB 
complex. Results indicated high un-stimulated levels of expression in H400 cells. 
Stimulation with P. gingivalis or F. nucleatum resulted in increased expression of 
this gene, whereas pre-incubation with α-lipoate caused reduced expression in 
both stimulated and un-stimulated cells. These reductions in expression may 
equate to reduced cellular levels of NF-κB levels potentially diminishing cellular 
activation and the downstream pro-inflammatory response. Interestingly, the 
reductions in stimulated levels of NF-κB1 with α-lipoate, did not completely block 
transcription of this gene, but reduced it to un-stimulated levels. This is potentially 
of importance as complete blocking of the cells pro-inflammatory response may 
lead the host exposed to bacterial challenge. 
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7.3.4 Cytokine production 
The effect of pre-incubation of H400 cells with α-lipoate prior to stimulation with F. 
nucleatum or P. gingivalis was to reduce subsequent production of levels of the 
cytokines investigated (IL-1β, GM-CSF, and IL-8; this was also the case for F. 
nucleatum stimulated TNF-α production, but P. gingivalis stimulation was below 
the levels of detection). Interestingly, the reductions seen with α-lipoate did not 
return levels to those of un-stimulated cells. This finding may be due to α-lipoate 
changing the intracellular REDOX potential of the cell either directly due to its 
antioxidant properties, or indirectly via boosting the key intracellular antioxidant 
glutathione. Boosting antioxidants will reduce intracellular oxidative stress resulting 
in reduced phosphorylation of IĸK, subsequent activation of NF-ĸB and 
downstream cytokine production.  
 
7.3.5 Summary 
Pre-incubation with α-lipoate induced a number of cellular changes in H400 cells in 
terms of NF-κB activation, gene expression and cytokine production. Taken as a 
whole the results show a reduction in pro-inflammation post stimulation with 
periodontal pathogens P. gingivalis and F. nucleatum, however α-lipoate does not 
completely block pro-inflammatory cascades. This has important ramifications 
biologically, as the aim of any new anti-inflammatory therapeutic agent is to reduce 
exaggerated levels of inflammation seen in patients with periodontitis, rather than 
completely inhibiting the inflammatory response. The epithelial response to 
bacteria is an important first line of defence against bacterial invasion and 
complete blocking may render the host susceptible to bacterial colonisation, 
virulence expression and indeed invasion. 
 
7.4 Future work 
The data presented in this thesis suggests a role for epithelium in peridodontal 
disease pathogenesis, however further study is required to firstly underpin and 
better understand the mechanisms of activation in epithelia, and secondly 
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determine the efficacy of inflammatory modulation in disease management. In 
order to address these questions it is proposed that three key areas of research 
will be explored in future work:- 
 
7.4.1 Explant epithelium 
Current experimentation has focused on an immortal H400 gingival epithelial cell 
line, how this relates to the in vivo situation would be of considerable interest and 
would allow further validation of this model system. Additionally comparisons of 
epithelium from patients with chronic periodontitis and comparison with healthy 
controls may demonstrate differences in epithelial response to bacterial challenge 
thereby predisposing patients to disease.   
 
7.4.2 Other transcription factor pathways 
This thesis focused on the REDOX sensitive transcription factor NF-κB which is 
thought to be the key pro-inflammatory transcription factor responsible for cell 
activation; however other transcription factors have been described which are pro 
and anti-inflammatory. Investigation of such pathways may result in a better 
understanding of the mechanisms of bacterial cell activation, and offer further 
therapeutic targets to modulated the exaggerated inflammatory response. Two 
other pathways have been identified and worthy of investigation: 
 
7.4.2.1 Nrf-2: (NE-F2 related factor) 
 This is also a REDOX sensitive transcription factor, and regulates the cell 
antioxidant response to oxidative stress. This response involves two major REDOX 
system regulators i.e. glutathione & thioredoxin, these systems acts to dampen 
down the cellular pro-inflammatory response. 
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7.4.2.2 AP-1 (activator protein 1) 
As with NF-κB this transcription factor orchestrates the expression of a range of 
genes involved in inflammation, as well as a number of other functions. Although 
activation of NF-κB and AP-1 are via different mechanisms, it appears that they 
are activated by similar stimuli. The literature suggests that some genes are only 
differentially expressed when both these transcription factors are activated.  
 
7.4.3 Clinical trials 
Research over the last few years has demonstrated the hyper-inflammatory nature 
of periodontitis and how this can cause collateral tissue damage and its 
importance in disease pathogenesis. Results obtained in this thesis suggest α-
lipoate may be able to modulate this hyper-inflammatory response. Randomised 
controlled clinical trials would aim to determine the efficacy of α-lipoate in 
managing chronic periodontitis.  
 
7.5 Concluding remarks 
This thesis reports the development of a model system to investigate the potential 
role of periodontal / sulcar epithelium in the initiation and propagation of the 
exaggerated inflammatory/immune response seen in periodontitis.  The data 
generated clearly show that the epithelial lining of the sulcus/pocket, which 
accumulates subgingival plaque, is capable of mounting a pro-inflammatory 
response to the bacterial biofilm and therefore could play a crucial role in the 
initiation and propagation of the hyper inflammation seen in periodontitis patients.  
α-lipoate has the ability to modulate this pro-inflammatory response, but 
importantly, does not completely block this key defence process. Treatment of 
periodontal disease has changed little over the last 50 years, with management 
focusing on reducing the bacterial load and thereby reducing tissue damage 
caused by the exaggerated inflammatory response seen in periodontitis patients. 
As our understanding of this fascinating and complex disease grows, opportunities 
will arise to modulate this exaggerated response. The findings of this thesis 
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suggest the potential for developing new, locally applied anti-inflammatory 
therapies for managing periodontitis. 
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Figure 1.2: The prevalence of significant periodontal attachment 
loss in the UK population (1998) by age 
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Figure 1.1: The prevalence of significant periodontal pocketing in 
the UK population (1998) by age 
Significant Pocketing (>3.5mm) UK population 1998
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 Dental Plaque Induced Gingival 
Disease 
Gingivitis associated with dental plaque 
only. 
Gingival disease modified by systemic 
factors. 
Gingival disease modified by medication. 
Gingival disease modified by malnutrition. 
Non-plaque Induced Gingival 
Lesions 
Gingival disease of bacterial origin 
Gingival disease of viral origin 
Gingival disease of fungal origin 
Gingival disease of genetic origin 
Gingival manifestations of systemic 
conditions 
Traumatic lesions 
Foreign body reactions 
Not otherwise specified 
 
 
Chronic periodontitis 
Localised (<30% of sites) 
Generalised (>30% of sites) 
Aggressive Periodontitis 
Localised 
Generalised 
Periodontitis as a manifestation 
of systemic disease 
Associated with systemic disorders 
Not otherwise specified 
Necrotising Periodontal Disease 
Necrotising Ulcerative Gingivitis 
Necrotising Ulcerative Periodontitis 
Abscess of the Periodontium 
Gingival abscess 
Periodontal abscess 
Pericoronal abscess 
Periodontal lesions associated 
with endodontic lesions 
Combined periodontal – endodontic lesions 
Developmental or Acquired 
deformities or conditions 
Localised tooth related factors that modify or 
predispose to plaque induced periodontitis 
Mucogingival deformities & conditions 
around teeth 
Mucogingival deformities & conditions on 
edentulous ridges 
Occlusal trauma 
 
Table 1.1: Classification of Gingival diseases 
Table 1.2: Classification of Periodontitis 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3:  A diagrammatic representation of a tooth section (longitudinal) 
showing normal (healthy) periodontal tissue architecture  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: A diagrammatic representation of a tooth section (longitudinal) 
showing periodontitis 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Clinical photograph showing patient with chronic 
periodontitis 
Figure 1.6: Full mouth long cone periapical radiographs, showing generalised 
severe bone loss in a chronic periodontitis patient 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Socransky’s coloured complexes showing association with periodontitis 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8:  The role of reactive oxygen species in normal and dysregulated innate 
immunity to periodontal bacteria, proposing the role of pocket/sulcular epithelium. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Schematic representation of normal tissue homeostasis and  
oxidative stress due to excess ROS. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10: Examples of local risk factors; A: root groove, B: overhanging crown 
margin, C: poorly designed plaque retentive partial upper acrylic denture. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Diagram showing the pathway of REDOX sensitive transcription 
factor activation leading to chronic inflammation. This may represent a normal 
inflammatory response or if exaggerated may lead to tissue damage. 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Activation of REDOX sensitive transcription 
factors 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.3: Examples of diseases where NF-κB dysregulation has been 
implicated in the aetiology 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: Activation of NF-κB leading to pro-inflammatory gene activation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Phosphatase pathway limiting NF-κB activation; however ROS inhibition of 
this pathway encourages NF-κB activation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15: Potential NF-κB blocking agents, illustrating their site of action. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16: Diagram illustrating one mechanism by which antioxidants may block 
NF-κB activation 
  
 
 
 
 
 
Figure 1.17: Molecular structure of α-lipoate and its reduced form dihydrolipoic acid 
  
 
 
 
 
 
 
 
In addition to the effect of ALA on ALA may contribute to regeneration of vand E 
from their oxidized  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.18: The impact α-lipoate on intracellular reduced glutathione  
Figure 1.19: α-lipoate re-cycling of antioxidants from their oxidized forms 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.20: The key biological stages following epithelial cell stimulation and 
activation of the NF-κB pathway. A: translocation of NF-κB to the nucleus, B: gene 
expression changes, C: production of cytokines. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: MSC 12 positive flow cell culture cabinet  
Figure 2.1: Anaerobic chamber (Don Whitley,UK) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3:  Substrates for H400 cell growth; A: Petri dish with multi-well slide. B: 
Plastic cell culture flask. C: Printed four well slide: D 96 well flat bottomed plate. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4:  Diagrammatic representation of immuno-cytochemical methodology.      
1: cell substrate, 2: primary monoclonal antibody, 3: biotinylated secondary antibody 
(multi-link), 4: peroxidase linked to streptavidin (label), 5: diaminobenzidene (DAB) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Flow diagram summarising the imunocytochemical 
staining method. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6:  A: Represents a microscopic field using a graticule to divide into 0.1mm 
by 0.1mm squares. B: Example of a Hunting curve.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Cellomics ArrayScan II imaging cytometer 
Figure 2.8: Quantification of nuclear and cytoplasmic intensity; A shows a 
diagrammatic representation of cell compartmentalisation, B shows how this is 
related to an actual scanned image. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Schematic diagram showing the stages in PCR 
reaction 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: Agarose gel electrophoresis plate 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Processing of RNA samples for microarray analysis (courtesy of 
Affymetrix, UK) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13: Introduction of hybridisation buffer to U133A 
microarrays. Second pipette tip to allowing venting and ensure 
complete wetting of the chip 
Figure 2.12: Affymetrix microarray test chip 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Diagrammatic representation of the H400 model indicating the 
range of investigations employed. 
Figure 3.2: H400 cells cultured (mean + SD, n=3) in DMEM (10% FCS at 37°C 
in 5% CO2) for 4 days. 
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Figure 3.3: Attached H400 cells grown in cell culture flask for 4 days  
viewed using an inverted microscope 
Figure 3.4: Growth characteristics of H400 cells (mean + SD, n=2 ) 
grown in DMEM (10% FCS at 37°C in 5% CO2) for 9 days 
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Figure 3.6: Changes in media pH (mean + SD, n=2 per time point) during 
H400 cell growth in DMEM (10% FCS at 37°C in 5% CO2) 
Figure 3.5: Attached H400 cells grown in cell culture flask for 6 days and 
viewed using an inverted microscope 
50µm 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: H400 cells cultured on glass slides. A: initial inoculum of 3x105 
cells incubated for 5 days; B: initial inoculum of 4x105 cells incubated for 5 
days. 
Figure 3.7: Unattached cell count for H400 cells (10% FCS at 37°C in 5% 
CO2) grown for 9 days (mean + SD, n=2 per time point) 
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Initial inoculum Days to reach 80% confluence 
3x105 6 
4x105 5 
5x105 4-5 
Table 3.1: H400 cells cultured on glass multi-well slides, 
showing time to reach confluence with varying initial inoculum 
Figure 3.9: H400 cells immuno-cytochemically stained for NF-κB; image A: un-
stimulated control (NF-κB staining localised in the cytoplasm); image B E.coli LPS 
(20μg/ml for 1 hour) stimulated (NF-κB staining localised to the nucleus).  
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Figure 3.10: Percentage of H400 cells (mean + SD, n=4) exhibiting NF-κB 
translocation following stimulation with 10μg/ml E. coli LPS for 1 hour. 
P=<0.001 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: H400 cells stimulated with E. coli LPS (10μg/ml) at varying time 
points, showing % NF-κB translocation (mean + SD, n=4).  
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Figure 3.12: H400 cells stimulated for 1 hour with two concentrations of E. coli 
LPS (mean + SD, n=4). 
p=<0.001 
p=<0.001 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Effect of level of cell confluence on NF-κB activation in H400 cells + 
stimulation with E. coli LPS (20μg/ml) mean + SD n=4. 
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Figure 3.14:  NF-κB translocation in H400 cells + stimulation with E. coli LPS 
(20μg/ml) mean + SD n=4. 
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Figure 3.15: Percentage translocation of NF-κB in H400 cells + 1 hr stimulation 
with whole dead bacteria (mean + SD n=4). 
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Figure 3.16: Relative expression of nuclear vs. cytoplasmic NF-κB in H400 cells + 
1 hr stimulation by high throughput immuno-cytochemical analysis (mean + SD 
n=4). 
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Figure 3.17: Nuclear to cytoplasmic ratio of NF-κB in H400 cells + stimulation with P. 
gingivalis & F. nucleatum over time using high throughput Immuno-cytochemistry 
(mean + SD, n=3) 
 Figure 4.2: Non adherent cell count for H400 cells seeded into DMEM supplemented 
with 1mM α-lipoate (red lines) or no α-lipoate (blue lines) (Error bars not included as 
n=2) 
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Figure 4.1: Adherent cell count for H400 cells incubated from initial seeding with 
DMEM supplemented with 1mM α-lipoate (red lines; n=2) or no α-lipoate (blue lines; 
n=2) (Error bars not included as n=2) 
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Figure 4.4: Cell viability (trypan blue exclusion) of adherent H400 cells 
supplemented with 1mM α-lipoate (red lines; n=2) or no α-lipoate (blue lines; n=2) 
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Figure 4.3: Cell viability (trypan blue exclusion) of non attached H400 cells supplemented 
with 1mM α-lipoate (red lines) or no α-lipoate (blue lines) (Errors not included as n=2) 
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Figure 4.5: H400 cells incubated for 24h with A: control solution (negative 
control); B: 4mM α-lipoate. 
Figure 4.6: Adherent H400 cells exposed to varying α-lipoate concentrations (n=2 
per concentration) each value plotted and the mean 
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Figure 4.7: Agarose gel electrophoresis of H400 cells 
exposed to α-lipoate for 24h (n=2; samples from each 
concentration pooled) 
Figure 4.8: Immuno-cytochemical images of H400 cells stained for caspase 3  
A= no α-lipoate; B= 1mM α-lipoate for 48h. Caspase positive cell stain red. 
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Figure 4.9: Levels of caspase 3 activity in H400 cells incubated for 48h with α-lipoate 
(mean + SD; n=3) (* p=0.039) 
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Figure 4.10: Photo-micrograph demonstrating the effect of calcium chloride 
concentration on attached H400 cell morphology / cell attachment when incubated + 
1mM α-lipoate. 
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Figure 4.11: Effect of calcium chloride concentration on attached H400 cell 
count when incubated + 1mM α-lipoate (n=2; each value and mean plotted) 
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Figure 4.12: H400 cells pre incubated +/- 4mM α-lipoate for 1h, stimulated +/- 
20μg/ml E.coli LPS for 1hour. (mean % NF-κB translocation + SD; n=3) 
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Figure 4.13: H400 cells pre-incubated with 0.5mM α-lipoate for 24h prior to 
stimulation with E. coli LPS for 1h (mean + SD; n=3) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: H400 cells pre incubated with a range of α-lipoate concentrations for 
24h, stimulated with E.coli LPS (1h) and immunocytochemically stained for      
NF-κB. (Negative control is a staining control; no NF-κB monoclonal antibody)   
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Figure 4.15: H400 cells incubated with a range of α-lipoate concentrations and stimulated 
with E.coli LPS. (n=2, therefore each value and mean plotted) 
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Figure 4.16: A: Images of florescent immuno-cytochemical (high 
throughput) analysis of H400 cells stimulated with P. gingivalis +/- α-
lipoate. B: Diagrammatic representation of colour changes seen.
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Figure 4.17: Quantitative analysis of high throughput immunocytochemical analysis 
of H400 cells stimulated with P. gingivalis +/- α-lipoate (n=3 + SD). (* p=0.0016;  
+ p=0.0026) 
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Figure 4.18: A: Fluorescent immuno-cytochemical 
analysis (high throughput) of H400 cells stimulated with 
F. nucleatum +/- α-lipoate. B: Diagrammatic 
representation of colour changes seen. 
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Figure 4.19: Quantitative analysis of high throughput immunocytochemical 
analysis of H400 cells stimulated with F. nucleatum +/- α-lipoate (n=3 + SD) 
(* p=0.02; + p=0.008) 
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Figure 5.1: Representative gel images of H400 cells stimulated with F. 
nucleatum, P. gingivalis or media for A: 24h, B: 4h, showing differential 
expression of pro-inflammatory cytokines 
Figure 5.2: Semi quantitative RT-PCR analysis of gel images showing gene 
expression of H400 cells stimulated with P. gingivalis, F. nucleatum (or 
media control) at 4 and 24h. 
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Figure 5.3: Agarose gel electrophoresis of RNA extracted 
from H400 cells stimulated with P.  gingivalis, F.  nucleatum 
or media (negative control) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Agarose gel electrophoresis to determine success 
of labelling and fragmentation of cRNA prior to hybridisation 
onto Affymetrix U133A arrays. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene (Affymetrix definition) 
Fold change 
FN PG 
interleukin 8 33.1 10.2 
interleukin 1, alpha 17.5 10.8 
interleukin 8 15.6 9.4 
tumor necrosis factor, alpha-induced protein 3 15.0 3.0 
inhibin, beta A (activin A, activin AB alpha polypeptide) 14.9 6.1 
interleukin 1 family, member 9 14.6 3.3 
epiregulin 14.3 20.6 
tumor necrosis factor, alpha-induced protein 3 13.6 3.8 
heparin-binding EGF-like growth factor 12.1 4.4 
A kinase (PRKA) anchor protein (gravin) 12 10.6 3.3 
a disintegrin and metalloproteinase domain 8 9.8 6.9 
interleukin 1, beta 9.8 5.9 
interleukin 1, beta 9.7 5.6 
arginase, type II 9.3 3.9 
amphiregulin (schwannoma-derived growth factor) 8.5 8.6 
tenascin C (hexabrachion) 8.5 3.1 
microtubule associated monoxygenase 8.1 2.9 
serine (or cysteine) proteinase inhibitor, 7.6 3.0 
pleckstrin homology-like domain, family A, member 1 7.1 3.8 
plasminogen activator, urokinase  7.0 3.7 
interleukin 32  6.9 3.7 
chemokine (C-X-C motif) ligand 2 6.8 3.3 
plasminogen activator, urokinase receptor 6.5 2.6 
secretory granule, neuroendocrine protein 1 (7B2 protein) 6.3 4.2 
high mobility group AT-hook 2 5.7 3.8 
Table 5.1: List of common genes up-regulated (top 25) in H400 cells 
following P. gingivalis and F. nucleatum stimulation 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene (Affymetrix definition) 
Fold change 
FN PG 
integrin, beta 4 -3.3 -3.1 
cysteine-rich protein 2 -2.8 -3.2 
hydroxyprostaglandin dehydrogenase 15-(NAD) -3.7 -3.3 
epiplakin 1 -3.4 -3.3 
Glycoprotein (transmembrane) nmb -2.5 -3.3 
Ribosomal protein L37a -2.7 -3.3 
stoned B-like factor -3.8 -3.4 
FAT tumor suppressor homolog 2 (Drosophila)  -3.2 -3.4 
keratin 15 -2.7 -3.5 
Unc-5 homolog B (C. elegans) -2.5 -3.7 
integrin, beta 4 -2.4 -3.9 
chloride channel, calcium activated, family member 2 -3.9 -3.9 
inhibitor of DNA binding 3 -3.6 -4.0 
matrix-remodelling associated 5 -5.0 -4.2 
myristoylated alanine-rich protein kinase C substrate -3.7 -4.3 
fibroblast growth factor receptor 3  -7.5 -4.3 
lysyl oxidase -2.5 -4.8 
chromosome 11 open reading frame 8 -5.2 -4.8 
plakophilin 3 -4.2 -5.0 
fatty acid binding protein 4, adipocyte -2.8 -5.7 
lysyl oxidase -4.1 -6.1 
keratin 14  -8.6 -6.2 
lysyl oxidase -3.2 -6.9 
matrix metalloproteinase 13 (collagenase 3) -4.0 -7.3 
matrix metalloproteinase 12 (macrophage elastase) -3.2 -9.1 
Table 5.2: List of common down-regulated genes (top 25) in H400 cells 
following P. gingivalis and F. nucleatum stimulation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene (Affymetrix definition) 
Fold 
change 
interleukin 8 33.1 
interleukin 1, alpha 17.5 
interleukin 8 15.6 
tumor necrosis factor, alpha-induced protein 3 15.0 
inhibin, beta A (activin A, activin AB alpha polypeptide) 14.9 
interleukin 1 family, member 9 14.6 
arachidonate 5-lipoxygenase-activating protein 14.5 
epiregulin 14.3 
hypothetical protein MGC4504 13.9 
tumor necrosis factor, alpha-induced protein 3 13.6 
activating transcription factor 3 12.7 
keratin 6B 12.4 
heparin-binding EGF-like growth factor 12.1 
chemokine (C-X-C motif) ligand 3 11.0 
A kinase (PRKA) anchor protein (gravin) 12 10.6 
a disintegrin and metalloproteinase domain 8  9.8 
interleukin 1, beta 9.8 
interleukin 1, beta 9.7 
heparin-binding EGF-like growth factor 9.5 
prostaglandin E receptor 4 (subtype EP4) 9.4 
arginase, type II 9.3 
protein phosphatase 1, regulatory (inhibitor) subunit 15A 9.2 
amphiregulin (schwannoma-derived growth factor) 8.5 
tenascin C (hexabrachion) 8.5 
dual specificity phosphatase 5 8.1 
Table 5.3: Genes up-regulated (top 25) in H400 cells following  
F. nucleatum stimulation. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene (Affymetrix definition) 
Fold 
change 
aldo-keto reductase family 1, member B10  -27.6 
KIAA0101 -12.4 
histone 1, H4c -11.5 
thymidylate synthetase -10.9 
epidermal growth factor receptor  -9.6 
keratin 14  -8.6 
epidermal growth factor receptor   -8.4 
Rho-related BTB domain containing 3 -8.0 
Rho-related BTB domain containing 3 -7.9 
epidermal growth factor receptor  -7.8 
thymopoietin -7.7 
fibroblast growth factor receptor 3  -7.5 
translocated promoter region (to activated MET oncogene) -7.3 
kinesin family member 20A -7.3 
topoisomerase (DNA) II alpha 170kDa -7.1 
solute carrier family 26 (sulfate transporter), member 2 -7.0 
ribonucleotide reductase M2 polypeptide -6.7 
lamin B1 -6.1 
PDZ binding kinase -5.9 
chromosome 10 open reading frame 3 -5.9 
MCM2 minichromosome maintenance deficient 2 -5.7 
chromosome 22 open reading frame 18 -5.6 
dihydrofolate reductase -5.6 
DKFZP586A0522 protein -5.5 
UDP glucuronosyltransferase 1 family, polypeptide A10  -5.4 
Table 5.4: Genes down-regulated (top 25) in H400 cells following  
F. nucleatum stimulation. 
 
  
 
 
 
Gene (Affymetrix definition) 
Fold 
change 
epiregulin 20.6 
heme oxygenase (decycling) 1 15.3 
cytochrome P450, family 1, subfamily A, polypeptide 1 11.8 
interleukin 1, alpha 10.8 
interleukin 8 10.2 
interleukin 8 9.4 
amphiregulin (schwannoma-derived growth factor) 8.6 
DnaJ (Hsp40) homolog, subfamily B, member 9 6.9 
a disintegrin and metalloproteinase domain 8  6.9 
chemokine (C-C motif) ligand 20 6.4 
inhibin, beta A (activin A, activin AB alpha polypeptide) 6.1 
interleukin 1, beta 5.9 
interleukin 1, beta 5.6 
cytochrome P450, family 1, subfamily B, polypeptide 1 5.5 
FOS-like antigen 1 5.2 
interleukin 7 receptor /// interleukin 7 receptor 5.1 
SRY (sex determining region Y)-box 9  4.7 
cytochrome P450, family 1, subfamily B, polypeptide 1 4.5 
DR1-associated protein 1 (negative cofactor 2 alpha) 4.5 
heparin-binding EGF-like growth factor 4.4 
spastic ataxia of Charlevoix-Saguenay (sacsin) 4.3 
secretory granule, neuroendocrine protein 1 (7B2 protein) 4.2 
cisplatin resistance-associated overexpressed protein 4.0 
neuron navigator 3 4.0 
aldo-keto reductase family 1, member C3  4.0 
 
 
 
 
 
 
Table 5.5: Genes up-regulated (top 25) in H400 cells following P. gingivalis 
stimulation. 
 
  
 
 
Gene (Affymetrix definition) 
Fold 
change 
kelch-like 22 (Drosophila) -12.5 
3-hydroxyisobutyrate dehydrogenase -10.9 
matrix metalloproteinase 12 (macrophage elastase) -9.1 
protocadherin gamma subfamily A, 3 -9.0 
matrix metalloproteinase 13 (collagenase 3)  -7.3 
lysyl oxidase -6.9 
keratin 14  -6.2 
Tumor necrosis factor (ligand) superfamily, member 10  -6.1 
lysyl oxidase -6.1 
Consensus includes gb:AW451806  -5.9 
matrix metalloproteinase 1 (interstitial collagenase) -5.8 
fatty acid binding protein 4, adipocyte -5.7 
lysosomal-associated membrane protein 1 -5.5 
MRNA full length insert cDNA clone EUROIMAGE 21920 -5.3 
plakophilin 3 -5.0 
olfactomedin 4 -4.9 
tumor necrosis factor (ligand) superfamily, member 10  -4.9 
tumor necrosis factor (ligand) superfamily, member 10  -4.8 
hydroxyprostaglandin dehydrogenase 15-(NAD) -4.8 
chromosome 11 open reading frame 8 -4.8 
lysyl oxidase -4.8 
RAD51-like 3 (S. cerevisiae) -4.5 
Consensus includes gb:BF739971 -4.4 
fibroblast growth factor receptor 3 (achondroplasia, 
thanatophoric dwarfism) 
-4.3 
acetyl-Coenzyme A carboxylase beta -4.3 
 
 
 
 
 
 
 
Table 5.6:  Genes down-regulated (top 25) in H400 cells following  
P. gingivalis stimulation. 
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Figure 5.5: Venn diagram representing the number of A: up-regulated genes, B: down-
regulated genes and C: differentially expressed genes (up & down) from microarray analysis 
(using a 2 fold cut off) of P. gingivalis (PG) and F. nucleatum (FN) stimulated H400 cells. Data 
includes common genes expressed by both periodontal pathogens. 
  
 
 
 
 
 
 
FN
Cell to cell signalling
Chemotaxis
Regulation of cell cycle
Signal transduction
Apoptosis 
Unknown process
Regulation of transcription
Transcription
inflammatory response
Cell proliferation
Other
PG
Cell to cell signalling
Chemotaxis
Regulation of cell cycle
Signal transduction
Apoptosis 
Unknown process
Regulation of
transcription
Transcription
Protein folding
Cell proliferation
Other
Cell to cell signalling
Chemotaxis
Regulation cell cycle
Signal transduction
Apoptosis 
Anti-apoptosis
Inflammatory response
Cell adhesion
Neutrophil activation
Neutrophil chemotaxis
Other
A B
C
Figure 5.6: Diagram illustrating ontological groups of genes up-regulated by A: F.nucleatum 
(247 genes), B: P. gingivalis (170) & C: genes common to F. nucleatum & P. gingivalis (47 
genes). Microarray analysis using a 2 fold change gene expression cut off. 
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Figure 5.7: Common up-regulated genes (2-fold or greater) for H400 cells stimulated with P.  
gingivalis and F.  nucleatum. Genes listed in ontological groups (higher level of expression 
between PG & FN highlighted in grey). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PG FN
Protein metabolism / processing / proteolysis 209596_at matrix-remodelling associated 5 MXRA5 -4.18 -4.99
221215_s_at receptor-interacting serine-threonine kinase 4 RIPK4 -3.02 -4.88
213640_s_at lysyl oxidase LOX -6.07 -4.14
205959_at matrix metalloproteinase 13 (collagenase 3) MMP13 -7.34 -4.02
204580_at matrix metalloproteinase 12 (macrophage elastase) MMP12 -9.05 -3.19
204298_s_at lysyl oxidase LOX -6.92 -3.17
214041_x_at Ribosomal protein L37a RPL37A -3.34 -2.68
215446_s_at lysyl oxidase LOX -4.75 -2.48
Cell cycle / growth / proliferation 211607_x_at epidermal growth factor receptor EGFR -2.72 -8.42
210984_x_at epidermal growth factor receptor EGFR -2.85 -7.83
204379_s_at fibroblast growth factor receptor 3 FGFR3 -4.34 -7.48
202718_at insulin-like growth factor binding protein 2, 36kDa IGFBP2 -2.37 -3.99
213413_at stoned B-like factor STON1 -3.39 -3.78
209784_s_at jagged 2 JAG2 -3.01 -2.5
32137_at jagged 2 JAG2 -2.98 -2.48
201141_at glycoprotein (transmembrane) GPNMB -3.29 -2.46
Cell adhesion / motility 209872_s_at plakophilin 3 PKP3 -4.95 -4.17
201668_x_at myristoylated alanine-rich protein kinase C substrate MARCKS -4.3 -3.74
211905_s_at integrin, beta 4 ITGB4 -3.11 -3.33
208153_s_at FAT tumor suppressor homolog 2 FAT2 -3.42 -3.19
201107_s_at thrombospondin 1 THBS1 -2.9 -2.7
201107_s_at thrombospondin 1 THBS1 -2.9 -2.7
204989_s_at integrin, beta 4 ITGB4 -3.92 -2.37
Epidermis development 209351_at keratin 14 KRT14 -6.17 -8.63
213240_s_at keratin 4 KRT4 -2.59 -4.89
222242_s_at kallikrein 5 KLK5 -2.51 -3.38
204734_at keratin 15 KRT15 -3.47 -2.67
207935_s_at keratin 13 KRT13 -2.71 -2.49
Fatty acid / lipid metabolism 211548_s_at hydroxyprostaglandin dehydrogenase 15-(NAD) HPGD -3.26 -3.69
211708_s_at stearoyl-CoA desaturase (delta-9-desaturase) SCD -2.8 -3.38
203980_at fatty acid binding protein 4, adipocyte FABP4 -5.72 -2.79
203914_x_at hydroxyprostaglandin dehydrogenase 15-(NAD) HPGD -2.57 -2.75
Nervous system signalling / development 205413_at chromosome 11 open reading frame 8 MPPED2 -4.76 -5.19
200648_s_at glutamate-ammonia ligase (glutamine synthase) GLUL -2.75 -3.78
217202_s_at glutamate-ammonia ligase (glutamine synthase) GLUL -3.07 -3.46
Transcription regulation 207826_s_at inhibitor of DNA binding 3 ID3 -4.01 -3.61
210892_s_at general transcription factor II, I GTF2I -2.67 -3.31
212016_s_at polypyrimidine tract binding protein 1 PTBP1 -2.45 -3.18
Transport 206165_s_at chloride channel, calcium activated, family member 2 CLCA2 -3.94 -3.89
Unclassified 207761_s_at DKFZP586A0522 protein METTL7A -2.9 -5.47
221805_at neurofilament, light polypeptide 68kDa NEFL -2.43 -3.57
208156_x_at epiplakin 1 /// epiplakin 1 EPPK1 -3.27 -3.41
213075_at olfactomedin-like 2A OLFML2A -2.83 -2.99
208978_at cysteine-rich protein 2 CRIP2 -3.22 -2.77
213069_at HEG homolog 1 (zebrafish) HEG1 -2.58 -2.74
213100_at Unc-5 homolog B (C. elegans) --- -3.71 -2.51
Fold change
GENEGo Annotation Affymetrix ID
Gene 
Symbol
Figure 5.8: Common down-regulated genes (2-fold or greater) for H400 cells stimulated with P.  
gingivalis and F.  nucleatum. Genes listed in ontological groups (higher level of expression 
between PG & FN highlighted in grey). 
 
  
Figure 5.9:  Comparative analyses of microarray and PCR data (right hand y scale 
represents microarray fold change (normalised); left hand y scale represents RT-
PCR relative expression).   
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Figure 6.1: SQ RT-PCR gel images of H400 cells pre incubated with α-lipoate or 
vehicle control; and stimulated with P. gingivalis, F. nucleatum or media control. 
All samples normalised to GAPDH. 
  
 
Figure 6.2 Pro-inflammatory gene expression changes determined by sq-RT-PCR in H400 
cells pre-incubated with 0.5mM α-lipoate (24h) or vehicle control, stimulated with 
P. gingivalis, F. nucleatum or media (negative control). Mean values of duplicate analyses 
are shown. 
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Figure 6.3 Bacterial recognition (Toll-like receptor) gene expression changes determined by sq-
RT-PCR in H400 cells pre-incubated with 0.5mM α-lipoate (24h) or vehicle control, stimulated with  
P. gingivalis, F. nucleatum or media (negative control). Mean values of duplicate analyses are 
shown. 
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Figure 6.4 Epithelial protective gene expression changes determined by sq-RT-PCR in H400 cells 
pre-incubated with 0.5mM α-lipoate (24h) or vehicle control, stimulated with P. gingivalis, F. 
nucleatum or media (negative control). Mean values of duplicate analyses are shown. 
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Figure 6.5 Anti-oxidant gene expression changes determined by sq-RT-PCR in H400 cells pre-
incubated with 0.5mM α-lipoate (24h) or vehicle control, stimulated with P. gingivalis, F. nucleatum  
or media (negative control). Mean values of duplicate analyses are shown. 
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Figure 6.6: LOX gene expression changes determined by sq-RT-PCR in H400 
cells pre-incubated with α-lipoate (24h) or vehicle control, stimulated with P. 
gingivalis, F. nucleatum or media (negative control). Mean values of duplicate 
analyses are shown. 
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Figure 6.7 CCL-2 & CCL-20 gene expression changes determined by sq-RT-PCR in H400 cells 
pre-incubated with α-lipoate (24h) or vehicle control, stimulated with P. gingivalis, F. nucleatum or 
media (negative control). Mean values of duplicate analyses are shown. 
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Figure 6.8:  NF-κB1 gene expression changes determined by sq-RT-PCR in 
H400 cells pre-incubated with 0.5mM α-lipoate (24h) or vehicle control, 
stimulated with P. gingivalis, F. nucleatum or media (negative control). Mean 
values of duplicate analyses are shown. 
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Figure 6.9 Cytokine levels in H400 cells pre-incubated with 0.5mM α-lipoate or vehicle 
control (24h) and stimulated with P. gingivalis, F. nucleatum or media (negative control). 
Samples run in duplicate with each value plotted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 Diagrammatic representation of the epithelial model system 
identifying the stages investigated in cell activation. 1: Activation of NF-κB; 2: 
Gene expression changes; 3: Pro-inflammatory cytokine production. Reduced 
activation of NF-κB by α-lipoate is also included (4). 
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Figure 7.2: Diagram illustrating ontological groups of genes up-regulated by A: F.nucleatum 
(247 genes), B: P. gingivalis (170) & C: genes common to F. nucleatum & P. gingivalis (47 
genes). Microarray analysis using a 2 fold change gene expression cut off. 
